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In humans, the epidermis is the main site for the synthesis of Vitamin D3 
(cholecalciferol) from 7-dehydrocholesterol. Cholecalciferol undergoes further 
hydroxylation in the liver and kidney to produce the active form of the circulating 
hormone 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3). In target cells, 1,25(OH)2D3 
interacts with the specific intracellular vitamin D receptor (VDR), a member of 
the nuclear receptor superfamily. However, epidermal keratinocytes, in addition 
to being target cells, have enzymes required for autocrine production of 
1,25(OH)2D3. They can convert cholecalciferol to 1,25(OH)2D3 via 25-
hydroxylase (CYP2R1) and 1α-hydroxylase (CYP27B1). Another enzyme, 24-
hydroxylase (CYP24A1), regulates local levels by inactivating 1,25(OH)2D3. 
While recent studies have shown that absence of VDR or 1,25(OH)2D3 impairs 
formation of granulation tissue during wound healing in mice, little is known 
about the autocrine and paracrine regulation of biologically active vitamin D3 by 
human dermal fibroblasts during cutaneous wound healing.  
Primary cultures of human keratinocytes and fibroblasts expressed VDR 
and all the cytochrome enzymes necessary for autocrine production of vitamin 
D. The relative expression of VDR mRNA was higher in dermal fibroblasts than 
donor-matched keratinocytes. In contrast, epidermal keratinocytes had a higher 
mRNA expression of vitamin D3 metabolising enzymes. A scratch wound assay 
confirmed that 1,25(OH)2D3 stimulated keratinocyte migration, but paradoxically 
inhibited fibroblast migration as early as 4h, yet neither cholecalciferol nor 25-
hydroxyvitamin D3 had any effect. VDR knockdown using small interfering RNA 
(siRNA) abolished the inhibitory effect of 1,25(OH)2D3 on fibroblast migration, 
demonstrating the requirement for the VDR in this response.  
Immunofluorescent staining revealed that 1,25(OH)2D3 increased nuclear 
VDR protein expression, without a corresponding increase in VDR mRNA 
transcription only in mechanically wounded dermal fibroblasts, indicating 
activation of the receptors. Incubation with either 1,25(OH)2D3, cholecalciferol or 
25(OH)D3 up-regulated CYP24A1 transcription. This response was most 
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pronounced with 1,25(OH)2D3, suggesting a tightly regulated feedback control 
on 1,25(OH)2D3 bioavailability within the dermis. In addition, cholecalciferol also 
increased CYP2R1 and CYP27B1 mRNA expression in scratched dermal 
fibroblasts, providing evidence for autocrine regulation of 1,25(OH)2D3 by 
dermal fibroblasts.  
Expression of α-SMA protein was up-regulated in cultured dermal 
fibroblasts following scratching, which was down-regulated in the presence of 
1,25(OH)2D3. These observations suggest that 1,25(OH)2D3 may restrict 
differentiation of wounded dermal fibroblasts into pro-fibrotic myofibroblasts. 
1,25(OH)2D3 also down-regulated MMP-2 secretion and collagen type I to III 
ratio in scratched dermal fibroblasts. Using a human ex vivo wound healing 
model, it was demonstrated that 1,25(OH)2D3, but not cholecalciferol, stimulated 
the rate of wound closure.  
In summary, this study has confirmed that human dermal fibroblasts 
express the transcriptional machinery for autocrine production of 1,25(OH)2D3, 
and a higher VDR expression suggests they are more responsive than 
keratinocytes. Changes in CYP and VDR expression in the presence of 
cholecalciferol, 25-hydroxyvitamin D3 or 1,25(OH)2D3 indicate fine-tuning of the 
bioavailability of vitamin D in the dermis after wounding. Down-regulation of α-
SMA, MMP-2 secretion and the collagen type I to III ratio by 1,25(OH)2D3 
highlight an important role for 1,25(OH)2D3 in modulating wound healing and the 
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1.1 Structure and function of the skin 
The skin is the largest organ of the body, contributing to 6% of total body mass 
and covering a surface area in excess of 2 m2 in the adult human (Guyton and 
Hall 1996; Tobin 2006). It is comprised of three main layers: the epidermis, the 
dermis and the hypodermis, with each layer exhibiting unique structural and 
physiological functions (D’Orazio et al. 2013; Park 2015). The epidermis and 
dermis are separated by a dermal-epidermal junction (DEJ). A variety of skin 
appendages are present in the skin, each serving their own unique functions 
(Figure 1-1). The skin plays multiple roles in the immune response, provides a 
mechanical barrier, thermoregulation and sensory functions (Park 2015). 
Another important function of the skin is in vitamin D3 synthesis and 
homeostasis (Mostafa and Hegazy 2015). Its precursor, 7-dehydrocholesterol, 
which is found mainly in the plasma membrane of epidermal keratinocytes, is 
converted to vitamin D3 following UV radiation, before being released into 






Figure 1-1: Three main layers of the skin – the epidermis, dermis and hypodermis. Sweat 
glands and hair follicles are examples of skin appendages that serve their unique functions in 
the skin. Adapted from (MacNeil 2007) 
1.1.1 The epidermis 
The epidermis is an avascular, stratified squamous epithelium that is continually 
keratinizing, and is normally between 75 and 150 µm thick in human skin (Tobin 
2006). The main cell population in the epidermis is the keratinocyte, constituting 
more than 90% of all epidermal cells (Lulevich et al. 2010). The epidermis is 
derived from embryonic ectoderm (Trounson 2006). The keratinocytes are 
arranged in five layers, namely the stratum basale, stratum spinosum, stratum 
granulosum, stratum lucidum and stratum corneum (Natarajan et al. 2014) 
(Figure 1-2). In the basal layer, keratinocytes are highly proliferative (Fuchs 
2008). As they migrate upwards, keratinocytes commit to three distinct 
differentiation stages (Goldsmith 1991)  (Figure 1-2). Eventually, the cornified 
layer is shed from the skin surface. In human skin, this dynamic flux takes 
around 28 days to complete, ensuring a continuous supply of inner cells to 
replace those that are lost at the skin surface (Goldsmith 1991; Braun-Falco 
1996; Fuchs 2008). Each stage of differentiation is associated with key 
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molecular markers such as keratins, loricrin, profilaggrin and involucrin (Braun-
Falco 1996) (Figure 1-2).   
The keratin intermediate filament (KIF) network contributes to the mechano-
resistive strength of the keratinocytes (Lulevich et al. 2010). Keratins represent 
a family of more than 20 polypeptides of 40 to 70 kilodaltons (kDa) in molecular 
weight (Sun et al. 1983; Bragulla and Homberger 2009). The different layers of 
the epidermis contain a varying amount of keratin, ranging from 30% to 80%, 
depending on the stage of differentiation (Tobin 2006). Basal cells, which are 
associated with proliferation, normally express lower molecular weight keratins. 
On the other hand, the more differentiated keratinocytes express higher 
molecular weight keratins (Sun et al. 1983). Keratin 5 (K5) and Keratin 14 (K14) 
are commonly used as markers of epidermal cell proliferation, while Keratin 1 
(K1) and Keratin 10 (K10) are associated with keratinocyte maturation (Sun et 
al. 1983; Tobin 2006). In addition to roles in maintaining cytoarchitecture, 
keratins also regulate cell growth, migration, proliferation, apoptosis and 
organelle transport (Kellner and Coulombe 2009). Keratin 6 (K6) has been 
implicated in the wound repair process using the murine model (Wong and 
Coulombe 2003; Rotty and Coulombe 2012). K6-null epidermis showed 
compromised keratinocyte migration following wounding (Wong and Coulombe 
2003).  
Other cells found within the epidermis include the melanocytes, Langerhans 
cells, and Merkel cells (Kidd et al. 1971; Boulais and Misery 2008). Melanocytes 
manufacture, package and transfer melanin to adjacent keratinocytes (Braun-
Falco 1996). The amount of melanin present determines the skin colour (Braun-
Falco 1996). Melanin has a protective role against UV damage in human skin 
(Brenner and Hearing 2008). Langerhans cells reside in the basal and 
suprabasal layers of the epidermis (Chomiczewska et al. 2009). They are 
specialised immune cells that are involved in antimicrobial immunity, skin 
immunosurveillance and the induction phase of the contact hypersensitivity 
reaction (Chomiczewska et al. 2009). Merkel cells have dense-core granules 
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which contain heterogeneously distributed neuropeptides (Moll et al. 2005). 
Their main function is to act as slowly adapting mechanoreceptors (Moll et al. 
2005). This explains their prevalence in touch-sensitive areas (Boulais and 
Misery 2008).  
 
Figure 1-2: Representative image of the epidermis of human skin. The cells at the basal 
layer are highly proliferative and migrate outwards in their differentiation process. The stratum 
corneum, which is the outermost layer, is mainly constituted of dead keratinocytes. A basal 
layer of keratinocytes are attached to the basement membrane, which separates them from the 
mesenchymal connective tissue. Adapted from (Alonso and Fuchs 2003) 
1.1.2 The dermis 
The main functions of the dermis are to provide mechanical support and 
nutritional needs to the epidermis (Goldsmith 1991). The dermal layer can be 
subdivided into an upper ‘papillary’ and a lower ‘reticular’ portion (Tobin 2006). 
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The papillary dermis is more cellular, and relatively thin with less collagen and 
elastic fibrils than its reticular counterpart. In contrast, the reticular dermis is 
thicker, with broad bands of dense collagen fibres and long thick interwoven 
elastin fibres, albeit relatively acellular (Sorrell and Caplan 2004). 
The fibroblast is the major cellular constituent of the dermal layer 
(Thangapazham et al. 2014). Fibroblasts are responsible for collagen and 
glycosaminoglycan synthesis, which contributes to the extracellular matrix 
(ECM) (Thangapazham et al. 2014). They are also involved in removing the 
ground substance of the ECM, via the action of proteolytic enzymes (Werb and 
Aggeler 1978). Dermal fibroblasts have the capacity to differentiate into 
myofibroblasts that generate wound contracture to promote healing 
(Thangapazham et al. 2014). In addition, fibroblasts play a vital role in paracrine 
and autocrine interactions in skin (Gilchrest et al. 1983; Boxman et al. 1993; 
Smola et al. 1993; Moulin 1995; Schroder 1995; Smith et al. 1997; Werner and 
Smola 2001; Sorrell and Caplan 2004). Fibroblasts secrete keratinocyte growth 
factor (KGF)-1, granulocyte-macrophage colony-stimulating factor (GM-CSF), 
interleukin 6 (IL-6) and epidermal growth factor (EGF) that regulate keratinocyte 
proliferation in wound repair (Waelti et al. 1992; Boxman et al. 1993; Smola et 
al. 1993; Rubin et al. 1995; Werner 1998; Breuhahn et al. 2000; Mann et al. 
2001; Werner and Smola 2001). 
Lymphocytes, macrophages and mast cells are also present in the dermis. 
These cells are vital for the inflammatory response and release a variety of 
growth factors and pro-inflammatory cytokines during the development of 
granulation tissue (Barrientos et al. 2008). In particular, mast cells that are often 
found in close proximity to dermal fibroblasts, have been found to modulate 
fibroblast proliferation in primary human cells in culture (Abe et al. 2000). In 
addition, the dermis houses skin appendages and the vascular, neural and 
lymphatic systems (Kanitakis 2002; Tobin 2006) (Figure 1-1). 
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1.1.2.1 Myofibroblast differentiation, matrix metalloproteinases 
(MMP) activities and collagen content in the dermis 
The differentiation of the dermal fibroblast into a myofibroblast is an 
important process during the wound healing response. Dysregulation of 
myofibroblast differentiation often leads to abnormal wound healing, 
which could result in chronic wounds or hypertrophic scarring (Goldberg 
et al. 2007). Alpha-smooth muscle actin (α-SMA) expression within the 
cytoplasmic stress fibres is the most significant marker for the 
myofibroblast (Goldberg et al. 2007). Morphologically, myofibroblasts are 
distinguished from “normal” quiescent dermal fibroblasts by the 
prominence of microfilament bundles in their cytoplasm (Darby et al. 
2014). When myofibroblasts were first identified, it was suggested that 
their main role is in contracting the wounds (Gabbiani et al. 1971). Since 
then, the presence of myofibroblasts has been linked to a pathological 
wound healing response, in which their sustained presence is often a 
marker of fibrosis and scarring (Darby et al. 2014). Myofibroblasts form 
fibronexus junctions with other cells and also form junctional complexes 
with the ECM, as a means of transducing mechanical force in the tissue 
and allowing them to remodel the ECM (Dugina et al. 2001; Goffin et al. 
2006; Darby et al. 2014). Apart from their contractile function, 
myofibroblasts also synthesise and deposit the ECM components in the 
granulation tissue (see Figure 1-3) (Darby et al. 2014). During scar 
formation, matrix metalloproteinases (MMPs) are involved in progressive 
remodelling of these granulation tissues (Darby et al. 2014). Myofibroblast 
cell numbers are reduced via apoptosis during the remodelling phase of 




Figure 1-3: The evolution of the myofibroblast phenotype. Fibroblasts are activated and 
acquire α-SMA expression and differentiate into myofibroblasts. The contractile properties of 
myofibroblasts are attributed to the α-SMA in microfilament bundles or stress fibres. 
Myofibroblasts secrete and deposit ECM in granulation tissues. Cell number of myofibroblasts is 
eventually reduced via apoptosis. Taken from (Darby et al. 2014) 
Dermal fibroblasts and myofibroblasts play an important role in the deposition of 
ECM products. They are also responsible for secreting ECM-degrading matrix 
metalloproteinases (Lindner et al. 2012). Matrix metalloproteinases (MMPs) are 
a family of zinc-dependent neutral endopeptidases, structurally related, which 
exert catalytic activity against ECM components (Nagase and Woessner 1999; 
Hieta et al. 2003). MMPs can be broadly categorised into soluble MMPs and 
membrane bound MMPs. Soluble MMPs include gelatinases (e.g. MMP-2, 
MMP-9), collagenases (e.g. MMP-1, MMP-8), matrilysin (e.g. MMP-7) and 
stromelysins (e.g. MMP-3, MMP-10) (Lindner et al. 2012). Membrane-type 
MMPs include MMP-14, MMP-16 and MMP-24 (Lindner et al. 2012).  The 
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structural integrity of the skin, in particular, constituents of the basement 
membrane, require fine-tuning of the deposition and degradation of ECM 
components. Hence, MMPs play a central role in tissue remodelling and wound 
healing. 
During wound healing, there is often overlap of MMP substrate specificity and 
inter-MMP compensation (Caley et al. 2015). Some of the MMPs that have 
been linked to well-characterised phenotypic changes in keratinocytes and 
fibroblasts during wound healing are summarised in table 1-1. MMPs that have 
organ specific function and are not related to wound healing are excluded from 
the table below. An example of this is MMP-20 which is mostly expressed in 
developing teeth and is important in enamel formation (Vaananen et al. 2004; 
Lu et al. 2008). In addition, MMPs in which a functional role in wound healing 








Role in wound healing Determined in 
cell culture 
Reference 
In vitro  
 
ex vivo 
MMP-1 Collagenase Upregulates human keratinocyte migration  √ √ (Pilcher et al. 1997) 
MMP-2 Gelatinase Accelerates human airway epithelial cell migration 
Induction of breast epithelial cell (HUMEC and MCF10) 
migration 
√  (Giannelli et al. 
1997; Lechapt-
Zalcman et al. 2006) 
MMP-3 Stromelysin Promotes re-epithelialization in mice  
Affecting wound contraction via re-organisation of multicellular 
actin network in mice 
√ √ (Bullard et al. 1999) 
MMP-7 Matrilysin Required for re-epithelialization of mice lung mucosal wounds 
via shedding of syndecan-1 
Promotes re-epithelialization in human lung mucosal wound 
via shedding of E-cadherin ectodomain 
√ √ (McGuire et al. 
2003; Chen et al. 
2009) 
MMP-8 Collagenase Neutrophil-derived MMP-8 is the predominant collagenase in 
normal human healing wounds, catalysing breakdown of 
collagen I, II and III. 
 √ (Nwomeh et al. 




MMP-9 Gelatinase Promotes human alveolar cell migration and re-
epithelialization 
Promotes human (HaCaT) and mice keratinocyte migration 
during wound healing. Found at the leading edge of the wound 
√ √ (Betsuyaku et al. 
2000; Mohan et al. 
2002; Seomun et al. 
2008; Kyriakides et 
al. 2009) 
MMP-10 Stromelysin Expressed at epithelial tongue of murine skin wounds. 
Modestly promotes re-epithelialization with over-expression.  
 √ (Krampert et al. 
2004) 
MMP-13 Collagenase Promotes re-epithelialization by upregulating murine 
epidermal keratinocyte migration, and indirectly by affecting 
wound contraction 
 √ (Hattori et al. 2009) 
MMP-14 Membrane-
type  
Promotes distal airway re-epithelialization, and keratinocyte 
migration and proliferation in mice.  
Promotes murine skin re-epithelialization 
Important for human keratinocyte (HaCaT, SCC-25) cell 
migration and proliferation. 
√ √ (Nagavarapu et al. 
2002; Mirastschijski 
et al. 2004; Atkinson 
et al. 2007; Seomun 
et al. 2008) 
Table 1-1: Matrix metalloproteinases in wound healing. The MMPs are broadly divided into membrane-bound MMPs and non-membrane bound 





Soluble MMP-2 and MMP-9 both express gelatinolytic activity and are important 
participants in the wound healing response (Kyriakides et al. 2009). They are 
involved in the degradation of ECM components such as the basement membrane 
collagens, thus also facilitate inflammatory cell migration into the injured tissue 
(Lindner et al. 2012). MMP-2, in particular, is highly expressed by human dermal 
fibroblasts compared to tissues from other sites of origin (Lindner et al. 2012). MMP-
2, also known as getatinase A, exhibits catalytic activity on gelatine, collagen I, IV, V, 
VII, and X, laminin, aggrecan, fibronectin, vitronectin and tenascin (Chakrabarti and 
Patel 2005; Caley et al. 2015). On the other hand, MMP-9 (i.e. gelatinase B) exerts 
effects on gelatine, collagen I, III, IV, V and VII, aggrecan, elastin and fibrillin (Caley 
et al. 2015). Their substrate specificities and relatively high expression in human 
dermal fibroblasts (Lindner et al. 2012), together with their established functional 
roles in wound healing (see Table 1-1) suggest that they have important roles during 
the wound healing response. In addition, MMP-2 and MMP-9 levels have been 
shown to be elevated in chronic wounds, which could lead to chronic tissue high 
turnover rate and failed wound closure (Wysocki et al. 1993).  Pro-MMP-2 is readily 
activated by the membrane-bound MMPs such as MMP-14 and MMP-16 (Murphy 
and Nagase 2008). On the other hand, MMP-1, MMP-3 and MMP-7 contribute to the 
activation of pro-MMP-9 into a biologically active form (Murphy and Nagase 2008). 
The levels of activating enzymes and proenzymes for MMP-2 and MMP-9 also are 
increased in chronic wounds (Wysocki et al. 1993).  
Extracellular matrix organisation and remodelling are of paramount importance 
during the wound healing and scarring process (Xue and Jackson 2015). Collagen, 
being the most abundant insoluble fibrous protein in the ECM, plays a pivotal role in 
this process (Lodish H 2000; Xue and Jackson 2015). There are currently more than 
16 known human collagen types (Lodish H 2000). Type I, and III collagens contribute 
to between 80-95 percent of the collagen in the dermis (Meigel et al. 1977; Lovell et 
al. 1987; Lodish H 2000; Chung et al. 2001; Cheng et al. 2011). They exert the most 
influence on healing tissue integrity, especially during early stages of wound healing, 




The content and ratio of type I and III collagen in the dermis differs with age and 
cutaneous injury (Cheng et al. 2011). In wound healing, both the level of expression 
of type I and III collagen, as well as the ratio of type I to III collagen are important 
determinants of the eventual outcome of the healing response and scarring (Cheng 
et al. 2011). Under basal conditions, type I to III collagen content and its ratio in 
normal human skin varies across the age spectrum (Cheng et al. 2011). With 
increasing age, relative levels of type III collagen are reduced to a greater degree 
than type I collagen, which results in an increase in the type I to III collagen ratio 
(Cheng et al. 2011). The ratio is also significantly higher in poor quality wound 
healing resulting in hypertrophic scarring. In early granulation tissue, type III collagen 
is normally secreted to a greater extent compared to type I collagen secretion 
(Haukipuro et al. 1991). As the wound contracts and remodelling takes over, 
immature type III collagen is gradually modified into type I collagen (Slemp and 
Kirschner 2006). Excessive secretion of type I collagen, with increased type I to III 
collagen ratio, often result in abnormal hypertrophic scarring (Cheng et al. 2011; Shi 
et al. 2013). The biologically active form of vitamin D3, 1,25(OH)2D3 has been shown 
to inhibit total collagen synthesis and increase resorption in articular cartilage and 
osteoblasts (Dickson and Maher 1985; Franceschi et al. 1988; Franceschi and Iyer 
1992; Li et al. 2016). On the other hand, in cultured human neonatal foreskin 
fibroblasts, 1,25(OH)2D3 has been shown to increase type I and III collagen 
production after a 4-day exposure to 100nM of 1,25(OH)2D3  (Dobak et al. 1994). 
 
1.1.3 The dermal-epidermal junction and its morphogenesis 
The dermal epidermal junction (DEJ) or the basement membrane, establishes the 
boundary between the epidermis and dermis (Marionnet et al. 2006). It is a thin 
acellular layer composed of type IV collagen, laminin and fibronectin (Kanitakis 2002; 
Guillaume 2012). The epidermis is avascular, therefore it relies on capillaries in the 
adjacent papillary dermis to provide it with metabolic support (Yannas 2000). The 
sub-papillary plexus is an upward projection of capillary loops of the dermis that 
extends to the dermal-epidermal junction (Yannas 2000) (Figure 1-3). The DEJ is 
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characterised by rete ridges, i.e. downward folding of the epidermis that interdigitate 
with the papillary dermis, to maximise the contact area between the two layers 
(Yannas 2000).   
De novo dermal epidermal junction morphogenesis depends on sequential gene 
expression, protein deposition, and localization of basement membrane zone 
components (Marionnet et al. 2006). During the early phase of the DEJ formation, 
assembly of laminins through binding to cell membrane receptors, as well as scaffold 
formation by type IV collagen occur (Fleischmajer et al. 1997; Fleischmajer et al. 
1998). There is tight interplay between fibroblasts and keratinocytes for synthesis 
and localization of DEJ components (Marionnet et al. 2006). Accurate DEJ formation 
is important due to its fundamental role during wound re-epithelialisation. Its 
constitutive glycoproteins (e.g. laminins) serve as a substrate for adhesion and 




Figure 1-4: Cutaneous and subpapillary plexus supplying the dermis and epidermis. Capillary 
loops project upwards and extends to the dermal-epidermal junction. Adapted from (Burkitt H. G. 
1993). CP denotes cutaneous plexus and SP denotes sub-papillary plexus. 
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1.1.4 The hypodermis, adipocytes and its relationship with 
myofibroblasts 
The hypodermis underlies the reticular dermis and connects the dermis to the 
underlying muscles and organs. It contains adipose tissue, blood vessels and 
nerves. Adipose tissue is important for fat storage and plays important roles in 
coagulation, glucose and lipid metabolism, angiogenesis, body weight homeostasis, 
fibrinolysis and vascular tone control (Coelho et al. 2013). Until recently, adipocytes 
found within the adipose tissues were generally regarded as a terminally 
differentiated cell type and has only been linked to its metabolic functions. However, 
there is an increasing recognition of the cellular plasticity of adipocytes and their 
potential roles in the wound healing and scarring response (Bogatkevich 2015; 
Plikus et al. 2017). Marangoni et al showed that adipocytes from 
hypodermal/subcutaneous adipose tissue have the ability to differentiate into 
myofibroblasts at the early stage of injury (Marangoni et al. 2015). The resultant 
increase in the myofibroblast population could potentially lead to upregulation of 
collagenous matrix synthesis and worsening fibrosis (Bogatkevich 2015; Marangoni 
et al. 2015). Therapeutic intervention targeting this pathway could help in reducing 
fibrosis and scarring. More recently, reprogramming of myofibroblasts to form 
adipocytes was observed when treated with bone morphogenetic protein (BMP) or 
placed with human hair follicles in vitro (Plikus et al. 2017). As myofibroblasts are 
responsible for secretion of profibrotic cytokines, collagen deposition and wound 
contraction, depletion of myofibroblasts by converting them to adipocytes has been 




Figure 1-5: Schematic illustration showing white adipose tissue found in the dermis layer 
and subcutaneous/hypodermis layer. Adapted from (Driskell et al. 2014). 
1.1.5 Skin appendages 
A variety of accessory appendages are found in the skin, each serving their unique 
functions. These include the secretory and excretory glands, the hair follicles, and 
nails. Each of these skin appendages serves various physiological functions. Eccrine 
glands are tubular sweat glands that are not connected to hair follicles and are found 
only in mammals, whilst apocrine glands generally develop around hair follicles 
(Kamberov et al. 2015). Eccrine glands are important for thermoregulation and are 
distributed throughout human skin (Kamberov et al. 2015). In the context of wound 
healing, eccrine sweat glands upregulate keratinocyte migration at wound edges that 
contribute to reepithelialisation (Rittié et al. 2013). They also serve as a highly 
proliferative cell reservoir that could quickly repopulate any wounded area (Rittié et 
al. 2013). Apocrine glands secrete sweat into the pilary canal of the hair follicle and 
are also important in thermoregulation (Porter 2001).  
1.1.5.1 The hair follicles (HF) and hair cycle 
The hair follicle is a tubular epithelial structure that can be divided into three 
segments. The upper segment comprises of the infundibulum, the middle segment 
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the isthmus, and the lower segment contains the suprabulb and bulb. (Alaiti 2015). 
The hair follicle is a complex mini-organ that contains the hair shaft, the inner root 
sheath (IRS), the outer root sheath (ORS), the connective tissue dermal sheath, and 
the dermal papilla (Figure 1-6) (Schneider et al. 2009). Together with the hair, the 
arrector pili muscle, and sebaceous gland, it makes up the pilosebaceous unit 
(Sundberg and Nanney 2012).   
The hair follicle is made up of a variety of embryologically distinct cell types, which 
include the keratinocytes, dermal papilla (DP) cells and melanocytes (Randall et al. 
2003). Ectodermal-mesodermal interactions that are tightly regulated contribute to 
hair follicle development (Schneider et al. 2009). The epithelial components of the 
hair follicle, the sebaceous glands and the apocrine glands are derived from 
ectodermal stem cells, whereas the dermal papilla and dermal sheath are derived 
from the mesoderm (Schneider et al. 2009). The follicular dermal papilla is an area of 
specialised connective tissue that not only regulates hair follicle development and 
growth, but also acts as a reservoir of multi-potent mesenchymal stem cells (Driskell 
et al. 2011). Dermal sheath (DS) cells share similar characteristics with the dermal 
papilla cells (Yang and Cotsarelis 2010). The DS serves as a cellular reservoir of DP 
cells during hair follicle cycling (Yang and Cotsarelis 2010). If the DP is loss, a DS 
cell has the ability to regenerate a new DP as it contains specialised mesenchymal 
stem cells (Horne and Jahoda 1992; Reynolds et al. 1999; McElwee et al. 2003; 
Yang and Cotsarelis 2010).  
The hair follicles are the only permanently regenerating organ in humans (Tobin 
2006). Human hair follicles undergo a lifelong repetitive cycling process, alternating 
between phases of active growth (anagen), regression (catagen), and relative 
‘quiescence’ (telogen) (Halloy et al. 2002). Human hair follicle cycling is distinctive 
from other mammals’ in that it cycles asynchronously in different parts of the body 
(Halloy et al. 2000). Initiation of a new hair cycle is induced by subpopulations of 
epithelial stem cells found in the hair bulge region and the outer root sheath 
immediately below the bulge of the anagen hair follicle (Chunmeng and Tianmin 
2004; Watt and Jensen 2009; Garza et al. 2011). These highly proliferative 
populations of stem cells also contribute to accelerated interfollicular wound healing 
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by acting as reservoir of epidermal cells for reepithelialisation (Ito et al. 2005; 
Snippert et al. 2010; Heidari et al. 2016).  
 
Figure 1-6: Diagrammatic representation of human hair anatomy. The hair follicle is made of an 
inner root sheath, outer root sheath, dermal sheath, dermal papilla, and bulge area. Hair follicle 
with the arrector pili muscle and sebaceous gland make up the pilosebaceous unit. Reproduced from 
(Alaiti 2015)  
1.2 Cutaneous wound healing 
Adult wound healing serves to restore the continuity of skin barrier following damage 
to the integrity of the skin. It is a homeostatic response that requires dynamic co-
ordination of different cellular and molecular events (Martin 1997). The whole 
process is complicated, involving blood cells, proteins, proteases, various cytokines, 
chemokines and growth factors (Sinno and Prakash 2013). Good quality wound 
healing requires the collaborative efforts of different cell types that are involved in 
migration, proliferation, differentiation, and apoptosis. Early angiogenesis at the 
wound site provides the necessary nutrients and oxygen for optimal cellular functions 
(Li et al. 2003). Inflammatory cells are transported to the site of injury to clear away 
cellular debris and micro-organisms (Li et al. 2003). Following haemostasis, wound 
healing is classically divided into three phases (Gurtner et al. 2008) (Figure 1-7).  
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1.2.1 Haemostasis  
Haemostasis is achieved via the actions of platelets and coagulation factors. 
Endothelial disruption following injury leads to extravasation of blood components 
into the extravascular space. Reactive vascular spasm serves to restrict the amount 
of blood loss. Platelet activation and aggregation occurs subsequently to plug the 
injured vessels and coagulation factors are recruited. Activation of the clotting 
cascade leads to thrombin production, which catalyses the formation of insoluble 
fibrin fibres (Golebiewska and Poole 2015). Accumulation of fibrin forms a network of 
provisional matrix that traps the platelets and binds to growth factors (Shaw and 
Martin 2009). Activated platelets also secrete fibronectin, cytokines such as TGF-β, 
and platelet derived growth factor (PDGF), that are all involved in fibroblast 
proliferation and differentiation, inflammatory cell chemotaxis and angiogenesis 
(Lynch et al. 1987).  
1.2.2 The inflammatory phase  
Transforming growth factor (TGF)-β1 and β2 secreted by activated platelets, 
macrophages and keratinocytes are essential chemotactic agents required to initiate 
the proliferation phase (Sinno and Prakash 2013). Neutrophils are recruited to the 
wound site via chemotactic migration within 24 hours of wounding. Phagocytosis of 
bacteria and degradation of necrotic tissues occurs and mediators such as TNF-α, 
IL-1β and IL-6 are released by neutrophils (Reinke and Sorg 2012), which amplifies 
the inflammatory response. Neutrophils also release reactive oxygen species (ROS), 
proteases and matrix metalloproteinases (MMPs) to remove damaged tissues. 
Monocytes start appearing at the wound site around day 3 after injury and perform 
further phagocytosis of pathogens and clearance of cell debris (Reinke and Sorg 
2012). They remain within the wound site for days to weeks. Other than their 
phagocytic actions, monocytes also provide a reservoir of growth factors. 
Lymphocytes arrive in the wound last. They clear away redundant neutrophils and 
secrete mitogens such as TNF-α (Battegay et al. 1995). This leads to fibronectin 
production and deposition by fibroblasts, initiating the proliferative phase 
(Stadelmann et al. 1998).  
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1.2.3 The proliferative phase  
Within 24 to 72 hours after injury, the re-epithelialization process starts at the wound 
edges by epidermal keratinocytes (Reinke and Sorg 2012). Abolition of contact 
inhibition at desmosomes and hemidesmosomes, coupled with release of different 
cytokines and growth factors initiates the process (Reinke and Sorg 2012).  
Fibroblasts and vascular endothelial cells proliferate into the wound to form 
granulation tissue (Krafts 2010). The newly formed blood vessels are leaky initially, 
giving rise to the oedematous appearance of the wound. Fibroblasts produce 
glycosaminoglycans (GAGs) and collagens that are essential to wound repair 
(Stadelmann et al. 1998). Synthesis and deposition of more collagen occurs to 
increase the mechanical strength of the wound. Initially, type III collagen is the 
principal collagen synthesised in the wound (Merkel et al. 1988). This is gradually 
replaced by type I collagen upon entering into the maturation phase of wound 
healing (Volk et al. 2011). Neovascularisation approaches its maximal point around 
day 5. Myofibroblast differentiation and consecutive apoptosis reduces the total 
number of maturing fibroblasts at the wound site (Reinke and Sorg 2012). This stage 
can last up to 21 days after injury. 
Reepithelialisation  
Under normal conditions, the basal keratinocytes are anchored to the basal lamina of 
the basement membrane by hemidesmosomes (Martin 1997). Upon wounding, these 
hemidesmosome attachments are dissolved by proteinases and new integrins that 
bind fibronectin and vitronectin are upregulated for migration to occur (Martin 1997). 
Forward locomotion of basal keratinocytes is directed by intracellular actinomyosin 
filaments that insert into new adhesion complexes (Mitchison and Cramer 1996). 
Protrusive structures of the wound-activated keratinocytes contain dense arrays of 
actin filaments. Filopodia are the simplest protrusive structures that are proposed to 
take part in keratinocyte migration (Mitchison and Cramer 1996). On the other hand, 
lamellipodia dominate the leading edges of motile fibroblasts during wound repair 
(Mitchison and Cramer 1996). Other than the classical actin-based keratinocyte 
motility, it has been suggested that suprabasal keratinocytes at the leading edge of 
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the wound may be able to “leapfrog” over basal cells to achieve a similar effect 
(Garlick and Taichman 1994). This epithelial-mesenchymal phenotype transition of 
keratinocytes enhances their migratory capacity and invasiveness (Kalluri and 
Neilson 2003). In hairy skin, stem cells from hair follicles and interfollicular epidermis 
(IFE) play a vital role in providing progenitor cells for the re-epithelisation process (Ito 
et al. 2005; Snippert et al. 2010). Initially, early-arriving IFE stem cells repopulate the 
wound basal layer (Vagnozzi et al. 2015). This is subsequently replaced by late-
arriving hair follicle-derived cells (Vagnozzi et al. 2015). Hair follicle bulge derived 
cells are normally constrained at the periphery of the regenerating epithelium 
(Vagnozzi et al. 2015). According to a murine study, hair follicle stem cells contribute 
to 25-50% of cells in the regenerated epidermis (Levy et al. 2007). New stratified 
epidermis is re-established from the margins of the wound inward (Gipson et al. 
1988). Epidermal migration ceases once the wound is covered by a monolayer of 
keratinocytes (Martin 1997).  
1.2.4 The remodelling phase  
The remodelling phase starts around three weeks after injury, when homeostasis 
between collagen synthesis and degradation is achieved (Stadelmann et al. 1998). 
The remodelling process can take up to two years. Degradation of collagen and 
other extracellular proteins occurs with the aid of matrix metalloproteinases (MMPs). 
Fibrillar collagens (mostly type I collagen) replace type III collagen to form the major 
portion of connective tissue in repair sites to optimise the recovery of tensile strength 
(Reinke and Sorg 2012). Reorganization of collagen fibres, determined by local 
mechanical factors, leads to a more organized lattice structure (Stadelmann et al. 
1998).  The number of blood vessels in the wound gradually decreases and cellular 





Figure 1-7: The three classical stages of wound repair (A) Inflammation phase (B) Proliferation 
phase (C) Remodelling phase. There is overlap between the three stages of wound healing. 
Separate parts of a wound may be at different stages of healing at any one time. Adapted from 
(Gurtner et al. 2008) 
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1.3 Vitamin D  
Vitamin D, also known as calciferol, is a fat-soluble secosteroid prohormone (Ross 
AC 2011; Jones et al. 2014; Mpandzou et al. 2016). It was first identified in 1919, 
when Huldschinsky et al noticed that sun exposure was a remedy for rickets 
(Huldschinsky 1919). Sir Edward Mellanby falsely credited the rickets preventative 
fat-soluble substance as Vitamin A (Johri 2006). It was later found that it was indeed 
a new substance, isolated from cod liver oil, and was named by McCollum as 
Vitamin D (McCollum et al. 1922). Its modes of haemostasis and actions are 
characteristic of a hormone (Norman 2008; DeLuca 2014).  
The two main forms of naturally existing vitamin D are: vitamin D3  (cholecalciferol) 
and vitamin D2 (ergocalciferol) (Nebbioso et al. 2015). Cholecalciferol is synthesised 
in the epidermis following sunlight or ultraviolet (UV) light exposure (Whiting and 
Calvo 2013; Bendik et al. 2014; Herrmann et al. 2016). It can also be obtained from 
food such as salmon and mackerel (Lu et al. 2007). On the other hand, ergocalciferol 
is acquired by consumption of plants or plant materials irradiated with UV (Huang et 
al. 2015). Structural differences exist between ergocalciferol and cholecalciferol. In 
ergocalciferol, there is a double bond between carbons 22 and 23, and a methyl 
group on carbon 24 while these are absent in cholecalciferol (Figure 1-8). 
The major source of vitamin D for most humans is sunlight exposure (Holick 2008). 
Cholecalciferol is 2-3 times more effective than ergocalciferol in raising the serum 
level of 25-hydroxyvitamin D, a major circulating and storage form of vitamin D 
(Trang et al. 1998; Armas et al. 2004; Haussler et al. 2013; Tripkovic et al. 2014; 
Wilson et al. 2014; Oliveri et al. 2015). In view of this, discussion in subsequent 




Figure 1-8: Chemical structures of cholecalciferol and ergocalciferol and their precursors. 
Vitamin D contains three intact rings (A, C and D) with a break between carbon 9 and 10 in the B ring. 
Cholecalciferol (vitamin D3) and ergocalciferol (vitamin D2) differ in the structure of their side chain, 




1.4 Vitamin D metabolism 
Vitamin D metabolism involves a variety of precursors, enzymes and metabolites 
(Bikle 1982; Lindh et al. 2012) (Figure 1-9). UVB radiation in sunlight converts 7-
dehydrocholesterol, which is found mainly in the epidermis, to cholecalciferol 
(Anderson et al. 2003; Slominski et al. 2004; Christakos et al. 2010; Whiting and 
Calvo 2013). Bound to vitamin D-binding protein (DBP), present in the capillary bed 
of the dermis, cholecalciferol is transported to the liver where a hydroxyl group is 
added to the 25 carbon position forming 25-hydroxyvitamin D3 (25(OH)D3) (Anderson 
et al. 2003). 25(OH)D3 is the major circulating form of vitamin D3, bound to DBP and 
albumin in the bloodstream (Ying et al. 2015) (Ohyama and Shinki 2016). A further 
hydroxylation process takes place in the kidney with the addition of a second 
hydroxyl group at 1α carbon position, forming the physiologically active form, 1α,25-
dihydroxyvitamin D3 (1α,25(OH)2D3) (Anderson et al. 2003).  
Cytochrome P450 enzymes, 25-hydroxylase (CYP2R1) and 1α-hydroxylase 
(CYP27B1) are the main enzymes involved in each of the hydroxylation steps 
(Christakos et al. 2010). The hormonal signal of 1,25-dihydroxyvitamin D3 is 
terminated by induction of 24-hydroxylase (CYP24A1) activity (Lindh et al. 2012). 
CYP2R1 is located in the endoplasmic reticulum, whereas CYP27B1 and CYP24A1 
are both expressed in the mitochondria (Bikle et al. 2014). Oxidative cleavage of the 
side chain by 24-hydroxylase converts 1,25(OH)2D3 to an inactive metabolite, 
1,24,25-trihydroxyvitamin D3 (1,24,25(OH)3D3), also known as calcitroic acid 
(Christakos et al. 2010). Alternatively, 23-hydroxylation can occur culminating in a 
26,23-lactone by-product (Wei Zheng 2013). CYP24A1 also acts to reduce the pool 
of 25(OH)D3 available for 1α hydroxylation by converting it to 24,25(OH)2D3 





Figure 1-9: Abbreviated metabolic pathway for vitamin D3 in human skin. High energy UVB 
radiation breaks the B-ring of the parent steroid between carbon-9 and carbon-10 to form 
cholecalciferol. CYP2R1 catalyses the addition of a hydroxyl group at carbon 25 (25-hydroxylase) 
whilst CYP27B1 (1α-hydroxylase) catalyses the addition of a hydroxyl group at position 1α of the 
secosteroid backbone of 25(OH)D3. Adapted from (Müller and Volmer 2015) 
Several other cytochrome (CYP) enzymes such as CYP27A1 (mammals, murine 
model), CYP3A4 (human) and CYP2J3 (murine model) have been proposed to have 
a similar capacity to catalyse the first step of the 25-hydroxylation reaction (Rosen et 
al. 1998; Gupta et al. 2004; Prosser and Jones 2004; Aiba et al. 2006; Ahn et al. 
2010; Zhu et al. 2013). These provide the possibilities of compensatory pathways for 
synthesis of 25(OH)D3. However, studies have shown that the CYP2R1 enzyme is 
the key vitamin D 25-hydroxylase in humans, with evidence that a genetic defect of 
CYP2R1 results in an atypical form of vitamin D deficiency clinically (Cheng et al. 
2004; Zhu et al. 2013; Thacher et al. 2015). On the other hand, 24-hydroxylase 
activity has also been detected with CYP3A4 (transfected insect cells model) (Gupta 
et al. 2005). Using high-performance liquid chromatography and gas 
chromatography–mass spectrometry techniques, Wang et al showed that CYP3A4 is 
capable of carrying out CYP24A1-independent catabolism of 25(OH)D3 to form 
4beta, 25-dihydroxyvitamin D3, thereby reducing the systemic pool of 25(OH)2D3 in 
48 
 
humans (Wang et al. 2012; Wang et al. 2013; Wang et al. 2013). Human uridine 5’-
diphophoglucuronyltransferases 1A4 (UGT1A4) is an enzyme of the glucuronidation 
pathway that plays a role in systemic homeostasis of 1,25(OH)2D3. It transforms 
1,25(OH)2D3 into water-soluble metabolites for excretion via the enterohepatic 
pathway (Hashizume et al. 2008) (Figure 1-10). The roles of parathyroid hormone 
and fibroblast growth factor-23 in regulating 1α-hydroxylase expression, thereby 
affecting bioavailability of 1,25(OH)2D3 is beyond the scope of this project so have 
been intentionally omitted from discussion (Krajisnik et al. 2007; Lavi-Moshayoff et 
al. 2010; Quarles 2012).  
 
Figure 1-10: Classical vitamin D metabolism pathways. Sunlight exposure and diet are sources of 
vitamin D in humans. Upon entering the systemic circulation bound to vitamin D transport protein 
(DBP), cholecalciferol is converted to 25-hydroxyvitamin D3 by CYP2R1 in the liver. It then undergoes 
further hydroxylation in the kidney to the active form 1,25(OH)2D3. Excess 1,25(OH)2D3 is inactivated 
by CYP24A1. Adapted from (Lindh et al. 2012) 
A novel alternative hydroxylating pathway for the metabolism of vitamin D has been 
proposed that involves the cytochrome P450 enzyme CYP11A1 (Slominski et al. 
2013). The products of CYP11A1-mediated metabolism on vitamin D are non-
calcemic and non-toxic at relatively high doses and may also serve as partial 
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agonists of the vitamin D receptors (Slominski et al. 2013). It has been shown that 
human epidermal keratinocytes and dermal fibroblasts can metabolise vitamin D3 to 
novel CYP11A1-derived mono-and dihydroxymetabolites, with 20(OH)D3, 
20,23(OH)2D3, 20,22(OH)2D3, 17,20(OH)2D3 and 17,20,23(OH)3D3 being the 
products (Slominski et al. 2014). In human dermal fibroblasts, the major product, 
which is 20(OH)D3, can be further hydroxylated by CYP27B1 to 1,20(OH)2D3 
(Slominski et al. 2016) (Figure 1-11). Products from this non-classical metabolic 
transformation of vitamin D3 could shed light on some of the pleiotropic effects of 
vitamin D3, which has previously been attributed only to 1,25(OH)2D3 (Slominski et al. 
2016).  
 
Figure 1-11: Metabolism of cholecalciferol by CYP11A1. CYP27A1, CYP27B1 and CYP24A1 are 
involved in the further hydroxylation of the metabolites from CYP11A1. Adapted from (Slominski et al. 
2014) 
1.4.1 Vitamin D binding protein (DBP) 
Vitamin D binding protein (DBP) is an albumin-like plasma protein with a molecular 
mass of approximately 56 kDa (DiMartino et al. 2007). The majority of circulating 25-
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hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 is tightly bound to vitamin D binding 
protein (DBP), 10-15% is bound to albumin, and less than 1% of circulating vitamin D 
exists in an unbound form (Yousefzadeh et al. 2014). Besides its role as a high 
affinity serum transporter, DBP also plays a role in mediating the uptake of DBP-
bound 25(OH)D3 into some cells capable of converting 25(OH)D3 to 1,25(OH)2D3 
(Yousefzadeh et al. 2014). DBP, in a form bound to a ligand, could have an 
alternative role as a signal transducer as a result of its cell membrane binding 
capability (Khan et al. 1990; Orchinik et al. 1997; Chun et al. 2014). Furthermore, 
DPB has been shown to have the capability to function as a macrophage-activating 
factor (MAF) and an actin-binder (Sanger et al. 1990; Yamamoto and Naraparaju 
1996). These effects are independent of its vitamin D metabolite binding functions 
(Chun et al. 2014).  
25(OH)D3 binds to DPB with a higher affinity than 1,25(OH)2D3 (Speeckaert et al. 
2006). Thus, serum 25(OH)D3 levels are highly influenced by DBP. This is an 
important factor to be taken into consideration when defining systemic vitamin D 
deficiency and providing supplementation (Sollid et al. 2016). In the context of target 
cells that are capable of autocrine production of biologically active vitamin D 
metabolites, one proposed main function of DBP is to modulate the sensitivity of 
these cells to 1,25(OH)2D3 (Zella et al. 2008; Chun et al. 2014). It also limits 
1,25(OH)2D3 bioavailability in these cells by regulating the magnitude of peripheral 
synthesis of 1,25(OH)2D3 via extra-renal 1α-hydroxylase (Chun et al. 2014).  
1.4.2 Extra-renal production of 1,25(OH)2D3 and local homeostasis of 
vitamin D by various cell types 
Extra-renal production of 1,25(OH)2D3 has been demonstrated in cells such as 
keratinocytes, macrophages, lymphocytes, osteoblasts and enterocytes (Hewison et 
al. 2000; Van Etten et al. 2008; Di Rosa et al. 2011). These cells express all the CYP 
enzymes necessary for 1,25(OH)2D3 production and degradation (van Etten et al. 
2008). Tightly regulated vitamin D homeostasis and the presence of vitamin D 
receptors suggests the important autocrine/paracrine roles of 1,25(OH)2D3 in these 
cells (van Etten et al. 2008). A few examples of their functions include inhibition of 
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cell proliferation, promotion of cell differentiation and immune regulation (Dusso et al. 
2005). These functions are cell type-dependent as a result of different 
coactivators/corepressor being recruited by the vitamin D receptor (VDR) modulators 
(Feldman 2011).   
1.5 Genomic and non-genomic actions of 1,25(OH)2D3  
1.5.1 Vitamin D receptor (VDR), genomic action of 1,25(OH)2D3  
Vitamin D Receptor 
1,25(OH)2D3 exerts its genomic actions by binding to the nuclear vitamin D receptor 
(VDR). Gene expression profiling studies have estimated that VDR signalling is 
involved in the regulation of up to 5% of human genes (Bouillon et al. 2008; Imai et 
al. 2013). The VDR is expressed in cells derived from a variety of organs and tissues 
(Vuolo et al. 2012). These include cardiomyocytes, smooth muscle cells, thyroid C-
cells, hair follicle stem cells, T lymphocytes, alveolar epithelial cells, epidermal 
keratinocytes, dermal fibroblasts, and melanocytes (Vuolo et al. 2012). The VDR 
belongs to a superfamily of nuclear receptors (Evans 1988; Moore et al. 2006). It has 
a molecular mass of approximately 50kDa and consists of 427 amino acids (Jones et 
al. 1998). The human VDR gene is located on chromosome 12q (Deeb et al. 2007). 
It encodes the full length VDR protein, which includes a DNA binding domain, a 
nuclear localization domain, a hormone ligand binding domain, a dimerization 
domain and a transactivation domain (Deeb et al. 2007) (Figure 1-12).  
The VDR functions as a ligand-activated transcription factor (Thompson et al. 1998). 
It is translocated into the nucleus by moving along microtubule tracts to the nuclear 
pores, directed by nuclear localization signals (Deeb et al. 2007). Its ligand binding 
domain has a high affinity for 1α,25(OH)2D3
 (Kd=10-10M), but not for cholecalciferol 
(Thompson et al. 1998; Ohyama and Shinki 2016). Activation by 1α,25(OH)2D3 
results in a conformational change to the VDR which strongly recruits the retinoid X 
receptor (RXR) to form a heterodimer (Thompson et al. 1998; Deeb et al. 2007) 
(Figure 1-13). The 1,25(OH)2D3-VDR-RXR complex binds to vitamin D response 
elements (VDREs) at the DNA-binding domain of target genes (Deeb et al. 2007). 
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The VDR can also bind to the basal transcription factor II B (TFIIB) via protein-
protein interactions (Haussler et al. 1997) (Figure 1-12). An amphipathic alpha-helix 
domain, VDR activation function-2 domain (AF-2) transactivation domain is 
positioned at the extreme C-termini of both the VDR and RXR (Figure 1-12). 
Interaction of AF2 with stimulatory co-activators such as steroid receptor coactivators 
is a pre-requisite for downstream transcriptional activity (Haussler et al. 1997; Deeb 
et al. 2007). The VDR, RXR and TFIIB complex, coupled with the RNA polymerase II 
transcription machinery leads to transcriptional initiation of VDRE-containing, vitamin 
D target genes (Haussler et al. 1997) (Figure 1-13). 
 
 
Figure 1-12: VDR protein with its five functional domains that mediate transcriptional 
activation of target genes. The VDR is stabilised by phosphorylation of serine 51 in the DNA-binding 
domain by protein kinase C and serine 208 in the hinge region. VDR localization signals direct the 
receptor into the nucleus. Upon binding of 1,25(OH)2D3 to the hormone ligand binding domain, the 
VDR associates with the retinoic acid receptor (RXR) though its dimerization domain.   The 1,25(OH)-
2D3-VDR-RXR complex then binds to vitamin D response elements (VDREs) through the DNA-binding 
domain. This results in a conformational change in the VDR that allows the interaction of the VDR 
activation function 2 (AF2) transactivation domain with stimulatory coactivators. Adapted from (Deeb 






Figure 1-13: Example of binding of coactivator proteins to the heterodimer-DNA complex leads 
to histone acetylation and subsequent release of histones from DNA. Protein-protein interaction 
with transcriptional factor IIB (TFIIB) initiates transcription of target gene. Adapted from (Jones et al. 
1998). CBP: Calcium-binding protein; VDRE: Vitamin D response elements; P300: transcriptional 
integrator p300; RNAP II: RNA polymerase II; TATA: Thymine Adenine Thymine Adenine; TFIID: 




Retinoid X Receptor (RXR) as an obligate heterodimer partner for VDR 
RXR is a member of the steroid superfamily of nuclear receptors (Dawson and Xia 
2012). Its main functions are in modulating cell differentiation, metabolism and cell 
death (Dawson and Xia 2012). 9-cis retinoic acid (RA) is the natural ligand for RXR. 
The RXR exerts its biological functions almost exclusively by forming heterodimers 
with other receptors such as the thyroid hormone receptor, retinoic acid receptor 
(RAR) and vitamin D receptor (Bugge et al. 1992). In the vitamin D signalling 
pathway, it generally acts as a silent (non-liganded) partner that serves as an 
auxiliary factor to stabilise DNA binding of liganded-VDR to the VDRE (Bugge et al. 
1992; Shaffer and Gewirth 2002). Upon binding to 1,25(OH)2D3, the VDR-RXR 
heterodimers becomes relatively resistant to dissociation and diversion to other RXR 
pathways (Figure 1-14) (Torma et al. 1996; Thompson et al. 1998; Zhang et al. 
2011). 9-cis RA binding to RXR causes release of nuclear corepressor such as 
NCoR, which further enhances transcriptional activity of VDR (Kang et al. 1997; 
Sanchez-Martinez et al. 2008).  
 
Figure 1-14: Schematic depiction of the VDR response to 1,25(OH)2D3 binding. 9-cis retinoid acid 
(9-cis RA) is a natural ligand for retinoid X receptor (RXR). RXR stabilises the VDR-RXR 





The precursors of 1,25(OH)2D3 and their involvement in VDR-mediated 
signalling pathway 
Cholecalciferol and 25(OH)D3 are the two precursors in the synthesis of 
1,25(OH)2D3. Cholecalciferol does not bind to vitamin D receptor. Hence, it does not 
exert any genomic effects (Ohyama and Shinki 2016). However, cholecalciferol can 
be metabolised by CYP11A1 to 20(OH)D3 and 20,23(OH)2D3, both of which are 
partial agonists for the VDR (Figure 1-11) (Slominski et al. 2014). On the other hand, 
it has been suggested in the literature that 25(OH)D3 can control the expression of 
various genes and suppress cell proliferation via genomic action mediated by VDR 
(Ritter et al. 2006; Peng et al. 2009; Munetsuna et al. 2014). However, the affinity of 
25(OH)D3 for VDR is remarkably low, approximately 100 times lower than that of 
1,25(OH)2D3 (Lips 2007).  
1.5.2 Subcellular distribution of vitamin D receptors 
At basal levels, de novo synthesised vitamin D receptors mainly reside in the 
cytoplasm (Prüfer et al. 1999; Ruth Wu-Wong et al. 2006). Cytoplasmic-nuclear 
cycling of the VDR is regulated largely by its binding to 1,25(OH)2D3 (Racz and 
Barsony 1999).  Dimerization of ligand-activated VDR with RXR promotes nuclear 
translocation and sub-nuclear targeting of VDRs (Prüfer et al. 2000; Yasmin et al. 
2005). It has been proposed that subcellular distribution/localization of VDR also 
plays a role in regulating transcriptional activities of nuclear proteins (Prüfer and 
Barsony 2002). Nuclear import of VDR is mediated by importin α through binding of 
its nuclear localization sequences (NLS) (Prüfer and Barsony 2002). Excessive 
nuclear accumulation of VDR is prevented by export of VDR from the nucleus, a 
process mediated by nuclear export receptors that bind to specific nuclear export 
signal sequences (NES) (Prüfer and Barsony 2002). It has been suggested that 
calreticulin, a calcium-binding protein, may also serve as an export adapter through 
binding to DBP (Barsony et al. 1997; Prüfer and Barsony 2002). Lastly, microtubules 
play an important part in the intracellular traffic of vitamin D receptor (Akner et al. 
1995). Sensitivity of fibrillary cytoplasmic VDR immunostaining pattern to 
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microtubule-disrupting drugs provides evidence to the vital role of microtubules in 
VDR nuclear translocation (Barsony and McKoy 1992; Barsony et al. 1997).  
1.5.3 Non-genomic actions of 1,25(OH)2D3  
1,25(OH)2D3 exert its functions through both non-genomic and genomic pathways 
(Vuolo et al. 2012). In recent years, there have been an increasing number of studies 
reporting rapid activation of signal transduction pathways that do not involve nuclear 
gene transcription and protein synthesis following 1,25(OH)2D3 treatment (Sitrin et al. 
1999; Farach-Carson and Nemere 2003; Fleet 2004) (Figure 1-15). The non-
genomic effects of 1,25(OH)2D3 are mediated by binding to specific receptors on the 
plasma membrane of target cells that are coupled to activation of signalling 
molecules (Farach-Carson and Nemere 2003). These binding sites are referred to 
collectively as Membrane Associated, Rapid Response Steroid (MARRS) binding 
receptors (Farach-Carson and Nemere 2003; Nemere et al. 2004; Rohe et al. 2005; 
Norman 2006). Once bound, the 1,25(OH)2D3-MARRS complex stimulates a variety 
of signalling pathways, through direct interaction with G-proteins or non-receptor 
tyrosine kinases such as Src kinase (Fleet 2004). The downstream consequences of 
these signal transduction pathways include opening of ion channels (calcium and 
chloride channels), activation of protein kinase A (PKA), protein kinase C (PKC), and 
mitogen-activated protein kinase (MAPK) (Fleet 2004; Norman 2006; Khanal et al. 
2008; Nemere et al. 2010) (Figure 1-16). For example, it has been shown in avian 
myoblasts and murine colonic cells that 1,25(OH)2D3 is capable of activating the G 
protein/c-src/PKCα pathway resulting in a rise of inositol triphosphate 3 (IP3), a 
secondary messenger that modulates diacylglycerol levels (Morelli et al. 1993; Sitrin 
et al. 1999). The rapid response to 1,25(OH)2D3 was noted within seconds to 
minutes with an increase in calcium fluxes through voltage-operated channels 
(Morelli et al. 1993; Rohe et al. 2005). In another study using prostate cancer LNCaP 
cells, 1,25(OH)2D3 bound to MARRS was shown to activate the JNK/SAPK MAPK 
signalling pathway, resulting in decreased cell invasiveness, which was observed 
within 10 minutes of treatment (Larsson et al. 2008). Studies by Schwartz et al. 
(2002) in matrix vesicles of growth zone murine chondrocytes which did not contain 
the nuclear VDR, found that 1,25(OH)2D3 activates PKC through a G-protein, 
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resulting in modulation of MAPK activity that became evident within 9 minutes of 
treatment (Schwartz et al. 2002). There is no documented non-genomic activities of 
cholecalciferol and 25(OH)D3 in vitamin D3 signalling pathway.  
 
 
Figure 1-15: The non-genomic and genomic pathways of 1,25(OH)2D3. In the non-genomic 
pathways, 1,25(OH)2D3 bind to a subset of membrane-bound VDRs to trigger rapid, non-genomic 
actions. In classical genomic pathways, 1,25(OH)2D3 bind to VDR, resulting in a conformational 
change of VDR that facilitates binding with RXR. The ligand-VDR-RXR complex then translocates into 
the nucleus and binds to vitamin D response elements (VDRE) within the DNA that regulate gene 
transcription. Genomic pathway is regulated by transcriptional co-regulators, such as transcriptional 





Figure 1-16: The non-genomic pathways of 1,25(OH)2D3. 1,25(OH)2D3 binds to MARRS receptors 
and activates signalling molecules such as G-protein and Src kinase. The downstream effects of this 
are opening of ion channels (e.g. calcium and chloride channels) and activation of secondary 
messengers such as PKA, PKC and MAPK that regulates physiological responses. Adapted from 
(Fleet 2004) 
1.6 Current understanding on the autocrine/paracrine roles of 
vitamin D in skin and hair follicles 
The evolution of light pigmentation at high latitudes suggests the importance of 
vitamin D3 photosynthesis in the skin (Jablonski and Chaplin 2010). It is now 
recognised that vitamin D indeed, plays a significant role in skin health. The skin is 
capable of autocrine production of 1,25(OH)2D3 (Milde et al. 1991; Bikle 2011) and is 
also an important target tissue (Milde et al. 1991).  
Skin cells differentiation and proliferation 
Vitamin D3 analogues are commonly used to treat skin conditions such as psoriasis 
vulgaris (Darley et al. 1996; Norris 2005). Their beneficial effects were initially 
attributed to anti-proliferative and differentiation-inducing effects on epidermal 
keratinocytes (Hansen et al. 1996). 1,25(OH)2D3 induces differentiation and growth 
inhibition by causing cell cycle arrest at the G1/G0 phase in synchronized normal 
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human keratinocytes (Kobayashi et al. 1998). In the presence of low concentrations 
of 1,25(OH)2D3 (0.12-12nM), basal cell populations within the epidermis are 
stimulated to differentiate into squamous cells (Hosoi et al. 1985). The effects of 
vitamin D analogues on epidermal cell proliferation and differentiation are dose-
dependent, promoting proliferation of keratinocytes at low concentration and 
inhibiting proliferation at higher pharmacological doses (>10-8 M) (Gniadecki 1996). 
Loss of VDR function or absence of 1,25(OH)2D3 disrupts differentiation of the 
epidermis and results in hyperproliferation of the basal keratinocytes (Bikle 2011). 
Photoprotective effect and melanogenesis 
Ultraviolet (UV) radiation increases nitric oxide products generated by skin cells 
(Bruch-Gerharz et al. 1998). The photo-protective effect of 1,25(OH)2D3 is attributed 
to its antioxidant properties (Hanada et al. 1995; Lee and Youn 1998). In murine 
studies, keratinocytes exposed to 1,25(OH)2D showed increased tolerance (higher 
cell survival) to ultraviolet B (UVB) injury (Hanada et al. 1995). Inactivation of the 
VDR enhances UV-induced skin tumorigenesis in mice (Ellison et al. 2008). In 
human keratinocytes, 1,25(OH)2D3 treatment was shown to increase p53 (tumour 
suppression gene) expression and decreases nitric oxide products in vitro (Gupta et 
al. 2007).  
Melanin synthesis by murine melanoma cells was reportedly stimulated by 
1,25(OH)2D3 in vitro (Oikawa and Nakayasu 1974; Hosoi et al. 1985). In primary 
human melanocytes in vitro, vitamin D increases melanogenesis and the tyrosinase 
content of melanocytes via its anti-apoptotic effect (Mason 2000; De Haes et al. 
2003). Using an immature melanocyte cell line derived from mouse neural crest 
cells, it has been shown that 1,25(OH)2D3 acts to induce immature melanocytes in 
the bulge region of the hair follicle to produce melanin by stimulating their 
differentiation in vitro (Watabe et al. 2002). Upregulation of pigment production by 
1,25(OH)2D3 confers a protective effect to the skin cells from DNA damage and 
tumorigenesis. This is highlighted by epidemiology studies that found that the risk of 
high stage melanoma was inversely proportional to serum vitamin D3 level (Nurnberg 




Immunomodulatory actions  
Various immune cell types such as lymphocytes, macrophages, neutrophils and 
dendritic cells express VDR and possess CYP27B1 (1α-hydroxylase) for autocrine 
production of the active vitamin D metabolites (Amento 1987; Aranow 2011; Di Rosa 
et al. 2011). The human cathelicidin antimicrobial peptide (CAMP) gene is now 
known to be a direct target of the VDR (Gombart et al. 2005). 1,25(OH)2D3 regulates 
the antimicrobial peptide cathelicidin, enhances Toll-like receptor 2 (TLR2) functions 
and improves dermatitis and wound healing (Schauber et al. 2007). It has also been 
shown clinically that administration of oral vitamin D induces cathelicidin production 
in patients with atopic dermatitis (Hata et al. 2008). There is also a complex interplay 
between 1,25(OH)2D3 and the skin microbiome. In murine models in vivo, it has been 
shown that 1,25(OH)2D3 may be able to suppress tissue inflammation by altering the 
microbiome at the airway lining and colon (Lagishetty et al. 2010; Gorman et al. 
2013). There is currently no data on the microbiome altering properties of 
1,25(OH)2D3 in cutaneous wounds. 
Hair follicle cycling, development and growth 
The hair follicle is a highly hormone-sensitive mini organ (Reichrath et al. 1994). In 
the murine model, the presence of both the VDR and 1,25(OH)2D3 is essential for 
hair follicle cycling  (Sakai and Demay 2000; Chen et al. 2001; Sakai et al. 2001). It 
has now been established that VDR is not only expressed in epidermal 
keratinocytes, but also in dermal papilla cells and outer root sheath cells of the hair 
follicles (Reichrath et al. 1994; Kong et al. 2002; Cianferotti et al. 2007). Murine 
studies have shown that VDR expression is related to the hair cycle, expression is 
increased in dermal papilla cells and outer root sheath keratinocytes during anagen 
IV-VI and in catagen, and decreased during telogen and anagen I-III (Reichrath et al. 
1994). These two sites correspond to the location of mesenchymal and epithelial 
stem cells found in hair follicles normally, suggesting its importance in both hair 
follicle and interfollicular epidermal regeneration (Yang and Cotsarelis 2010; 
Mistriotis and Andreadis 2013). Similarly, murine studies have shown that the VDR is 
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required for the initiation of the postnatal hair follicle cycle, and knockout of VDR 
resulted in alopecia (Kong et al. 2002). Furthermore, the matrix cells of hair follicles 
express all the necessary enzymes for synthesising 1,25(OH)2D3, suggesting they 
play an important autocrine and paracrine roles in regulating 1,25(OH)2D3 
homeostasis (Zehnder et al. 2001). In fact, absence of 1α,25(OH)2D3, the ligand for 
VDR, results in hair loss in mice (Chen et al. 2001; Meindl et al. 2005; Teichert et al. 
2010). This effect is VDR-independent, further supporting the notion that the hair 
follicle is an important target cell for 1, 25(OH)2D3. Mutations in the VDR gene are 
associated with alopecia in humans and topical 1,25(OH)2D3 administration prevents 
chemotherapy-induced alopecia in mice (Takeda et al. 1987; Jimenez and Yunis 
1992). Clinically, there have been case reports of the successful treatment of 
alopecia areata with calcipotriol (a vitamin D analogue), suggesting a possible role of 
vitamin D in restoration of hair follicle dysfunction (Kim et al. 2012). 
1.6.1 Vitamin D signalling in response to wounding 
Upon injury, cytokines and growth factors are released at the wound site (Bikle et al. 
2014). These stimulate proliferation and migration of dermal and epidermal cells for 
wound closure (Bikle et al. 2014). Calcium interacts with 1,25(OH)2D3-VDR pathways 
in regulating skin differentiation and proliferation processes (Bikle et al. 2014; 
Mostafa and Hegazy 2015). This is achieved by induction of the calcium receptor 
and phospholipase C via 1,25(OH)2D3 binding in human keratinocytes (Pillai et al. 
1995). Expression of involucrin, transglutaminase, loricrin, and filaggrin are 
upregulated, thereby enhancing keratinocyte differentiation into the cornified 
envelope, and eventually leading to reformation of the epidermal barrier (Mostafa 
and Hegazy 2015).  
Vitamin D and calcium signalling are equally necessary for an adequate 
immunomodulatory response to epidermal wounding (Bikle et al. 2014). 
1,25(OH)2D3-dependent actions of the VDR are fundamental in promoting a normal 
inflammatory response to cutaneous injury (Luderer et al. 2013). In murine studies, 
absence of VDR has been shown to result in defective granulation tissue formation, 
which was attributed to impaired TGF-β signalling and a decrease in macrophage 
62 
 
recruitment to the wound site (Luderer et al. 2013). In a separate study, mice lacking 
the VDR or CYP27B1 showed a defective innate immune response, downregulated 
β-catenin transcription, reduced proliferation of keratinocytes at the wound edges 
and delayed wound healing (Oda et al. 2015). Lastly, vitamin D plays a vital role in 
maintaining the hair follicle stem cell population, which is vital for good quality wound 
repair (Chen et al. 2001; Cianferotti et al. 2007; Teichert et al. 2010; Demay 2012).  
1.6.2 The role of dermal fibroblasts (DFs) in 1,25(OH)2D3 production 
and its function as a target cells 
Surprising, there are limited studies investigating the role of human dermal 
fibroblasts in 1,25(OH)2D3 production and their potential as target cells in cutaneous 
wound healing. Scatchard analysis using human dermal fibroblasts showed that 
cultured fibroblasts grown from infant foreskin expressed the VDR (Feldman et al. 
1980). A Kd for [3H]1,25(OH)2D3 of 0.2nM and a Bmax of approximately 40 fmol/mg 
cytosol protein was reported in this study (Feldman et al. 1980). Since then, dermal 
fibroblasts have been used to demonstrate VDR mutations in patients with hereditary 
vitamin D-resistant rickets (HVDRR) (Feldman and Malloy 2014). A correlation with 
the development of alopecia in this group of patients was also established (Feldman 
and Malloy 2014). However, little is known about the role of dermal fibroblasts in 
vitamin D homeostasis locally. Using a Northern Blot technique, researchers have 
shown that dermal fibroblasts derived from human foreskin respond to 1,25(OH)2D3 
by upregulating CYP24A1 mRNA expression (Vantieghem 2006). These dermal 
fibroblasts also expressed VDR, CYP2R1 and CYP24A1 mRNA. However, 
CYP27B1 (1α-hydroxylase) RNA was not detected by Northern Blot analysis 
(Vantieghem 2006). In a recent study utilising real time PCR and ELISA techniques, 
Norlin et al showed that primary human dermal fibroblasts derived from skin biopsies 
expressed all the vitamin D3 metabolising enzymes and are thus potentially capable 
of autocrine production of active 1,25(OH)2D3 (Norlin et al. 2017). However, the 
source of the skin biopsies (i.e. the sites, hairy/non-hairy, and age groups of 




1.7 Prevalence of Vitamin D deficiency in the general population 
Over the past decades, vitamin D deficiency as an epidemic has been recognised 
(Blair 2012). It has been linked with a multitude of diseases, including diabetes, 
tuberculosis, pancreatic cancer, breast cancer, bone diseases, and cardiovascular 
diseases (Autier et al. 2014). The importance of vitamin D in general health was 
reaffirmed and highlighted by the establishment of an European Union (EU) funded 
project that aims to provide high quality scientific evidence in the prevention of 
vitamin D deficiency among EU citizens (Cashman et al. 2016). The four-year 
“Optimal Vitamin D in Nutrition” (ODIN) project that started in 2013 has identified a 
13% prevalence of vitamin D deficiency in all EU population across a variety of ages 
(Cashman et al. 2016). In the United Kingdom (UK), pilot studies and regional 
monitoring suggests that vitamin D deficiency is likely to affect at least half the UK’s 
white population, up to 90% of the multi-ethnic population and a quarter of all 
children living in Britain (Blair 2012).  
Surprisingly, the population that are at risk of developing chronic wounds are often 
found to be vitamin D deficient. A study looking at differences in the capacity for 
synthesis of vitamin D3 in  human skin among different age groups reported an 
chronological age-dependent decrease in the epidermal concentrations of provitamin 
D3 (7-dehydrocholesterol) in surgically-obtained human skin (MacLaughlin and 
Holick 1985). This study also showed an age-dependent reduction in the capacity of 
the skin to produce cholecalciferol (MacLaughlin and Holick 1985). Vitamin D 
deficiency is also more prevalent among diabetic patients (Hyppönen et al. 2001; 
Mohr et al. 2008). Clinical trials have shown that oral vitamin D supplementation 
results in better venous ulcer healing (Burkiewicz et al. 2012). Unfortunately, data 
from molecular biology studies investigating the effect of vitamin D deficiency on 






1.8 Aim and objectives 
While human epidermal keratinocytes are the main source of vitamin D, they are 
also important target cells. However, little is known about the role of dermal 
fibroblasts in the autocrine and paracrine regulation of biologically active vitamin D. 
The main aim of this project was to establish the effects of vitamin D on human 
dermal fibroblasts, in particular investigating its potential role in cutaneous wound 
healing.  
 
The first aim of this study was to investigate the autocrine and paracrine roles of 
primary human dermal fibroblasts in 1,25(OH)2D3 homeostasis in vitro at basal 
conditions. The mRNA expression of CYPs by dermal fibroblasts was quantified and 
compared with both donor-matched and non-matched epidermal keratinocytes. VDR, 
which is an important mediator of genomic actions by 1,25(OH)2D3, was also 
quantified and its relative expression in dermal fibroblasts and keratinocytes 
established.  
 
There is evidence in the literature suggesting 1,25(OH)2D3 upregulates the migration 
of epidermal keratinocytes in vitro. However, studies looking at the effect of vitamin 
D3 on dermal fibroblast migration after wounding are lacking. This study aims to 
compare the effects of 1,25(OH)2D3 and its precursors on migration of primary 
cultures of epidermal keratinocytes and dermal fibroblasts; effects on fibroblasts 
were also determined under a variety of conditions (i.e. different treatment 
concentrations, with or without serum). Furthermore, to investigate whether the 
modulatory effect on migration was mediated by VDR, knockdown of VDR was also 
performed.  
 
The next aim of this study was to determine how 1,25(OH)2D3 and its precursors 
modulate VDR and CYP expression in primary cultures of epidermal keratinocytes 
and dermal fibroblasts at basal conditions. Subsequently, their transcriptional 
expression was also determined under wounded conditions.  The genomic pathway 
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in which 1,25(OH)2D3 or its precursors exert their biological functions was 
investigated by measuring VDR protein expression.  
 
Dermal fibroblasts are heavily involved in wound contraction, extracellular matrix 
deposition and degradation, and the modulation of collagen content during wound 
healing. The effects of 1,25(OH)2D3 and its precursors on these aspects of wound 
healing were assessed by measuring metabolic activity, expression of markers for 
myofibroblast differentiation, secretion of matrix metalloproteinases and changes in 
the ratio of type I and III collagen in primary cultures of dermal fibroblasts.  
 
Finally, an ex vivo human skin wound healing model was developed that more 
closely resembles the actual three-dimensional microenvironment in human wounds 



















2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals 
The following chemicals were supplied by  
Sigma-Aldrich, UK: 
 1α,25-Dihydroxyvitamin D3 
 25-hydroxyvitamin D3  
 2-Mercapto-ethanol  
 Acrylamide  
 Cholecalciferol  
 Dimethyl sulfoxide (DMSO) 
 Eosin Y-solution 0.5% alcoholic 
 Ethanol  
 Formaldehyde  
 Gelatin  
 Mayer’s Haematoxylin MHS-16 
 Phosphate buffered saline  
 Thermo Scientific Pierce Tetramethylethylenediamine (TEMED) 
 Triton X-405  
 
Thermo Fisher Scientific, UK: 
 Alamar Blue® 









2.1.2 Human Skin samples 
Skin samples from healthy patients undergoing facelift plastic surgery, 
abdominoplasty or breast reduction surgery were obtained from female donors with 
informed consent. The samples were collected by Ethical Tissue Bank from the 
hospital and immediately placed in transporting media (Section 2.1.3.1) until it was 
processed no longer than 6 h later.  
2.1.3 Cell Culture  
2.1.3.1 Transporting media 
Minimum Essential Medium (MEM), GlutaMAX supplement  was 
supplemented with 10% foetal calf serum (FCS), 250 Units/ml penicillin and 250 
µg/ml streptomycin (Pen/Strep), 7.5 µg/ml of amphotericin B and 6.15 µg/ml of 
sodium deoxycholate, both contained in fungizone antimycotic and 2 mM of L-alanyl-
L-glutamine dipeptide in 0.0085% of NaCl or glutaMAX and stored at 4˚C. (All 
reagents/chemicals were from GIBCO, UK) 
2.1.3.2 Primary Keratinocyte Growth Media (PKGM) 
Primary keratinocyte growth media (PKGM) was made up using keratinocyte 
growth media 2 (PromoCell, UK) supplemented with 0.004 ml/ml of bovine pituitary 
extract, 0.125 ng/ml of epidermal growth factor (recombinant human), 5 µg/ml of 
insulin (recombinant human), 0.33 µg/ml of hydrocortisone, 0.39 µg/ml of 
epinephrine, 10 µg/ml of tranferrine, holo (human), 100 Units/ml penicillin with 100 
µg/ml streptomycin (GIBCO) and 2.48 µg/ml fungizone (GIBCO). Keratinocyte growth 
media 2 was stored at 4 ˚C and all supplements at -20 ˚C. PKGM was kept at 4 ˚C 
and used within 4 weeks 
2.1.3.3 Primary Keratinocyte Starvation Media (PKSM) 
Primary keratinocyte starvation media (PKSM) was made up using keratinocyte 
growth media 2 (PromoCell, UK) and all the supplements as in PKGM apart from the 
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epidermal growth factor and fungizone. PKSM was kept at 4 ˚C and used within 4 
weeks. 
2.1.3.4 Primary Fibroblast Growth Media (PFGM) 
Primary fibroblast growth media (PFGM) was made up using Dulbecco’s 
modified eagle medium (DMEM) with L-glutamine (Sigma-Aldrich, UK) supplemented 
with 10% foetal bovine serum (FBS) (GIBCO), 100 Units/ml penicillin and 100 µg/ml 
streptomycin (Pen/Strep) (GIBCO), 2.5 µg/ml of amphotericin B and 2.05 µg/ml of 
sodium deoxycholate, both contained in fungizone antimycotic (GIBCO). DMEM was 
stored at 4 ˚C and all supplements at -20 ˚C. Once PFGM was prepared, it was kept 
at 4 ˚C and used within four weeks.  
2.1.3.5 Primary Fibroblast Starvation Media (PFSM)  
Primary Fibroblast Starvation Media (PFSM) was made with phenol red-free 
Dulbecco’s Modified Eagle Medium (DMEM) with L-glutamine (Sigma-Aldrich, UK) 
supplemented with 100 Units/ml penicillin and 100 µg/ml streptomycin (Pen/Strep) 
(GIBCO) and 2.5 µg/ml of amphotericin B and 2.05 µg/ml of sodium deoxycholate, 
both contained in fungizone antimycotic (GIBCO). Once PFSM was prepared it was 
stored at 4 ˚C and used within four weeks. 
2.1.3.6 Primary Cells Freezing Media 
Cryo-SFM (Promocell) was used to freeze primary human keratinocytes. 
Dermal fibroblasts were frozen in media consisting of 80% of PFGM (see Section 
2.1.2.4), 10% FBS (GIBCO) and 10% dimethyl sulfoxide (DMSO). 
2.1.4 Human primary cell lines used 
A list of human primary cell lines that were established for this study is given 
in table 2-1. Each cell line was assigned a sample identification code (bottom row) 




Table 2-1: All primary cell lines used in the experiments were derived from female (F) facial 
skin. Donor-matched epidermal keratinocytes and dermal fibroblasts are highlighted in purple: EK2 
and DF4; EK4 and DF7; EK5 and DF10. EK denotes epidermal keratinocyte and DF denotes dermal 
fibroblast.  
2.2 Methods 
2.2.1 Establishment of primary cells cultures from human skin  
The skin samples were all derived from female facelift surgery. They arrived at 
the laboratory in transport media as detailed in section 2.1.2.1 and  processed within 
12 hours. Each skin sample was transferred to a 60mm tissue culture dish 
(Starstedt) and washed with PBS three times. Fat tissue was carefully dissected 
away. The remaining skin was cut into squares of tissue measuring approximately 1 
to 1.5cm2. They were then placed in 5.2 U/ml of dispase (GIBCO) in PBS with 100 
Units/ml penicillin and 100 µg/ml streptomycin (GIBCO) and 2.5 µg/ml of 
amphotericin B and 2.05 µg/ml of sodium deoxycholate (Fungizone antimycotic, 
GIBCO), and kept at 4ºC overnight.  
With the aid of a Leica dissecting microscope, the epidermis was carefully 
separated from the underlying papillary dermis using a pair of fine-tipped, non-tooth 
forceps. The epidermis collected was placed in a 15ml Falcon tube containing 
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primary keratinocyte growth media (PKGM) whereas the remaining dermis was 
placed in primary fibroblast growth media (PFGM). 
2.2.1.1  Primary epidermal keratinocyte isolation, culture, and passaging 
The epidermis was transferred to a separate 15ml Falcon tube containing 3 ml 
of 0.05% Trypsin/EDTA (Sigma-Aldrich, UK) and incubated at 37ºC for 5 minutes. 
The Falcon tube containing the epidermis was then vortexed briefly for 10 to 15 
seconds. After removing the excess epidermis, 3 ml of trypsin neutralising solution 
(TNS) (Lonza, UK) was added. The suspension was centrifuged at 800 rpm for 5 
minutes. The resulting pellet was re-suspended in PKGM (section 2.1.2.2). A cell 
count was performed using a Neubauer haemocytometer (Hawksley, UK). The cells 
were then cultured in a T75 flask (Corning, UK) containing 15 ml of PKGM (section 
2.1.2.2) at a cell density of 30,000 cells/ml. The T75 flasks were transferred to a 
HeracellTM 150i humidified incubator and incubated at 37ºC and 5% CO2 in air. The 
PKGM (Section 2.1.2.2) was changed every other day until the primary epidermal 
keratinocytes reached 80% confluency. This normally took between 7 to 14 days.  
Once they had reached 80% confluency, the primary epidermal keratinocytes 
were passaged. They were washed with PBS twice before 0.5 mM (2.5 ml) of 
ethylenediaminetetraacetic acid (EDTA) (GIBCO, UK) was added. The cells were 
incubated at 37ºC for 4 minutes to disrupt cell-cell interactions before the EDTA was 
discarded. Subsequently, 0.05% (2 ml) Trypsin/EDTA (Sigma-Aldrich, UK) was 
added and the keratinocytes were incubated for another 2 minutes at 37ºC. The T75 
flasks were examined under a phase contrast microscope to check that cells had 
detached from the flasks. Trypsin Neutralising Solution (TNS) (Lonza, UK) that was 
double in volume to the Trypsin/EDTA solution (4 ml) was added to each flask and 
the keratinocytes resuspended in the TNS. 
The cell suspension was transferred to a 15 ml Falcon tube (Starstedt, UK). A 
cell count and viability count was determined using a Neubauer haemocytometer 
(Hawksley, UK). To determine cell viability, trypan blue solution 0.4% (Sigma-Aldrich, 
UK) was used. The following formulas were used to determine total number of viable 
and non-viable cells: 
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Total number of cells/ml = total cells counted x (dilution factor/number of squares) x 10
4
 
% Viability = Total number of viable cells/total number of cells x 100  
Once the cell count was determined, the cell suspension was centrifuged for 5 
minutes at 1000 rpm. The supernatant was removed and the cell pellet re-
suspended in PKGM (Section 2.1.2.2). For routine keratinocyte passaging, the cells 
were split at a ratio of 1:2 and cultured in T25 or T75 flasks.  
2.2.1.2 Primary dermal fibroblast isolation, culture and passaging 
Between 6 and 10 pieces of dermis measuring approximately 1cm2 were 
placed into a T75 flask (Corning, UK) with the papillary dermis facing down. Five 
millilitres of PFGM was added to each flask and they were transferred to the 
HeracellTM 150i incubator and cultured at 37ºC and 5% CO2 in air. The dermal 
explants were checked the following day to make sure that they were attached to the 
flasks. The PFGM (Section 2.1.2.4) was changed every other day until the primary 
dermal fibroblasts reached 80% confluency. This normally took between 10 to 21 
days.  
The dermal fibroblasts were passaged once they reached 80% confluency. The 
monolayers were washed twice with PBS before0.05% (2 ml) of Trypsin/EDTA 
(Sigma-Aldrich, UK) was added and the cells incubated at 37ºC for 5 minutes. Cell 
detachment from the flask was determined under the phase contrast microscope. 
PFGM containing 10% FBS (Section 2.1.2.4) that was double in volume to the 
Trypsin/EDTA solution (4 ml) was added to each flask. The cell suspension was 
transferred to a 15 ml Falcon tube. Cell count and viability was determined as 
described previously (Section 2.2.1.1). Once the cell count was determined, the cell 
suspension was centrifuged for 5 minutes at 1000 rpm. The supernatant was 
removed and the cell pellet re-suspended in 1mL of PFGM (Section 2.1.2.4). For 
routine passaging, dermal fibroblasts were split with a ratio of 1:3 and cultured in T25 
or T75 flasks.  
72 
 
2.2.2 Cryopreserving and thawing of human epidermal keratinocytes and 
dermal fibroblasts 
Both cell types can be frozen using the appropriate cryopreservation medium. 
Once the cells were processed and centrifuged (Section 2.2.1.1 and Section 2.2.1.2) 
and the supernatant discarded, the cells were re-suspended in 1ml of 
cryopreservation medium; Cryo-SFM for epidermal keratinocytes and fibroblasts 
freezing medium for dermal fibroblasts (Section 2.1.2.5).  
The cell suspension was transferred to 1ml CryoPure tubes (Sarstedt). Sample 
tracking number, passage number, gender and age of the patient, date of freezing 
and size of flask were recorded on the CryoPure tubes label as appropriate. The 
tubes were placed in liquid nitrogen vapour tank for 24 hours before finally being 
transferred to the liquid nitrogen storage tank. 
Thawing of cells was done rapidly (<1 minute) by holding the CryoPure tube 
under warm running tap water. The thawed cell suspension was added to pre-
warmed growth medium (37ºC) in T25 or T75 flasks. The media was changed after 
24 hours once the cells were attached. 
2.3 Quantitative real-time PCR (qRT-PCR) to determine 
transcriptional expression of genes 
2.3.1 Relative mRNA expression of VDR, CYP2R1, CYP27B1, and 
CYP24A1 in human epidermal keratinocytes (EK) and dermal fibroblasts 
(DF) at basal level. 
Primary epidermal keratinocytes and dermal fibroblasts were plated in 6-well 
plates (Greiner Bio-one, UK) at a density of 50,000 cells per well and 30,000 cells 
per well respectively in two mls of PKGM or PFGM (Section 2.1.2) The medium was 
changed every other day. When cells were 80-90% confluent, they were ready for 
mechanical wounding.  
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For donor-matched epidermal keratinocytes and dermal fibroblasts (Table 2-2), 
two horizontal and two vertical scratch marks were created across the monolayer of 
cells using a 10µl pipette tip (0.2mm in width)  as shown in Figure 2-1A. A template 
was used to ensure consistency in producing the scratch marks. After scratching, all 
the wells were washed with PBS twice to ensure removal of any dead or floating 
cells. The cells were then incubated in either PFGM or PKGM (Section 2.1.2) at 37ºC 
for a further 24 hours, before RNA was harvested for VDR, CYP2R1, CYP27B1, and 
CYP24A1 mRNA expression analysis.  
For non-donor-matched keratinocytes and fibroblasts (Table 2-2), the RNA was 
harvested following a scratch-wound migration assay, therefore only one  vertical 
scratch wound (0.8mm in width) was created using a scratching device provided by 
Dr. Ola Kamala using a predesigned template as shown in Figure 2-1B (Kamala 
2014). After scratching, incubation and RNA extraction were performed the same 
way as described for the donor-matched samples.  
 Epidermal keratinocytes Dermal fibroblasts 
Sex F F F F F F F F F F F F F 
Age 51 55 58 59 60 53 55 56 57 59 59 59 60 
Passage 2 3 3 3 3 4 3 3 3 3 5 4 3 
Sample 
code 
EK1 EK2 EK3 EK4 EK5 DF3 DF4 DF5 DF6 DF7 DF8 DF9 DF10 
Table 2-2: Primary human epidermal keratinocytes and dermal fibroblasts used in qRT-PCR to 
determine relative expression of VDR, CYP2R1, CYP27B1 and CYP24A1 expression at basal 
level. Donor-matched epidermal keratinocytes and dermal fibroblasts are highlighted in purple: EK2 






Figure 2-1: Scratch marks across monolayer of cells within a well in a 6-well plate for total RNA 
collection. A) Method used for donor-matched epidermal keratinocytes and dermal fibroblasts. Two 
horizontal and two vertical scratch marks were created across the monolayer of cells using a 10µl 
pipette tip (width of scratch - 0.2mm); B) Method for non-donor-matched epidermal keratinocytes and 
dermal fibroblasts. A single vertical scratch was created using a scratching device provided by Dr. Ola 
Kamala (width of scratch – 0.8mm). 
2.3.2 Relative mRNA expression of VDR, CYP2R1, CYP27B1, and 
CYP24A1 in human epidermal keratinocytes (EK) and dermal 
fibroblasts (DF) after incubation with 1,25(OH)2D3 or its precursors. 
Total RNA was harvested from epidermal keratinocytes or dermal fibroblasts 
following the assessment of migrationas described in Section 2.4.1. The age of the 
donors, passage number and sample code of epidermal keratinocytes and dermal 
fibroblasts used are specified in Table 2-3. The method used for scratching is as 







 Primary epidermal keratinocytes Primary dermal fibroblasts 
Sex F F F F F F 
Age 55 59 60 59 59 60 
Passage 3 3 3 3 4 3 
Sample code EK2 EK4 EK5 DF7 DF8 DF10 
Table 2-3: Primary human epidermal keratinocytes and dermal fibroblasts used in qRT-PCR to 
determine relative expression of VDR, CYP2R1, CYP27B1 and CYP24A1 expression in 
scratched assay after incubation with 1,25(OH)2D3 or its precursors. 
2.3.3 Relative mRNA expression of collagen I and III in human dermal 
fibroblasts (DF) after incubation with 1,25(OH)2D3  
Total RNA was harvested from dermal fibroblasts as cultured and treated as 
described in Section 2.4.1. The age of the donors, passage number and sample 
code of dermal fibroblasts used are specified in Table 2-4. Method used for 
scratching is as described in Section 2.3.1 and Figure 2-1B. 
 Primary dermal fibroblasts 
Sex F F F 
Age 59 59 60 
Passage 3 4 3 
Sample code DF7 DF8 DF10 
Table 2-4: Primary dermal fibroblasts used in qRT-PCR to determine relative expression of 
collagen I and III expression in scratched assay after incubation with 1,25(OH)2D3. 
2.3.4 RNA extraction and quantification 
Total RNA extraction was performed with the RNeasy Mini Kit (QIAGEN, UK). 
10µL/ml of β-mercaptoethanol (Sigma-Aldrich, UK) was added to Buffer RLT 
provided with the kit. 200µL of the mixture was then added to the cell monolayer in 
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each well (in triplicate), and pipetted up and down several times. The resulting 
suspension was transferred to a 1.5 ml micro centrifuge tube. One volume of 70% 
ethanol was added to the cell lysate and mixed well by pipetting up and down briefly. 
Immediately after, the resulting suspension was transferred to a RNeasy spin column 
and centrifuged at 13000 rpm for 15 seconds at 4 ºC. Flow-through was discarded 
and 350µl of buffer RW1 (Table 2-5) was added to wash the spin column by 
centrifuging at 13000 rpm for 15 seconds at 4ºC. DNase digestion was performed 
using the RNase-free DNase set (QIAGEN 2012) to remove possible DNA 
contamination of the sample. 70µl of RNAse-free Buffer RDD (Table 2-5) was mixed 
with 10 µl (2.72 U/ µl) of DNase  and the resulting mixture (80μl of 0.34 U/µl DNAse 
I) was added to the spin columns and allowed to stand for 15 minutes at room 
temperature. Following on-column DNA digestion, a further 350µl of buffer RW1 was 
added to each spin column and centrifuged at 13000 rpm for 15 seconds at 4 ºC. 
Five hundred microliter of Buffer RPE (Table 2-5) was used to wash each column 
with a centrifugation speed of 13000 rpm for 15 seconds at 4 ºC. The flow-through 
was discarded and the RPE buffer wash was repeated with a longer centrifugation 
period of 2 minutes, while maintaining the same speed and temperature. The 
RNAeasy column was placed in a new collection tube and further centrifuged at 
13,000 rpm for 1 minute at 4 ºC for removal of residual RPE buffer. Lastly, the 
RNeasy spin columns were placed in 1.5 ml RNase free collection tubes and 25 to 
30 µl of RNase-free water was added to each. They were centrifuged at 13,000 rpm 
for 1 minute at 4 ºC. The RNA collected in the tubes was then stored at -80ºC until 
future use.  
NanoPhotometer (IMPLEN) was used for RNA quantification. One microliter of 
nuclease-free water was used as a blank for calibration. For quantification of RNA, 
absorbance measurements were made using the NanoDrop spectrophotometer. The 
purity of RNA extracted was determined by the ratio of absorbance at 260nm and 
280nm given by the spectrophotometer reading. A ratio of ~2.0 is accepted as 
reasonably ‘pure’ RNA, indicating the sample is unlikely to be contaminated by the 
presence of protein, phenol or other contaminants. On the other hand, nucleic acid 
purity was determined using the 260/230 values. A range of 2.0-2.2 was considered 
to be acceptable.  
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Reagents Details/composition of reagents 
Buffer RW1 Contains a guanidine salt, as well as ethanol and is used as a 
stringent washing buffer that efficiently removes biomolecules 
such as carbohydrates, proteins, fatty acids etc., that are non-
specifically bound to the silica membrane of the RNeasy mini 
spin columns (QIAGEN, UK) 
Buffer RDD Buffer RDD, when used with DNase from the RNAse-Free 
DNase Set (QIAGEN, UK), provides efficient on-column 
digestion of DNA and also ensures that the RNA remains bound 
to the RNeasy mini spin columns (QIAGEN, UK) 
Buffer RPE It is a mild washing buffer. Its main function is to remove traces 
of salts, which are still on the column due to buffers used earlier 
in the protocol (QIAGEN, UK) 
Table 2-5: Components of RNeasy Kits (QIAGEN, UK). The contents and functions of the buffer 
used in RNeasy Kits.  
2.3.5 cDNA synthesis 
For cDNA synthesis, the high capacity cDNA reverse transcription kit from 
Applied Biosystems (UK) was used. Single-stranded cDNA was synthesised from 
total RNA following the protocol provided by the manufacturer. Preparation of the 
Master Mix was done on ice. Firstly, 2x Reverse Transcription (RT) Master Mix was 
prepared and total RNA was added to the 2x RT Master Mix. The components of the 
final RT master mix were as shown in Table 2-6. The total RNA used was 2 µg per 
20 µl of reaction. Reverse transcription was performed in a Thechne TC-3000 PCR 
thermal cycler (Scientific Laboratory Supplies, UK). Conditions of the thermal cycler 







10x RT Buffer  2.0 
25x dNTP Mix (100mM) 0.8 
10x RT Random Primers 2.0 
MultiScribe™ Reverse Transcriptase 1.0 
RNAse inhibitor 1.0 
Nuclease-free water 3.2 
Total per Reaction 10.0 
Table 2-6: Components of the RT master mix using high capacity cDNA reverse transcription 
kit from Applied Biosystem (UK). 
 
 Step 1 Step 2 Step 3 Step 4 
Temperature 
(ºC) 
25 37 85 4 
Time 10 minutes 120 minutes 5 minutes ∞ 
Table 2-7: cDNA synthesis cycle conditions for high capacity cDNA reverse transcription kit 
(Applied Biosystems). 
The resulting cDNA from the RT reaction was collected in RNAse free tubes 





2.3.6 Quantitative reverse transcription-polymerase chain reaction (qRT-
PCR) 
Fast SYBR® Green Real-Time PCR (Applied Biosystems) was used for all 
qRT-PCR. The preparation of the reaction master mix was done on ice. TipOne® 
filters (Starlab) were used to prevent RNAse contamination. Components of the PCR 
reactions master mixes were as shown in Table 2-8.  
Component Volume for One 20 µl reaction (µl) 
Fast SYBR® Green Master Mix (2x) 10.0 
Forward and Reverse Primers Variable* 
cDNA template + RNase-free water Variable** 
Total Volume 20.0 
Table 2-8: Components of Fast SYBR® Green PCR master mixes; *For forward and reverse 
primers mix, it was made up to 1µM of final concentration. **For cDNA template, a final diluted 
concentration of 0.03 µl/µl in RNase-free water was used.  
Primers used were designed using the on-line tool Primer-BLAST. Self-
complementary and primer specificity to the target RNA were determined. The list of 

































































































































Table 2-9: qRT-PCR primers and conditions for VDR, CYP2R1, CYP27B1, CYP24A1, collagen I 
and collagen III amplication and the housekeeping genes U6 and GAPDH. 
The final PCR master mix was loaded into 96-well Fast plates (STARLAB) 
and centrifuged briefly to spin down the contents and eliminate any air bubbles. 
Finally the PCR reaction plate was run in the Real-Time PCR machine (Applied 
Biosystems).   
2.3.7 Statistical analysis of qRT-PCR results 
Analysis Software template iCycleriQ® Real-Time PCR Detection System 
(Bio-Rad) was used for qPCR data analysis. The analysis was done using the Ct 
(CtΔΔ) equation method and normalised to the housekeeping gene GAPDH. The 
resulting analysis data was transferred to Graph Pad Prism (GraphPad, San Diego, 
CA, USA) or Microsoft Excel (Microsoft Office) for further analysis, construction of 
graphs and statistical analysis.   
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2.4 Migration of human epidermal keratinocytes and dermal 
fibroblasts following mechanical wounding in vitro using a 
scratch wound assay 
To determine the effects of 1,25(OH)2D3, cholecalciferol or 25-hydroxyvitamin 
D3 on cell migration in vitro, a scratch wound assay was used. The age of the 
donors, passage number and sample code of epidermal keratinocytes and dermal 
fibroblasts are specified in Table 2-10. Epidermal keratinocytes and dermal 
fibroblasts were plated into 6-well plates at a cell density of 300,000 cells per well, or 
200,000 cells per well respectively. The cells were incubated at 37ºC and 5% CO2 in 
air and grown to a confluency of 80%, which takes approximately two days for both 
keratinocytes and fibroblasts. Culture media was changed every two days for both 
cell types.  
2.4.1 Epidermal keratinocytes and dermal fibroblasts migration 
Once epidermal keratinocytes or dermal fibroblasts had reached 80% 
confluency, they were washed twice with PBS and the media was changed to PKSM 
(Section 2.1.2.3) or PFSM (Section 2.1.2.5). The keratinocytes/fibroblasts were 
incubated for a further 24 hours at 37ºC and 5% CO2 in air. After 24 h, the cells were 
incubated with 10μg per ml of mitomycin C for 3 hours to inhibit cell proliferation, and 
determine the true migration rate (O’Toole et al. 1999; Li et al. 2004; Wang et al. 
2012; Pomari et al. 2014). A scratch assay was performed using sterile scratch 
wound device provided by Dr. Kamala which removes a fixed width of 0.8mm of cells 
(Kamala 2014). To ensure consistency of the scratch, a predesigned template was 
used as shown in Figure 2-2A. After scratching, cells were washed twice with PBS. 
2mLs of fresh PKSM (Section 2.1.2.3)/PFSM (Section 2.1.2.5) with vehicle control 
(0.01% ethanol) or either 1nM, 10nM or 100nM of 1,25(OH)2D3 / cholecalciferol / 25-
hydroxyvitamin D3 was added to each well. Three replicates were carried out for each 
of the conditions studied. A CooLpi x4500 Nikon camera was used to take the 
images at intervals of 0, 4, 8 and 24 hours. A separate template (Figure 2-2B) was 
used to ensure pictures were taken at fixed points across the scratch wound at each 
time point. The distance between the wound edges was captured at six fixed points 
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in triplicate dishes (Figure 2-2B). 24 hours after scratching, total RNA was extracted 
from the cells to analyse changes in mRNA expression of VDR, CYPs, collagen I 
and collagen III as described in section 2.3.2 and section 2.3.3. 
 Primary epidermal keratinocytes Primary dermal fibroblasts 
Sex F F F F F F 
Age 55 59 60 59 59 60 
Passage 3 3 3 3 4 3 
Sample code EK2 EK4 EK5 DF7 DF8 DF10 
Table 2-10: Primary human epidermal keratinocytes and primary dermal fibroblasts used for 
scratch assays. F denotes female donor, EK denotes epidermal keratinocyte and DF denotes dermal 
fibroblast.  
 
Figure 2-2: Template used in scratch migration assay. (A) A vertical scratch wound was created 
using a predesigned template. (B) A separate template was created to ensure measurement of 
distance between wound edges at fixed points in each time point. 
2.4.2 Analysis of migration  
Images were taken at x125 magnification. The pictures were analysed using 
Image J. An image of the stage micrometer graticule (Ltd Tonbridge, UK) taken 
under the same magnification was used for conversion from pixels to mm. 
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The distance between the wound edges was measured at six fixed points for 
each well. As each condition was replicated in triplicate dishes, a total of 18 data 
points were obtained from each condition. The average distance was then calculated 
at the different time points (0, 8 and 24 hours). The mean migratory distance across 
the wound edges at different time points was determined. The data was transferred 
to GraphPad Prism for further statistical analysis.  
 
2.5 Metabolic activity of dermal fibroblasts quantitated by Alamar 
Blue® assay  
An Alamar Blue® assay was performed to assess whether 1,25(OH)2D3 and its 
precursors modulate dermal fibroblast metabolic activity. Dermal fibroblasts were 
seeded into 96-well plates (Corning, UK) at a density of 2000 cells/well and allowed 
to grow to a confluency of 80% in approximately 24 to 48 hours. The age of the 
donors, passage number and sample code of dermal fibroblasts used are specified 
in Table 2-11. Dermal fibroblasts were then incubated in PFSM for 24 hours. The 
PFSM was discarded and the cells washed twice with PBS before the addition of 
PFSM containing either vehicle control (0.01% absolute ethanol), or 1nM, 10nM or 
100nM of either cholecalciferol, 25-hydroxyvitamin D3 or 1,25(OH)2D3 (total volume 
of 100 μl). The Alamar Blue® (Thermo Fisher Scientific) reagent (10 μl) was added 
into each well at 21 hours after incubation with 1,25(OH)2D3 or its precursors. The 
fluorescence intensity was measured 3 h after adding the Alamar Blue® reagent, 
using a plate reader at 37ºC (FLUOstar Omega II, BMG Labtech) (excitation: 540nm, 
emission: 590nm).  
Fluorescence intensity values were exported into Microsoft Excel, and the 
results were analysed by plotting fluorescence intensity against different treatment 
conditions. Six technical replicates were performed for each of the 
1,25(OH)2D3/cholecalciferol/25(OH)D3 treatments at 3 different concentrations. Mean 
values from four different donors were used for further statistical analysis.  
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  Primary dermal fibroblasts 
Sex  F F F F 
Age 59 59 60 66 
Passage  3 3 3 3 
Sample code DF7 DF8 DF10 DF11 
Table 2-11: Primary dermal fibroblasts used in the Alamar Blue® assay 
2.6 Protein expression by immunocytochemistry 
Immunocytochemistry was performed to determine vitamin D receptor (VDR) 
and alpha-smooth muscle actin (α-SMA) protein expression. The age of the donors, 
passage number and sample code of dermal fibroblasts used are specified in Table 
2-12. Primary fibroblasts were plated in Millicell EZ slide 8-well chamber slides 
(Figure 2-3) at a cell density of 5,000 cells per well in 500µl PFGM. The media was 
changed every other day until they reached 70 to 80% confluence, which typically 
takes 3 to 5 days.   
Once the desired confluence was reached, cells were washed twice with PBS 
the media was changed to PFSM and cells incubated for 24h. A horizontal scratch 
was made using a 10µL pipette tip and the medium changed to PFSM containing 
either 10nM of 1,25(OH)2D3, cholecalciferol or 25-hydroxyvitamin D3. Each of the 
treatment conditions was done in triplicate (Figure 2-3). The cells were incubated for 
a further 24 hours before the medium was removed and the cells fixed in 4% 
formaldehyde (500 μl) for 10 minutes at room temperature. The cells were washed 
with 0.1% triton in PBS three times (5 minutes each), before 100μl 2% donkey serum 
in PBS was added to each well for blocking non-specific staining. The cells were 
incubated at room temperature for an hour before the blocking solution was removed 
by gently tapping the chamber slides upside down on tissue paper. Then 100µl of 
primary antibody (Table 2-13) was added to each well and cells were incubated for 4 
˚C overnight in a humidity chamber. For each chamber slide, a well was designated 
to be the negative control where no primary antibody was used. After incubation 
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overnight, the primary antibody was removed and the cells washed 3 times with PBS 
(15 minutes each) before addition of 100µl of secondary antibody (FITC anti-rabbit; 
Abcam: Ab98502) diluted in PBS (1:200) to each well. The cells were incubated at 
37 ˚C for one hour in a dark humidity chamber. The secondary antibody was 
removed and the cells washed with PBS three times (15 minutes each). Finally the 
wells were detached from the glass slide following the manufacturer’s protocol. 
Several drops of VECTASHIELD® Mounting Media containing 4',6-diamidino-2-
phenylindole (DAPI) (VECTOR laboratories) were added onto the slide before 
carefully covering with cover slips (22x22 mm; 0.13-0.17mm thick). Finally, the cover 
slips were fixed to each slide using nail varnish. The dilution factors of the primary 
antibodies are listed in Table 2-13.  
 VDR expression α-SMA expression 
Sex F F F F F F 
Age 38 59 60 38 59 60 
Passage 3 3 3 4 4 3 
Sample code DF2 DF7 DF10 DF2 DF7 DF10 
Table 2-12: Primary human dermal fibroblasts used for VDR and α-SMA expression in 







































Table 2-13: List of primary antibodies used in immunofluorescence study of VDR and α-SMA.  
 
Figure 2-3: Scratch assay performed in Millicell EZ slide 8-well glasses.  
2.6.1.1 Quantification of protein expression  
Fluorescence imaging was done using a confocal microscope, the ZEISS 
AxioVert 200 M with Zeiss AxioCam camera. For FITC, excitation wavelength used 
was 488 nm and emission wavelength was 514 nm. For DAPI, excitation wavelength 
used was 364 nm and emission wavelength was 460 nm.  Quantitative analysis of 
protein expression was performed using imageJ software. The values were analysed 
using Microsoft Excel and final graphs plotted using Prism (GraphPad, San Diego, 
CA, USA). For each treatment condition, two images per well were taken using the 
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same laser settings and four single cells in each image were selected randomly for 
quantitative analysis. The intensity of immunofluorescent staining was calculated 
using a formula adapted from the work of Gavet et al (Gavet and Pines 2010).  
Corrected integrated density (corrected for background fluorescence noise) 
was calculated by subtracting the density of staining signal in the region of interest 
with the multiplication product of the area of region of interest with mean of 
background staining signal (Figure 2-4). Mean of background staining signal was the 
average value of six different measurements of background noise fluorescence (i.e. 
signal per pixel) around the fibroblast cell of interest (Figure 2-4).  
 
Figure 2-4: Immunofluorescence staining of α-SMA in a human dermal fibroblasts. The yellow 
arrow is pointing at the staining signal in the region of interest, the orange arrow is showing where the 
area of region of interest is, and the grey arrow showing the background staining signal of six 
randomly selected sites around the fibroblast of interest that do not contain any cells.  
Corrected integrated density = staining signal density in the region of interest – (Area 
of the region of interest x mean background staining signal)  
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2.7 Silencing of VDR using VDR small interfering RNA (siRNA) 
Primary dermal fibroblasts were plated into 12-well plates at a density of 20,000 
to 30,000 cells per well in 1mL of PFGM. The age of the donors, passage number 
and sample code of dermal fibroblasts used are specified in Table 2-14. Once they 
were 80% confluent, the media was changed to PFSM after washing with PBS twice. 
VDR small interfering RNA (SMARTpool: ON-TARGETplus VDR siRNA from 
Dharmacon) was used for transfection. Non-target siRNA (Dhamarcon) was used as 
scramble. siRNA/Scramble-RNA mix and Lipofectamine (Thermo Scientific) mix 
were prepared separately by diluting them in Opti-MEM® medium (Table 2-15). 
siRNA/Scramble-RNA mix was then added to Lipofectamine® mix at a 1:1 ratio. The 
mixture was incubated at room temperature for 5 minutes. Finally, 100µl of the 
mixture was added to each well that already contained 1ml of PFSM. After 24 hours 
incubation at 37 ˚C, a scratch assay was performed as described in Section 2.4.1. 
RNA was then harvested for qRT-PCR to determine the extent of VDR knockdown 
and changes in the expression of CYP2R1, CYP27B1, CYP24A1 mRNA expression.  
 Primary dermal fibroblasts 
Sex F F F 
Age 56 60 66 
Passage 3 3 3 
Sample code DF7 DF10 DF11 
Table 2-14: Primary human dermal fibroblasts used in the silencing experiment for the 
migration study. F denotes female patient, DF denotes dermal fibroblasts. 
siRNA/Scamble RNA mix Lipofectamine mix 










Table 2-15: Components of siRNA/Scramble mix and Lipofectamine mix. 
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2.8 Gelatine zymography to quantify matrix metalloproteinase 
(MMP) activity 
Conditioned media was collected from dermal fibroblasts following the scratch 
assay as described in Section 2.4.1. The age of the donors, passage number and 
sample code of dermal fibroblasts used are specified in Table 2-16.  Parallel dishes 
were set up at the same time to collect media from unscratched cells. As a positive 
control, conditioned medium of fibroblasts treated with Phrobol 12-myristate 13-
acetate (PMA) at a final concentration of 100nM (Abcam ab120297) was also 
included. After 24 hours, the conditioned media was collected and pooled from the 
triplicate wells before centrifuging (Hettich Rotine 420R) for six minutes at 900g. The 
supernatant was transferred into a new Falcon tube and stored at -80°C until used in 
the zymography assays. The conditioned media was thawed out and placed on ice 
before the start of zymography. The conditioned media was diluted at 1:10 with 2x 
non-reducing sample buffer (see Appendix 9.1). 
Gelatine zymography was used to quantitate the gelatinolytic MMP-2 (Gelatinase 
A) and MMP-9 (Gelatinase B) activity of the conditioned media. The electrophoresis 
gels were prepared with acrylamide (Sigma-Aldrich, A3449) and containing 1.5 
mg/ml gelatin (Sigma-Aldrich, G6650). The separating gel contained 3.75ml of 
separating gel buffer composed of 1.5M Tris base pH 8.8, 150μl 10% Sodium 
dodecyl sulphate (SDS), 3.7ml 30% acrylamide, 0.8% bis-acrylamide mix, 75μl 10% 
ammonium persulfate (APS) (Sigma-Aldrich, UK) and 1.325ml distilled water, while 
the stacking gel contained 1.875 ml stacking gel buffer 0.5M Tris base pH 6.8, 75μl 
10% SDS, 0.975μl 30% acrylamide, 0.8% bis-acrylamide mix, 37.5μl 10% APS 
(Sigma-Adrich, UK) and 4.58ml distilled water (see Appendix 9.1 for all buffer 
compositions). Tetramethylethylene diamine (TEMED) (Sigma-Aldrich, T9281) was 
added to polymerize the gels; 30μl for the separating gel and 15μl for the stacking 
gel.  
The diluted conditioned media was loaded into the gels and the electrophoresis 
was performed for 110 minutes at 120V in 350ml running buffer. Then the gels were 
washed three times (each time for 20 minutes in 80ml 12.5x washing buffer for two 
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gels) with gentle agitation at room temperature. The gels were incubated with 1x 
incubation buffer to reactivate the gelatinase activity (100ml for each gel), for 24h in 
an incubator at 37°C (LEEC classic incubator). Gels were then stained with 
Coomassie brilliant blue staining solution (see Appendix 9.1) (100ml to stain two 
gels) for 45 minutes at room temperature on an orbital shaker (Denley Orbital Mixer). 
Images were taken using an UV/white light conversion screen-visualisation system 
(Bio-Rad, UK). Protease activity was visualised as lytic bands against the blue 
background. ImageJ software was used to quantitate the percentage change in 
levels of active MMP-2 and MMP-9 compared to vehicle control.  
  Primary dermal fibroblasts 
Sex  F F F 
Age 59 60 66 
Passage  3 3 3 
Sample code DF7 DF10 DF11 











2.9 Ex vivo wound healing assay 
An ex vivo wound healing assay was used to determine the effects of 
cholecalciferol  and 1,25-dihydroxyvitamin D3 treatment on wound closure in human 
skin. The assay was adapted from (Stojadinovic and Tomic-Canic 2013; Pellicena 
2017). The assay was performed on three individual donors,  the first was abdominal 
skin from a 59-year-old female, the second was breast skin derived from a 34-year-
old female and the third was abdominal skin from another 59-year-old female (Table 
2-17). Upon receiving the tissue samples in transporting media (Section 2.1.3.1), the 
skin was washed twice in 1 x PBS in a 60mm tissue culture dish (Sarstedt). The fat 
tissue was carefully dissected away followed by another wash with PBS. Using a 
surgical scalpel, the skin sample was cut into smaller pieces of tissue of rectangular 
shape, each measuring about 1.5cm2 (1.5cm by length and 1cm by width). The 
processed skin samples were divided into two groups, providing the non-wounded 
and wounded groups. For the wounded group, two vertical incisions were made in 
the epidermis and upper part of the papillary dermis measuring approximately 2mm 
in width and 2mm in depth. Using forceps and scissors, the epidermis was cut so 
that a wound was created. The final results produced a 40 mm3 rectangular wound 
(Figure 2-5). 
In the first ex vivo experiment, six groups of wounds from the same donor (n=3 
wounds per group) were cultured in either vehicle control (0.01% ethanol), 10% FBS 
in PFSM (Section 2.1.2.5), 10nM cholecalciferol in PFSM, 100nM cholecalciferol in 
PFSM containing 10% FBS, 1,25(OH)2D3 in PFSM, or 1,25(OH)2D3 in PFSM 
containing 10% FBS. In the second ex vivo experiment, the number of wounds per 
group was increased (n=8), and skin was cultured in either the vehicle control 
(0.01% ethanol), 10% FBS in PFSM, 10nM cholecalciferol in PFSM or 10nM 
1,25(OH)2D3 in PFSM. The third ex vivo experiment was carried out in the same way 
as the second ex vivo experiment.  
The skin explants were cultured at the air-liquid interface to simulate the in vivo 
environment. This was achieved by placing the skin explants in the lid of a 60 mm 
tissue dish (Sarstedt) (Figure 2-5). In each well, the treatment medium (2 ml) was 
93 
 
changed every day and 200 μl of treatment medium was applied onto the wound 
area using a pipette at the same time, as the media change.  
Images of each skin sample were taken using the digital camera CooLpi x4500 
Nikon magnified with the dissecting microscope (Leica) (Figure 2-5) on a daily basis. 
At either three days or four days after wounding, the ex vivo wounds from each sub-
group were frozen down rapidly by immersing in liquid nitrogen followed by storage 
in the -80ºC freezer. At day 7, all remaining skin samples were frozen down in the 
same way. Frozen samples were processed by cryosectioning (10μm) and 
haematoxylin and eosin (H&E) staining was used for histology.  
For H&E staining, the slides were thawed and air dried for several minutes to 
remove moisture. They were then fixed with acetone at -20ºC for 3 minutes. The 
slides were washed with PBS for 10 minutes before staining with 0.1% Mayer’s 
Haematoxylin (Sigma-Aldrich, UK) for 10 minutes in a 50 ml conical tube. The slides 
were transferred to a Coplin jar and were rinsed in cool running distilled water for 5 
minutes. They were then dipped in Eosin Y solution (Sigma-Aldrich, UK) for 30 
seconds. This is followed by dipping the slides in distilled water for 2 minutes. The 
slides were then equilibrate in 70% ethanol and 90% ethanol for 30 seconds each, 
followed by 100% ethanol for 1 minute. Subsequently, the slides were dipped in 3 
changes of xylene, up to 5 minutes each. Lastly, the stained tissue sections were 




Figure 2-5: Ex vivo wound healing model using skin from abdominoplasty and breast 
reduction surgery.  
The wound area of each skin sample at each time point (0, 3, 4 and 6 days) 
was analysed using ImageJ. Rate of wound closure was calculated. The results were 
















group at day 6 
1 Female 59 Abdomen 3 2 
2 Female 34 Breast 8 5 
3 Female  59 Abdomen 8 5 




2.10 Statistical Analysis 
Statistical analysis of the results obtained from the experiments were 
performed to examine the quantitative data, interpret the differences in the observed 
data and test the statistical significance of the findings, in order to accept or reject a 
null hypothesis (Nayak and Hazra 2011). In this work, statistical values were 
obtained using Microsoft Office Excel 2010 and GraphPad Prism Version 6.01.  
In experiments involving two groups, normal Gaussian distribution of the data 
from two groups was confirmed using the Kolmogorov-Smirnov test. When normally 
distributed, the difference between each donor mean was analysed using either 
paired or unpaired (parametric) Student’s t-test to compare means. If the data was 
not normally distributed, the Mann Whitney U-test (non-parametric) was used instead 
to compare medians (Hart 2001).  
When more than two groups of samples were involved, the analysis of variance 
(ANOVA) test was used. This allows comparison of any number of sample means in 
one single test. One-way ANOVA was used to analyse the effect of one variable over 
the sample mean of different treatment groups while two-way ANOVA was used to 
analyse the effects of two independent variables on a continuous dependent variable 
(Nayak and Hazra 2011).  The Bonferroni test was used as the post-hoc test.  
Significance testing of the results was assessed using the p-value (Dahiru 
2008). A p-value of less than 0.05 was considered statistically significant. A p value 
of equal or below 0.05 (denoted by * in the result section), 0.01 (denoted by **) and 




3.1 A comparison of the relative mRNA expression of VDR, 
CYP2R1, CYP27B1, and CYP24A1 in cultured human epidermal 
keratinocytes (EKs) and dermal fibroblasts (DFs) 
3.1.1 Dermal fibroblasts expressed higher levels of VDR mRNA than 
epidermal keratinocytes; while epidermal keratinocytes expressed 
higher level of vitamin D3 metabolising enzymes, in both donor-matched 
and non donor-matched samples derived from facial skin of female 
donors. 
In donor-matched samples (n=3), primary cultures of epidermal keratinocytes 
and dermal fibroblasts were derived from female donors with a mean age of 58 
(Table 2-2).  In non donor-matched samples, the mean age was 57 years (Table 2-
2). All cells were analysed at passage 2-5. 
It was confirmed that primary cultures of epidermal keratinocytes and human 
dermal fibroblasts both expressed VDR and all the CYPs for vitamin D3 metabolism. 
Cultured human dermal fibroblasts expressed a higher level of VDR mRNA 
compared to epidermal keratinocytes (Figure 3-1 and Figure 3-2). In donor-matched 
samples, it was 22-fold higher (Figure 3-1). On the other hand, epidermal 
keratinocytes expressed higher levels of CYP2R1, CYP27B1 and CYP24A1 (Figure 
3-1 and Figure 3-2). There was variability in GAPDH Ct values between donor 




Figure 3-1: The expression of VDR, CYP2R1, CYP27B1 and CYP24A1 in donor-matched 
primary cultures of human epidermal keratinocytes and dermal fibroblasts. Relative expression 
of mRNA in donor-matched EKs and DFs (n=3 donors) ± SEM quantitated by RT-qPCR. Relative 
expression level in DFs was normalised against donor-matched EKs. *Denotes p<0.05, ** denotes 











Figure 3-2: Relative expression of VDR and CYPs mRNA in the unmatched EKs (n=5, indicated by a circle) and DFs (n=8, indicated by squares) ± 
SEM quantitated by RT-qPCR. (A) VDR mRNA expression, (B) CYP2R1 mRNA expression, (C) CYP27B1 mRNA expression and (D) CYP24A1 mRNA 
expression. The relative expression was normalised against the housekeeping gene, GAPDH. Matched samples were: EK2 and DF4 (purple), EK4 and DF7 





3.2 1,25(OH)2D3 modulates migration of human epidermal 
keratinocytes and dermal fibroblasts in culture 
3.2.1 1,25(OH)2D3 stimulates migration of human epidermal keratinocytes 
in a scratch wound assay. 
To assess the effect of 1,25(OH)2D3 on cell migration, a scratch wound assay was 
carried out. All epidermal keratinocytes were derived from facial skin of female 
donors and assayed at passage number 3 (Table 2-10). The mean age of donors 
was 58 years. Scratch wound assays were conducted for up to 24 hours. Mitomycin 
C was used to block keratinocyte proliferation so that only migration was observed.  
The migratory distance of keratinocytes from the edges of the scratch wound was 
measured and analysed at 4h, 8h and 24h after the initial scratch, between fixed 
points using the template described in Section 2.4.1 (Figure 2-2B). Images of 
epidermal keratinocytes at 0 and 24 hours are shown in Figure 3-3A. At 4 and 8 
hours, 1,25(OH)2D3 had no effect on epidermal keratinocyte migration. However, by 
24 hours, 1,25(OH)2D3 had accelerated epidermal keratinocyte migration at all three 







Figure 3-3: 1,25(OH)2D3 accelerates epidermal keratinocytes migration in a scratch wound 
assay. (A) Representative images of epidermal keratinocytes incubated with vehicle control (0.01% 
ethanol) or 1nM/10nM/100nM of 1,25(OH)2D3. (B) Analysis of migration was performed after 4, 8 and 
24 hours. Cells were assayed in triplicate wells, with six measurements per well. Data presented as 
mean (n=3 donors) ± SEM *Denotes p<0.05, **denotes p<0.01 using two-way ANOVA. 
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3.2.2 1,25(OH)2D3 inhibits migration of human dermal fibroblasts in a 
scratch wound assay. 
All dermal fibroblasts were derived from facial skin of female donors and assayed 
between passage number 3-4 (Table 2-10). The mean age of donors was 59 years. 
Scratch wound assays were conducted for up to 24 hours. Mitomycin C was used to 
inhibit fibroblasts proliferation so that true migration could be observed.  
The migratory distance of fibroblasts from the edges of the scratch wound was 
measured and analysed at 4h, 8h and 24h following scratching, between fixed points 
using the template described in Section 2.4.1 (Figure 2-2B). In the presence of 10% 
FBS, incubation with 1,25(OH)2D3 had no effect on dermal fibroblast migration up to 
24 hours. At 24 hours, migration was inhibited by 1,25(OH)2D3 at all three 
concentrations (Figure 3-4B). Images of dermal fibroblasts at 0 and 24 hours are 
shown in Figure 3-4A.  
To assess whether the presence of serum masks the effect of migration or possibly 
reduces bio-availability of 1,25(OH)2D3, migration assays were repeated in serum 
free media. In serum free media, incubation with 1,25(OH)2D3 at all three 
concentrations inhibited dermal fibroblast migration as early as 4 hours and for up to 











Figure 3-4: In the presence of serum, 1,25(OH)2D3 inhibits dermal fibroblast migration in a 
scratch wound assay after 24 hours. (A) Representative images of dermal fibroblasts incubated 
with vehicle control (red hatched bar-0.01% ethanol) or 1nM/10nM/100nM (grey/light yellow/dark 
yellow hatched bars) of 1,25(OH)2D3. (B) Analysis of migration was performed after 4, 8 and 24 hours. 
Cells were assayed in triplicate wells, with six measurements per well. Data presented as mean (n=3 





Figure 3-5: 1,25(OH)2D3 inhibits dermal fibroblast migration in serum free media as early as 4 
hours and for up to 24 hours. (A) Representative images of dermal fibroblasts incubated with 
vehicle control (0.01% ethanol) or 1nM/10nM/100nM of 1,25(OH)2D3. (B) Analysis of migration was 
performed after 4, 8 and 24 hours. Cells were assayed in triplicate wells, with six measurements per 




3.2.3 Precursors of 1,25(OH)2D3 did not modulate migration of cultured 
human dermal fibroblasts in a scratch wound assay. 
Incubation with cholecalciferol (1-100nM) did not modulate migration of dermal 
fibroblasts at any time points measured up to 24 hours in either media containing 
10% FBS or serum free media (Figure 3-6A and Figure 3-6B). 
Similarly, incubation with 25(OH)D3 (1-100nM) did not modulate migration of 
dermal fibroblasts at any of the time points up to 24 hours in either media containing 










Figure 3-6: Cholecalciferol and 25(OH)D3 do not modulate cultured dermal fibroblasts 
migration in a scratch wound assay. Migration distance of dermal fibroblasts at 4, 8 and 24 h 
after scratching, incubated with (A) vehicle control (0.01% ethanol) in 10% FBS or 1/10/100nM 
cholecalciferol in 10% FBS (B) vehicle control (0.01% ethanol) in serum free media or 
1/10/100nM cholecalciferol in serum free media (C) vehicle control (0.01% ethanol) in 10% FBS 
or 1/10/100 25(OH)D3 in 10% FBS (D) vehicle control (0.01% ethanol) in serum free media or 
1/10/100 25(OH)D3 in serum free media. Vehicle control (red), 1/10/100nM cholecalciferol (light 
green to dark green), 1/10/100nM 25(OH)D3 (light purple to dark purple). Data presented as 





3.3 Incubation with 1,25(OH)2D3 or its precursors did not 
modulate metabolic activity of human dermal fibroblasts 
after 24 hours  
An Alamar Blue Assay was used to assess the effect of 1,25(OH)2D3 and 
its precursors on metabolic activity of human dermal fibroblasts in a scratch 
wound assay. Dermal fibroblasts were derived from facial skin of four female 
donors, with a mean age of 61 years (Table 2-11).  
1,25(OH)2D3, cholecalciferol and 25(OH)D3 did not modulate metabolic 
activity of dermal fibroblasts after 24 hours incubation, under either non-















Figure 3-7: Fluorescence intensity reading from the Alamar Blue Assay, representative of 
the relative metabolic activity of dermal fibroblast, after 24 h incubation of either non-
scratched or scratched dermal fibroblasts, in (A) vehicle control (0.01% ethanol), 
1/10/100nM 1,25(OH)2D3; (B) vehicle control (0.01% ethanol), 1/10/100nM cholecalciferol; 
(C) vehicle control (0.01% ethanol), 1/10/100nM 25-hydroxyvitamin D3. Solid bar = non-
scratched dermal fibroblasts, hatched bar = scratched dermal fibroblasts. Data was presented 
as the mean of four donors ± SEM.    
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3.4 Nuclear VDR protein expression was upregulated only in 
scratched dermal fibroblasts, in the presence of 
1,25(OH)2D3 
All dermal fibroblasts were derived from facial skin of female donors and 
assayed at passage 3 (Table 2-12). The median age of donors (n=3) was 59 
years. At basal conditions, VDR was found localised mainly in the perinuclear 
region of dermal fibroblasts (Figure 3-8A, Figure 3-9A, and Figure 3-10A). 
While incubation with 1,25(OH)2D3 did not alter the nuclear protein 
expression of VDR in unscratched dermal fibroblasts, in mechanically wounded 
dermal fibroblasts incubation with 10nM of 1,25(OH)2D3 significantly 
upregulated the nuclear protein expression of VDR (Figure 3-8).  However, 
nuclear protein expression of VDR in unscratched and scratched dermal 
fibroblasts were unchanged after 24 hours incubation with either 10nM 















Figure 3-8: 1,25(OH)2D3 upregulates nuclear VDR expression in scratched human dermal 
fibroblasts. Vitamin D receptor (VDR) immunofluorescent staining (green) with nuclear DAPI 
staining (red) in non-scratched and scratched dermal fibroblasts, incubated with or without 
10nM 1,25(OH)2D3 for 24 hours. (A) vehicle control (0.01% ethanol): non-scratched dermal 
fibroblasts; (B) vehicle control (0.01% ethanol): scratched dermal fibroblasts; (C) 10nM 
1,25(OH)2D3: non-scratched dermal fibroblasts; (D) 10nM 1,25(OH)2D3: scratched dermal 
fibroblasts. (E) Corrected integrated density of nuclear staining of VDR in non-scratched (non-
hatched bars) and scratched (hatched bars) dermal fibroblasts, in the absence (red) or the 
presence (yellow) of 10nM 1,25(OH)2D3. Data are presented as patient mean (n=3 donors), 
normalised against (A) ± SEM. **Denotes p<0.01 using one-way ANOVA test. Magnification = 





Figure 3-9: Cholecalciferol does not modulate nuclear VDR expression. Vitamin D receptor 
(VDR) immunofluorescent staining (green) with nuclear DAPI staining (blue) in non-scratched 
and scratched dermal fibroblasts, incubated with or without 10nM cholecalciferol for 24 hours. 
(A) vehicle control (0.01% ethanol): non-scratched dermal fibroblasts; (B) vehicle control (0.01% 
ethanol): scratched dermal fibroblasts; (C) 10nM cholecalciferol: non-scratched dermal 
fibroblasts; (D) 10nM cholecalciferol: scratched dermal fibroblasts. (E) Corrected integrated 
density of nuclear staining of VDR in non-scratched (non-hatched bars) and scratched (hatched 
bars) dermal fibroblasts, in the absence (red) or the presence (green) of 10nM choleclaciferol. 
Data are presented as patient mean (n=3 donors), normalised against (A) ± SEM. Magnification 






Figure 3-10: 25(OH)D3 does not modulate nuclear VDR expression. Vitamin D receptor 
(VDR) immunofluorescent staining (green) with nuclear DAPI staining (blue) in non-scratched 
and scratched dermal fibroblasts, incubated with or without 10nM 25(OH)D3 for 24 hours. (A) 
vehicle control (0.01% ethanol): non-scratched dermal fibroblasts; (B) vehicle control (0.01% 
ethanol): scratched dermal fibroblasts; (C) 10nM 25(OH)D3: non-scratched dermal fibroblasts; 
(D) 10nM 25(OH)D3: scratched dermal fibroblasts. (E) Corrected integrated density of nuclear 
staining of VDR in non-scratched (non-hatched bars) and scratched (hatched bars) dermal 
fibroblasts, in the absence (red) or the presence (purple) of 10nM 25(OH)D3. Data are 
presented as patient mean (n=3 donors), normalised against (A) ± SEM.  Magnification = 40x. 
Scale bar = 10 µm 
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3.5 Knockdown of VDR abolished the inhibitory effect of 
1,25(OH)2D3 on human dermal fibroblast migration  
All dermal fibroblasts were derived from facial skin of female donors and 
assayed at passage 3 (Table 2-13). The median age of donors was 61 years. 
VDR siRNA transfection was successful with efficiency between 89-91% (Figure 
3-11). Silencing of VDR resulted in abolishment of the inhibitory effects of 10nM 
1,25(OH)2D3 on dermal fibroblasts migration up from 4 hours and for up to 24 
hours (Figure 3-12A and Figure 3-12B).  
 
 
Figure 3-11: VDR siRNA transfection achieved VDR knockdown efficiency of 89-91% in 
scratched dermal fibroblasts. Quantitative comparison of mRNA expression levels for VDR in 
vehicle control (red hatched); 10nM 1,25(OH)2D3 and non-target siRNA control (yellow 
hatched); 1,25(OH)2D3 and VDR siRNA (grey hatched). All assays were performed in triplicate. 







Figure 3-12: VDR knockdown with siRNA abolished the inhibitory effect of 1,25(OH)2D3 on 
dermal fibroblast migration in a scratch wound assay. (A) Representative images of dermal 
fibroblasts incubated with, or without 10nM 1,25(OH)2D3, transfected with either non-target 
siRNA or VDR siRNA. Red: vehicle control + non-target siRNA; pink: vehicle control + VDR 
siRNA; yellow: with 1,25(OH)2D3 + non-target siRNA; orange: with 1,25(OH)2D3 + VDR siRNA 
(B) Analysis of migration was done at 4, 8 and 24 hours after scratching. Cells assayed in 
triplicate wells, with six measurements per well. Data presented as mean (n=3 donors) ± SEM. 
*Denotes p<0.05 using two-way ANOVA. 
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3.6 Mechanical wounding did not modulate relative mRNA 
expression of VDR, CYP2R1, CYP27B1 and CYP24A1 
mRNA in epidermal keratinocytes and dermal fibroblasts. 
 
In order to understand why there are differences in the migratory response 
of epidermal keratinocytes and dermal fibroblasts to 1,25(OH)2D3, mechanical 
wounding (scratching) of monolayers of epidermal keratinocytes and dermal 
fibroblasts was performed to investigate whether it affects mRNA expression of 
VDR, CYP2R1, CYP27B1 and CYP24A1. Both the keratinocytes and fibroblasts 
were derived from facial skin of female donors and assayed between passages 
3 to 5. The mean age of donors for keratinocytes (n=5) and fibroblasts (n=8) 
was 57 years (Table 2-2). 
There was no significant change in the transcriptional activities of vitamin 
D receptor (VDR) or the vitamin D3 metabolising enzymes 24 hours after 
mechanical wounding in either cell type in the absence of any of the vitamin D3 
ligands (Figure 3-13). To determine whether the presence of 1,25(OH)2D3 
modulated the expression of the VDR or the CYP enzymes, further studies were 




Figure 3-13: Mechanical wounding of cultured epidermal keratinocytes and dermal 
fibroblasts does not modulate VDR and CYP transcriptional activities in a scratch wound 
assay. Relative mRNA expression of VDR, CYP2R1, CYP27B1, and CYP24A1 in non-
scratched and scratched (A) epidermal keratinocytes (n=5 donors) (B) Dermal fibroblasts (n=8 
donors), quantified by qRT-PCR. Relative expression for scratched epidermal 
keratinocytes/dermal fibroblasts were normalised against non-scratched epidermal 
keratinocytes/dermal fibroblasts. For each donor, the assay was performed in triplicates. Data 





3.7 1,25(OH)2D3 and 25(OH)D3 increased CYP24A1 mRNA 
expression in epidermal keratinocytes and dermal 
fibroblasts, but did not modulate VDR mRNA expression. 
Cholecalciferol increased VDR and all the CYP enzymes 
mRNA expression in scratched dermal fibroblasts. In non-
scratched dermal fibroblasts, only CYP27B1 expression 
was upregulated by cholecalciferol. 
All epidermal keratinocytes and dermal fibroblasts were derived from facial 
skin of female donors with a mean age of 58 years and 59 years respectively.  
All cells were assayed at passage 3-4 (Table 2-10). There was variability 
between GAPDH Ct values between donors, up to a maximum of 1 cycle. 
However, there was no variability in GAPDH Ct values between treatments, 
within the same donor samples.  
Incubation with 10nM of 1,25(OH)2D3 increased CYP24A1 mRNA 
expression in both keratinocytes and fibroblasts, under both non-scratched and 
scratched conditions after 24 hours. Upregulation in CYP24A1 expression was 
approximately 100-200 times higher in epidermal keratinocytes than dermal 
fibroblasts. In addition, the upregulatory effect of 1,25(OH)2D3 seen in scratched 
keratinocytes almost doubled that seen in non-scratched keratinocytes. On the 
other hand, mRNA expression of VDR, CYP2R1 and CYP27B1 was not 
modulated by the presence of 1,25(OH)2D3 in either cell types (Table 3-1).  
In non-scratched dermal fibroblasts, incubation with 10nM cholecalciferol for 
24 hours almost doubled CYP27B1 mRNA expression compared to vehicle 
control. In scratched fibroblasts, 10nM cholecalciferol increased VDR, CYP2R1, 
CYP27B1 and CYP24A1 mRNA expression. The increase in CYP24A1 
expression was approximately a quarter of that seen in scratched dermal 
fibroblasts incubated with 1,25(OH)2D3 (Table 3-1). 
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Incubation with 25(OH)D3 for 24 hours upregulated CYP24A1 mRNA 
expression in dermal fibroblasts, at a level lower to that seen in 1,25(OH)2D3. 
There were no changes to the mRNA expression of VDR, CYP2R1 and 
















0.88 ± 0.09 0.69 ±0.19 0.94 ± 0.05 0.78 ± 0.14 
Scratched 0.99 ± 0.11 0.78 ± 0.11 4.00 ± 0.08 
*** 
0.83 ± 0.09 
CYP2R1 Non-
scratched  
1.03 ± 0.06 0.76 ± 0.12 0.96 ± 0.07 0.88 ± 0.10 
Scratched 0.97 ± 0.08 0.88 ± 0.06 3.53 ± 0.52 
*** 
0.93 ± 0.05 
CYP27B1 Non-
scratched 
1.19 ± 0.13 1.27 ± 0.22 1.81 ± 0.14 
** 
1.22 ± 0.24 
Scratched 1.10 ± 0.05 1.37 ± 0.24 2.00 ± 0.46 
** 





15.18 ± 1.64 
*** 
0.93 ± 0.11 13.55 ± 1.72 
*** 
Scratched 2749.59 ± 
68.45 *** 
12.00 ± 1.38 
*** 
3.53 ± 0.47   
*** 
8.55 ± 0.96 
*** 
Table 3-1: Summary of the relative mRNA expression of VDR, CYP2R1, CYP27B1 and 
CYP24A1 in primary keratinocyte (n=3) and dermal fibroblast (n=3) after 24h incubation 
with 10nM of 1,25(OH)2D3 or its precursors. Data presented as the mean relative expression 
normalised against vehicle control (0.01% ethanol) ± SEM. **Denotes p<0.01, *** denotes 
p<0.001 using two-way ANOVA. 
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3.8  VDR knockdown with siRNA upregulated CYP27B1 mRNA 
expression, only in scratched dermal fibroblasts. 
All dermal fibroblasts were derived from facial skin of female donors with a 
mean age of 61 years and assayed at passage 3-4 (Table 2-13). All dermal 
fibroblasts were incubated with or without 10nM 1,25(OH)2D3. Dermal 
fibroblasts without siRNA transfection were used as a negative control. Relative 
mRNA expression of VDR, CYP2R1, CYP27B1 and CYP24A1 was normalised 
against the negative control (i.e. PFSM with 2.5 μl of Lipofectamine® RNAiMAX 
reagent and 105 μl of opti-MEM).  
VDR knockdown in scratched and non-scratched dermal fibroblasts resulted 
in approximately 89-91% decrease in VDR mRNA expression, in both scratched 
and non-scratched dermal fibroblasts (Table 3-2). In scratched dermal 
fibroblasts, there was a 2-fold increase in CYP27B1 expression after silencing 
of VDR, in the absence or presence of 1,25(OH)2D3. There was no change in 
CYP27B1 expression in non-scratched dermal fibroblasts (Table 3-2). CYP2R1 
and CYP24A1 mRNA expression were not modulated by VDR knockdown 








































1.02 ±  
0.03 
0.11 ±  
0.02 *** 




1.01 ±  
0.04 








1.02 ±  
0.07 
1.03 ±  
0.03 




1.03 ±  
0.05 








1.01 ±  
0.04 
1.10 ±  
0.02 




0.98 ±  
0.03 








1.03 ±  
0.05 
1.13 ±   
0.06 




0.96 ±  
0.03 
1.08 ±  
0.05 
Table 3-2: Summary of the relative mRNA expression of VDR, CYP2R1, CYP27B1 and 
CYP24A1 in human dermal fibroblasts (n=3) after 24h incubation with vehicle control or 
10nM of 1,25(OH)2D3 and non-target siRNA/VDR siRNA. Data was presented as the mean 
relative expression normalised against vehicle control ± SEM. **Denotes p<0.01, *** denotes 
p<0.001 using two-way ANOVA test. 
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3.9 1,25(OH)2D3 downregulated α-SMA expression in scratched 
human dermal fibroblasts after 24 hours incubation 
It has previously been shown that mechanical scratching increases the 
expression of α-SMA in cultured human dermal fibroblasts (Pomari et al. 2014). 
To determine whether 1,25(OH)2D3 or its precursors modulate α-SMA 
expression in dermal fibroblasts, in particular after mechanical scratching, 
immunofluorescent staining of α-SMA was performed. Dermal fibroblasts were 
derived from facial skin of three female donors, with a median age of 59 years, 
all assayed at passage number 3-4 (Table 2-11). 
Scratching results in an upregulation of α-SMA expression by dermal 
fibroblasts in vehicle control (Figure 3-14). However, 10nM 1,25(OH)2D3 
significantly downregulated expression of α-SMA in mechanically wounded 
dermal fibroblasts after 24 hours (Figure 3-15 and Figure 3-16). This 
downregulation of α-SMA was confirmed by preliminary results using Western 
Blotting technique (Appendix 9.2). Incubation of scratched dermal fibroblasts 
with 10nM cholecalciferol and 10nM of 25-hydroxyvitamin D3 for 24 hours had 
no significant effect on α-SMA protein expression by dermal fibroblasts in vitro 










Figure 3-14: Scratching upregulated α-SMA expression in human dermal fibroblasts. α-
SMA immunofluorescent staining (green) with nuclear DAPI staining (blue) in (A) non-scratched 
(unhatched bar) and (B) scratched (hatched bar) dermal fibroblasts. (C) Quantitative data of 
cytoplasmic staining of α-SMA are presented as patient mean (n=3 donors) ± SEM. ***Denotes 










Figure 3-15: Only 1,25(OH)2D3 downregulated α-SMA expression in scratched human 
dermal fibroblasts. α-SMA immunofluorescent staining (green) with nuclear DAPI staining 
(blue) in (A) vehicle control (0.01% ethanol); (B) 10nM 1,25(OH)2D3 (C) 10nM cholecalciferol; 











Figure 3-16: Quantitative data of cytoplasmic staining of α-SMA in scratched dermal 
fibroblasts after 24h incubation with vehicle control-0.01% ethanol (red bars) or (A) 10nM 
1,25(OH)2D3 (yellow bars); (B) 10nM cholecalciferol (green bars); and (C) 10nM of 
25(OH)D3 (purple bars). Data are presented as patient mean (n=3 donors) ± SEM. ***Denotes 
p<0.001 using paired student’s t-test.  
124 
 
3.10 Soluble MMP-2 activity was upregulated by 10nM 
cholecalciferol but downregulated by 10nM 1,25(OH)2D3 in 
scratched dermal fibroblasts after 24 hours  
Soluble MMP-2 activity was quantified using gelatine zymography. Dermal 
fibroblasts were derived from facial skin of three female donors, assayed at 
passage 3, with a mean age of 62 (Table 2-15).  
Scratching cultured dermal fibroblasts resulted in the downregulation of 
soluble MMP-2 activity (Figure 3-17). Neither 10nM of cholecalciferol or 
1,25(OH)2D3 modulated MMP-2 activity by non-scratched dermal fibroblasts. 
However, in scratched dermal fibroblasts, cholecalciferol upregulated MMP-2 















Figure 3-17: Scratching downregulates MMP-2 activity by cultured human dermal 
fibroblasts. Soluble MMP-2 activity by dermal fibroblasts (non-scratched and scratched) after 
24 hours incubation with 10nM  cholecalciferol or 10nM 1,25(OH)2D3 were quantified using 
imageJ software. (A) Gelatine zymography image: S-VC (scratched-vehicle control), NS-VC 
(non-scratched-vehicle control), NS-Cho (non-scratched, cholecalciferol), NS-1,25 (non-
scratched, 1,25(OH)2D3); (B) Gelatine zymography image: S-VC (scratched-vehicle control), 
NS-VC (non-scratched-vehicle control), S-Cho (scratched, cholecalciferol), S-1,25 (scratched, 
1,25(OH)2D3) (C) Data presented as percentage of control (n=3) ± SEM, with non-scratched 
dermal fibroblasts (vehicle control) being the control. Non-scratched dermal fibroblasts 
(unhatched bars); scratched dermal fibroblasts (hatched bars); vehicle control (0.01% ethanol) – 
red bars; 10nM 1,25(OH)2D3 – yellow bars; 10nM cholecalciferol – green bars *Denotes p<0.05, 
** p<0.01, *** p<0.001 using two-way ANOVA. 
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3.11 1,25(OH)2D3 upregulated type I collagen mRNA expression 
in non-scratched dermal fibroblasts. However, collagen I/III 
mRNA expression and type I to III collagen ratio were 
downregulated by 1,25(OH)2D3 in scratched dermal 
fibroblasts.  
The effect of 1,25(OH)2D3 on mRNA expression of collagen I and collagen 
III by cultured dermal fibroblasts were assessed using qRT-PCR.  Mechanical 
scratching increased mRNA expression of type I collagen while having no effect 
on type III collagen expression at 24 hours (Figure 3-18). Type I to III collagen 
ratio was upregulated (Figure 3-18).  
In non-scratched dermal fibroblasts, incubation with 10nM and 100nM of 
1,25(OH)2D3 upregulated collagen I mRNA expression. The opposite effect was 
observed in scratched dermal fibroblasts, where incubation with 1nM, 10nM and 
100nM of 1,25(OH)2D3 downregulated both collagen I and collagen III mRNA 
expression.  
24 hours incubation with 10 and 100nM of 1,25(OH)2D3 upregulated type I 
to III collagen ratio in non-scratched dermal fibroblasts. In scratched fibroblasts, 
type I to III collagen ratio was downregulated by 1,25(OH)2D3 at all 











Figure 3-18: Scratching upregulates collagen I mRNA expression in cultured human 
dermal fibroblasts.  mRNA expression was normalised against non-scratched dermal 
fibroblasts. Data was presented as the mean of 3 donors ± SEM. Non-scratched dermal 
fibroblasts (unhatched bars); scratched dermal fibroblasts (hatched bars); *Denotes p<0.05 





     
 
 
Figure 3-19: Collagen I and collagen III mRNA expression in the presence or absence of 
1,25(OH)2D3. mRNA expression was normalised against vehicle control (0.01% ethanol) in 
either (A) non-scratched (unhatched bars) or (B) scratched (hatched bars) dermal fibroblasts. 
Data was presented as the mean of three donors ± SEM. Vehicle control (red bars); 1nM 
1,25(OH)2D3 (grey bars); 10nM 1,25(OH)2D3 (light yellow); 100nM 1,25(OH)2D3 (dark yellow); 







3.12 The establishment of an ex vivo human skin wound 
healing model 
Figure 3-20 showed that partial thickness wounds artificially created on 
skin explants gradually closed over a 6 day period. Haematoxylin and Eosin 
(H&E) staining demonstrated the extension of the epithelial tongue into the 
wound at day 6. This is characterised by epithelial cells from the epidermis 
neighbouring the wound site migrate over the surface of the wound bed. There 
was an increase in the thickness of granulation tissues at day 6 compared to 
immediately after wounding (Figure 3-20). 
The effect of cholecalciferol or 1,25(OH)2D3 on cutaneous wound repair was 
assessed by measuring the rate of wound closure (re-epithelialization) at 
different time points.  
Two separate ex vivo wound healing studies were carried out using either 










Figure 3-20:  Human skin explants used for ex vivo wound healing model. A partial 
thickness incisional wound was created, comprising the epidermis and upper part of the dermis, 
by making two parallel incision with a scalpel. The width of each cut was approximately 1mm. 
(A) Partial thickness incisional wound at 0 hour. (B) Partial thickness incisional wound after 6 
days. (C) H&E staining of representative section of 8 µm, cut nearest to the center of the wound 
at 0 hour. (D) H&E staining of representative section of 8 µm, cut nearest to the center of the 
wound after 6 days. There was an increase in the thickness of the granulation tissue at day 6 








3.12.1   1,25(OH)2D3, but not cholecalciferol accelerated rate of wound 
closure in a human ex vivo model. 
In abdominal skin, incubation with 10% FBS increased the rate of wound 
closure after 3 days (n=3 replicates). Incubation with 10nM 1,25(OH)2D3 
produced similar upregulation at day 3, independent to the presence of FBS. 
Incubation with both 10% FBS and 10nM 1,25(OH)2D3 did not  increase the rate 
of wound closure any further. At day 6, there was no difference in wound 
closure rate between the groups (Figure 3-21).  
Ex vivo wound healing assay was repeated using breast skin, with an 
increased number of replicates of group. After 4 days, 10% FBS and 10nM 
1,25(OH)2D3 both increased the rate of wound closure. The effect of FBS 
(240%) was greater than 1,25(OH)2D3 (115%), although the difference between 
the two groups was not statistically significant. Cholecalciferol had no effect as 
seen previously. After 6 days, while 1,25(OH)2D3 had no effect as seen in the 
previous donor, FBS still exerted a stimulating effect on wound closure by 166% 
(Figure 3-22).  
The third ex vivo wound healing assay was performed using abdominal 
skin again, with a higher number of technical replicates per treatment group this 
time. 10% FBS and 10nM 1,25(OH)2D3 both increased the rate of wound 
closure after 3 days (n=8 replicates). At day 6, only 10% FBS produced an 
increase in wound closure (n=5 replicates) but no effect was seen with either 





Figure 3-21:  Rate of closure of ex vivo wounds (abdominal skin) treated with 10nM 
cholecalciferol or 10nM 1,25(OH)3D3 with or without FBS. Negative control refers to PFSM 
with 0.01% ethanol and positive control refers to PFSM with 10% FBS. (A) Rate of wound 
closure at day 3 without FBS; (B) Rate of wound closure at day 3 with 10% FBS; (C) Rate of 
wound closure at day 6 without FBS; (D) Rate of wound closure at day 6 with 10% FBS. n=3 
technical replicates per group at 3 days after wounding and n=2 technical replicates per group 
at 6 days hours after wounding. Vehicle control (red bars); 10nM cholecalciferol (green bars); 





Figure 3-22:  Rate of closure of ex vivo wounds (breast skin) treated with 10nM 
cholecalciferol or 10nM 1,25(OH)3D3. PFSM with 0.01% ethanol was used as a negative 
control and PFSM with 10% FBS was used as a positive control. (A) Rate of wound closure at 4 
days; (B) Rate of wound closure at 6 days. n=8 technical replicates per group at day 4 after 
wounding and n=5 technical replicates per group at day 6 after wounding. Serum free media 
(red bars); PFSM with 10% FBS (grey bars); PFSM with 10nM cholecalciferol (green bars); 






Figure 3-23:  Rate of closure of ex vivo wounds (abdominal skin) treated with 10nM 
cholecalciferol or 10nM 1,25(OH)3D3. PFSM with 0.01% ethanol was used as a negative 
control and PFSM with 10% FBS was used as a positive control. (A) Rate of wound closure at 3 
days; (B) Rate of wound closure at 6 days. n=8 technical replicates per group at day 3 after 
wounding and n=5 technical replicates per group at day 6 after wounding. Serum free media 
(red bars); PFSM with 10% FBS (grey bars); PFSM with 10nM cholecalciferol (green bars); 




The ageing population presents a huge challenge to the healthcare service. 
As the elderly is commonly burdened with chronic non-healing wounds, new 
therapies aimed at improving wound healing are always being sought. Over the 
past decades, there is an increasing recognition in the multitude of regulatory 
roles played by vitamin D in maintaining healthy tissue functions. Low serum 
level of vitamin D is associated with chronic non-healing venous ulcers in 
clinical trials (Burkiewicz et al. 2012). In addition, vitamin D supplementation for 
12 weeks was shown to improve wound healing in patients suffering from 
diabetic foot ulcer (Razzaghi et al. 2017). In murine study, absence of VDR or 
1,25(OH)2D3 resulted in impaired granulation tissue formation (Luderer et al. 
2013). While there is renewed interest in exploring the molecular pathways that 
vitamin D utilises to exert its regulatory functions in the skin, most studies have 
placed emphasis on the epidermal keratinocyte model (Vantieghem et al. 2006; 
Gombart 2009). Little is known about the roles of vitamin D in human dermal 
fibroblasts. In addition, many questions remain unanswered about the autocrine 
and paracrine functions served by dermal fibroblasts in regulating the 
bioavailability of active vitamin D in the skin.  
4.1 Dermal fibroblast express higher VDR mRNA while 
epidermal keratinocytes express higher CYPs 
Previous studies have shown that a complete and functional photo-
endocrine vitamin D system exists in human epidermal keratinocytes 
(Vantieghem et al. 2006; Bikle 2011). Upon UVB irradiation, epidermal 
keratinocytes are able to produce cholecalciferol from endogenous 7-
dehydrocholesterol (Vantieghem et al. 2006). Cholecalciferol is further activated 
in the skin via a two-step hydroxylation process to the physiologically active 
form, 1,25(OH)2D3 (Vantieghem et al. 2006). Although there have been previous 
studies confirming the expression of VDR in the human dermal fibroblast, there 
is limited, conflicting literature providing evidence to dermal vitamin D3 
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photoproduction (Vantieghem et al. 2006; Ellfolk et al. 2009; Zerr et al. 2015). A 
recent study by Norlin et al (2017) suggested that primary dermal fibroblasts 
also have an active vitamin D3 metabolising system and express mRNA for 
VDR (Norlin et al. 2017). In their study, 25-hydroxylase (CYP2R1) and 1α-
hydroxylase (CYP27B1) activities in cultured human dermal fibroblasts were 
confirmed using high performance liquid chromatography (HPLC) and an 
enzyme-linked immunosorbent assay (ELISA) (Norlin et al. 2017). The limitation 
in their study is that it was not specified in the study which body sites the skin 
samples were harvested from, although the study did mention that it was skin 
donated from plastic surgery excision biopsy. In another study by Vantieghem 
et al (2006) using dermal fibroblasts derived from juvenile foreskin, it was 
reported that only CYP2R1 and CYP24A1 activity were detected using Northern 
Blot analysis, but CYP27B1 was not detected (Vantieghem et al. 2006).  
In order to clarify, the present study uses both donor-matched (n=3 donors) 
and non donor-matched keratinocytes (n=3 donors) and fibroblasts (n=8 
donors). It has been demonstrated that both epidermal keratinocyte and dermal 
fibroblast exhibit a complete vitamin D3 metabolising system at the 
transcriptional level (Figure 3-1 and Figure 3-2). Moreover, by using donor-
matched samples, it was shown for the first time that human dermal fibroblast 
expressed a much higher level of VDR than keratinocytes (Figure 3-1 and 
Figure 3-2). This suggests that fibroblasts could be more responsive to the 
actions of 1,25(OH)2D3 than keratinocytes. In addition, by including non donor-
matched samples, data from up to eight individual donors were analysed to 
account for possible inter-individual variability. The finding that VDR mRNA 
expression was still significantly higher in fibroblasts lends strength to the 
observation in donor-matched samples. Higher VDR expression by dermal 
fibroblast indicates that fibroblast is an active key player in regulating normal 
tissue homeostasis in the skin. This is in contrast to the traditional view of 
fibroblast as a quiescent cell solely responsible for extracellular matrix 
production (Frazier et al. 1996; Roh et al. 2010). While epidermal keratinocytes 
play a central role in maintaining the integrity of epithelial barrier, dermal 
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fibroblast has a wider range of functions, due to its close proximity and cross-
talk with other cell types such as adipocytes, vascular endothelial cells and 
inflammatory cells (Hughes 2008; Ezure and Amano 2011; Van Linthout et al. 
2014; Costa-Almeida et al. 2015; Haubner et al. 2015).  
In contrast cultured human epidermal keratinocytes expressed higher levels 
of the vitamin D3 metabolising enzymes – CYP2R1, CYP27B1 and CYP24A1 
than dermal fibroblasts in both donor-matched and non donor-matched 
samples. This is hardly surprising as the highest concentration of 7-
dehydrocholesterol (7-DHC) is found in the epidermis, mainly in the stratum 
basale and stratum spinosum (Gaylor and Sault 1964; Herrmann et al. 2016). 7-
DHC is an intermediate metabolite during endogenous synthesis of 
cholecalciferol. It is secreted by the sebaceous glands and absorbs UVB 
radiation most effectively at wavelengths of 280-315 nm for photolysis of the B 
ring of the sterol nucleus (Whiting and Calvo 2013). UVB with a relatively high 
frequency and short wavelength reaches the skin and is absorbed to a great 
extent by the epidermis (Figure 4-1). Only a small fraction of UVB reaches the 
dermis (Gupta et al. 2013). The anatomical positioning of keratinocytes and 
fibroblasts within different layers of the skin hence plays a large part in 
determining their participation in the photoproduction of active vitamin D3. This 
could also partly explain the conflicting findings by Vantieghem et al (2006) and 
Norlin et al (2017). Skin from juvenile foreskin and plastic surgery skin biopsy 
were used respectively in each study. Juvenile foreskin is generally non sun-
exposed. In contrast, skin donated in plastic surgery is commonly obtained from 
body sites that has greater sun exposure such as face and neck (Trost et al. 
2016). This present study has used skin from facelift surgery (Table 2-1), and it 
showed that dermal fibroblast expressed the VDR and all the CYPs at the 
transcriptional level (Figure 3-1 and Figure 3-2), which correlates with the 
findings by Norlin et al (2017). This supports the hypothesis that there is site 
specific variation in the activity of the CYPs in the dermis, and only sun-exposed 






Figure 4-1: Wavelength-dependent penetration of UV radiation in the skin affects site of 
vitamin D3 photoproduction. UVB of 280-315nm wavelengths are absorbed to a greater 
extent in the epidermis. Sebaceous glands secrete 7-dehydrocholesterol, an intermediate 
metabolite in the synthesis of cholecalciferol in the skin. It then accumulates at the Malpighian 
layer of the epidermis, in the stratum spinosum and stratum basale (Beckman and Deluca 




4.2 1,25(OH)2D3 stimulates epidermal keratinocyte migration. 
Conversely, it inhibits dermal fibroblast migration in a 
scratch wound assay.  
Keratinocyte migration is an important part of the re-epithelialization 
process during wound healing. For keratinocyte migration to occur, the cells first 
needs to detach from the underlying basal lamina, a process dependent on loss 
of cell-cell and cell-matrix adhesion (Wu et al. 2016). Previous studies using 
HaCaT keratinocyte cell line has shown an increase in migration following 
incubation with 1,25(OH)2D3 (Adiri 2009). In agreement with the results from cell 
line studies, this study showed that 1,25(OH)2D3 at 1, 10 and 100nM 
upregulates human epidermal keratinocyte migration at 24 hours (Figure 3-3). 
In contrast, 1,25(OH)2D3 inhibits dermal fibroblast migration at all three 
concentrations, as early as 4 hour and for up to 24 hours (Figure 3-5).   
Effect seen after 24 hours – the genomic response 
1,25(OH)2D3 increases keratinocyte migration  
An increase in keratinocyte migration is possibly to be mediated by steroid 
receptor coactivator (Src) (Rotty and Coulombe 2012; Sophors et al. 2016; Wu 
et al. 2016). Being a coactivator, it is known that Src protein interacts with the 
activation domain, AF-2 on VDR to augment 1,25(OH)2D3-dependent 
transcription (Gill et al. 1998; Takeyama et al. 1999; Buitrago et al. 2000; Zhang 
et al. 2001; Choi et al. 2011). Once 1,25(OH)2D3 binds to VDR, it induces a 
conformational change of AF-2, thus allowing protein-protein contacts between 
the VDR and Src to form a ternary complex (Masuyama et al. 1997). The bound 
Src then functions as bridging proteins that link VDR to RNA polymerase II and 
the basal transcription machinery (Zhang et al. 2001). In addition, Src also 
interacts with general transcription factors (transcription factor IIB/TATA-binding 
protein) and general transcription activator (CBP/p300) to form a multi-protein 
complex assembled at the VDRE of targeted gene promoters (Kamei et al. 
1996; Takeshita et al. 1996; Yao et al. 1996; Zhang et al. 2001). The intrinsic 
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histone acetyltransferase activity of Src also helps to remodel chromatin 
structure to allow VDR-RXR heterodimers greater access to the DNA 
transcriptional machinery (Zhang et al. 2001; Deeb et al. 2007; Carlberg and 
Seuter 2009; Carlberg and Campbell 2013).  
A recent in vitro study by Wu et al (2016) using human epidermal 
keratinocytes showed that Src is important in upregulating MMP-2 secretion and 
downregulates E-cadherin, which enhanced a transient breakdown of 
extracellular matrix and cell-cell adhesion to initiate keratinocyte migration (Wu 
et al. 2016). Src overexpression promotes keratinocyte migration and Src 
silencing shows the opposite effect (Wu et al. 2016). Downregulation of E-
cadherin is also an important marker for epithelial to mesenchymal transition 
(EMT). Loss of apical-basal polarity of keratinocytes allows rearrangement of 
cytoskeletal structures for enhanced keratinocyte motility, more closely 
resembling the mesenchymal features (Levayer and Lecuit 2008; Yan et al. 
2010; Micallef et al. 2012; Lamouille et al. 2014). As 1,25(OH)2D3 is capable of 
interacting with the Src protein via binding to VDR, it can be postulated that  
MMP-2 and E-cadherin genes are important downstream target gene for 
1,25(OH)2D3 to exert its modulatory effect on keratinocyte migration (Figure 4-2) 
(Masuyama et al. 1997; Yamauchi et al. 2012). In this study, the observed 
increase in keratinocyte migration was only significant at 24 hours. This late 
response suggests that a genomic response was required for 1,25(OH)2D3 to 
exert its migratory effect in keratinocyte (Figure 3-3).  
1,25(OH)2D3 decreases fibroblast migration after 24 hours 
Paradoxically, dermal fibroblast migration was inhibited by 1,25(OH)2D3 
(Figure 3-4 and Figure 3-5). The observed difference as compared to epidermal 
keratinocytes indicates that response to 1,25(OH)2D3 are cell-type specific in 
the skin. Binding of 1,25(OH)2D3 to VDR allows its partner receptor, RXR, to 
bind the corepressors such as  nuclear receptor corepressor (NcoR) or 
silencing mediator of retinoid and thyroid hormone receptor (SMRT) (Sánchez-
Martínez et al. 2008). Binding of 9-cis RA to RXR causes dissociation of these 
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corepressor from the VDR-RXR heterodimer (Figure 4-2) (Kang et al. 1997; 
Sanchez-Martinez et al. 2008). Studies have shown that human dermal 
fibroblast expresses higher level of retinoic acid receptor (RAR)α than 
epidermal keratinocyte (Redfern and Todd 1992). As 9-cis retinoic acid (9-cis 
RA) is a ligand to both RAR and RXR, it is possibly that in dermal fibroblast, 
when both VDR and RARα are highly expressed, there is reduced local 
bioavailability of endogenous 9-cis RA to bind to RXR. This leads to a reduction 
in the release of co-repressor from the 1,25(OH)2D3-activated VDR-RXR 
heterodimer, resulting in downregulation of the transcription of downstream 
target genes such as MMP-2. This manifests as an inhibition in dermal 
fibroblast migration (Figure 3-5).   
 
Figure 4-2: Dermal fibroblast expresses higher level of RAR, which compete for the 
binding of 9-cis RA and reduces bioavailability of endogenous 9-cis RA. Without 9-cis RA 
binding, co-repressor is bound to the activated VDR-RXR complex, thereby downregulates 






Effect seen as early as 4 hours – the non-genomic response 
Early inhibition of dermal fibroblast migration is possibly to be mediated 
by MARRS and calcium channel modulation  
Upon wounding, fibroblast migrates into the wound site and differentiates 
into myofibroblast, to exert contraction at wound area (Kohyama et al. 2008). 
However, excessive fibroblast migration into the wound area can distort normal 
parenchymal elements of tissues, resulting in excessive tissue remodelling and 
fibrotic changes (Kohyama et al. 2008; Zhao et al. 2016). In the present study, 
1,25(OH)2D3 inhibits dermal fibroblast migration as early as 4 hours. The early 
response can be explained by the non-genomic actions of 1,25(OH)2D3 
(Buitrago et al. 2001; Trochoutsou et al. 2015).  A rapid non-genomic response 
of 1,25(OH)2D3 has been described in the modulation of rat aortic vascular 
smooth muscle cell migration (Rebsamen et al. 2002). The rapid inhibitory effect 
on fibroblast migration is achieved through the activation of PI3K/Akt/GSK3β/β-
catenin pathway (Figure 4-3) (Imai and Clemmons 1999; Reiske et al. 1999; 
Vanhaesebroeck et al. 1999; Rebsamen et al. 2002; Lam et al. 2011). β-catenin 
is important in regulating cell migration and adhesion (Amini-Nik et al. 2014). 
Once 1,25(OH)2D3 binds to MARRS on dermal fibroblasts, it activates 
PI3K/Akt/GSK3β/β-catenin signalling in the cytosol, leading to an accumulation 
of cytosolic β-catenin, with reduced nuclear β-catenin levels. This is 
accompanied by a reduction in the level of MMP-2 and MMP-9 (downstream 
targets of β-catenin) and result in a decrease in dermal fibroblast motility (Bian 
et al. 2000; Richard et al. 2010; Vaid et al. 2011; Webb et al. 2017).  
Another possible non-genomic pathway that could have been employed 
involves the downregulation of calcium channels (Yang and Huang 2005). A 
study by Yang et al (2005) showed that calcium influx via voltage-gated calcium 
channel into mouse embryonic fibroblasts increases fibroblast migration via 
phosphorylation of the myosin light chain at the trailing end of the migrating 
fibroblast (Yang and Huang 2005). In the present study, the calcium 
concentration used in the media contains 1.8 mM of calcium, a level sufficient 
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for normal cellular function of human dermal fibroblast (Praeger and Gilchrest 
1986). It has been shown in previous studies that 1,25(OH)2D3 at a 
concentrations of 1nM to 100nM can downregulate  L-type voltage sensitive 
calcium channels in neuron cells (Brewer et al. 2001; Gezen-Ak et al. 2011). 
Hence, it is possibly that 1,25(OH)2D3 decreases motility of dermal fibroblast by 
reducing the expression of the apical membrane calcium channel at the brush 
border of the fibroblast cellular membrane, thereby causing a decrease in 
activation of the myosin light chain in fibroblasts, manifested as an inhibition of 
migration.  
 
Figure 4-3: PI3K/Akt/GSK3β signalling models to explain the non-genomic response of 
dermal fibroblasts to 1,25(OH)2D3. 1,25(OH)D3 binding to MARRS results in the activation of 
PI3K. Inactivation of GSK3β results in an accumulation of cytosolic β-catenin, with reduced nuclear 
β-catenin level. A reduction in nuclear β-catenin expression decreases MMP-2 and MMP-9 secretion, 




Serum contains albumin and growth factor that can mask the effect of 
1,25(OH)2D3 on cell migration 
To ensure that the cellular responses observed were due to autocrine or 
paracrine properties of the cells themselves, primary cultures of dermal 
fibroblasts were cultured in serum-free condition. The use of serum-free media 
is to avoid binding of 1,25(OH)2D3 and its precursors to plasma proteins such as 
albumin that could confound evaluation of cell function and response 
(Stevenson 2005). Dermal fibroblasts were able to maintain normal growth 
characteristics in serum-free condition for up to 48 hours (Thornton 1990). 
However, as the fibroblasts used in this study were already serum starved for 
24 hours prior to treatment in serum-free media, all the experiments were only 
carried out for a further 24 hours period (Lu et al. 2017). Beyond 48 hours of 
serum starvation, the number of surviving cells gradually decreases (Inoue et al. 
1999). The scratch wound assays in dermal fibroblasts were repeated in 10% 
fetal bovine serum as a positive control. In agreement with previous study by 
Brink et al (2005), there is an increase in migration by dermal fibroblast in the 
presence of serum (Figure 3-4) (Brink et al. 2005). The inhibitory effect of 
1,25(OH)2D3 on migration of dermal fibroblasts was masked up to 24 hours as 
serum contains growth factors that can stimulate cell migration (Stevenson 
2005).  
Cholecalciferol or 25(OH)D3 did not modulate dermal fibroblast migration 
 Although dermal fibroblast express vitamin D3 metabolising enzymes at 
the transcriptional level, incubation with either cholecalciferol or 25(OH)D3 did 
not modulate human dermal fibroblast migration in this study (Figure 3-6). This 
could be due to the inability of cultured dermal fibroblasts to metabolise both 
precursors to the active form, 1,25(OH)2D3. There are three possible 
explanations for this observation. Firstly, keratinocyte-fibroblast paracrine 
interaction may be essential to initiate vitamin D3 metabolism in vivo (Sato et al. 
1997; Witte and Kao 2005). As there are no co-culture studies that specifically 
examine the paracrine regulation of vitamin D3 synthesis in the skin, it is difficult 
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to determine whether this inability could just be due to a lack of paracrine 
signalling from the neighbouring cells (Bailey 2010). In the present study, 
human dermal fibroblasts clearly expressed high levels of VDR, while donor-
matched epidermal keratinocytes exhibit a higher expression of the vitamin D3 
metabolism enzymes (Figure 3-1). This would suggest that a paracrine 
regulatory model of 1,25(OH)2D3 synthesis is a highly plausible model. The 
second explanation is that even though there may be some de novo synthesis 
of 1,25(OH)2D3 from the precursors, the final concentration of the active 
metabolites from this de novo synthesis could be too low or may take longer 
than 24 hours to exert any biological effect in culture conditions. Thirdly, 
CYP11A1 metabolising pathway as suggested by Slominski et al (2014) could 
have taken place, resulting in the production of other metabolites such as 
20(OH)D3 and 20,23(OH)2D3, which only serve as partial agonist of the VDR 
(Figure 1-11) (Slominski et al. 2014).  
The lack of inhibition on dermal fibroblast migration when incubated with the 
precursors of 1,25(OH)2D3 can also be explained by their lack of binding affinity 
to the VDR (Lips 2007; Ohyama and Shinki 2016). Although 25(OH)D3 is the 
major circulating form of vitamin D in humans, it has a lower affinity to VDR than 
1,25(OH)2D3. In human tissue, the VDR binds 25(OH)D3 100 times less 
effectively than 1,25(OH)2D3 (Bouillon et al. 1995; Chawla et al. 2001; Lips 
2007). The reduced binding affinity can be attributed to the 5.8-16.1% larger 
VDR-Ligand Binding Pocket (VDR-LBP) of 25(OH)D3 compared to that of the 
1,25(OH)2D3, thus creating less tension and pressure in the ligand binding 
pocket (Lou et al. 2010). In addition, 25(OH)D3 can form fewer hydrogen bonds 
with the VDR due to a lack of the 1,hydroxyl-group (Lou et al. 2010). On the 
other hand, cholecalciferol does not bind to VDR and hence cannot control 




4.3 1,25(OH)2D3 or its precursors did not modulate metabolic 
activity of human dermal fibroblasts  
An Alamar Blue assay was used to assess the metabolic activity of 
cultured human dermal fibroblasts. It is a useful assay to determine whether 
dermal fibroblasts remain viable and retain their proliferative activity in vitro (Al-
Nasiry et al. 2007). There was no demonstrable difference in the metabolic 
activity of human dermal fibroblasts after 24 hours in the presence of 10nM of 
1,25(OH)2D3 or cholecalciferol or 25(OH)D3. In view of this, it is safe to conclude 
that dermal fibroblasts used in this study were all still viable after incubation in 
serum free media for 48 hours and the treatment media did not alter cell viability 
or proliferation significantly for up to 24 hours. However, it is possible that the 
effect of 1,25(OH)2D3 and its precursors on fibroblast metabolic activity are 
different over a longer time period, as they enter into different stages of wound 
healing.  
 
4.4 VDR nuclear expression was upregulated in scratched 
human dermal fibroblast, in the presence of 1,25(OH)2D3 
VDR is a nuclear transcription factor (Pike and Meyer 2010). It is activated 
mainly through binding with 1,25(OH)2D3 (Lips 2007; Pike and Meyer 2010). 
Upon binding with 1,25(OH)2D3, VDR forms a heterodimer with RXR which 
results in the nuclear import of VDR (Yasmin et al. 2005).  All genomic actions 
of 1,25(OH)2D3 are mediated by VDR and these genomic actions give rise to 
the majority of the effects of this hormone (Carlberg and Campbell 2013). In the 
present study, incubation of dermal fibroblasts with 1,25(OH)2D3 on their own 
did not increase VDR nuclear expression (Figure 3-8). However, when coupled 
with mechanical wounding, an upregulation of VDR nuclear expression was 
observed, indicating that mechanical wounding of dermal fibroblasts regulates 
transcriptional activities of ligand activated-VDR. An example of transcriptional 
regulatory factors that has been shown to be consistently upregulated after 
injury is activator protein (AP)-1 family of transcription factors (Aslam et al. 
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1999; Yates and Rayner 2002; Gangnuss et al. 2004; Gangnuss et al. 2004; 
Neub et al. 2007; Landén et al. 2016). AP-1 is a group of transcription factors 
that typically binds as to a common enhancer sequence on target gene 
promoters (McDonald 2004). In fact, interaction between VDR and AP-1 has 
been well documented (Aslam et al. 1999; Kongsbak et al. 2013). AP-1 
mediated trans-activation of VDR is possibly to result in the upregulation of VDR 
nuclear expression observed in the present study (Qi et al. 2002; Zenz et al. 
2008).  
Secondly, the increase in nuclear expression of VDR could be explained 
by an increase in binding of co-activators to VDR-RXR heterodimer. Mechanical 
wounding results in the release of various cytokines (e.g. TGFβ and IL-6) and 
growth factors (e.g. FGF, EGF, and VEGF) from dermal fibroblast (Werner and 
Grose 2003; Stevenson 2005; Barrientos et al. 2008; Behm et al. 2012; Xu et al. 
2013). These cytokines and growth factors stimulate diverse signalling 
cascades within the dermal fibroblast. A common denominator in these signal 
transduction pathway is the activation of members of the Src-kinase family 
(Row et al. 2005). The Src co-activator stabilises VDR to RNA polymerase II 
and the basal transcription machinery binding (Zhang et al. 2001). Binding of 
Src also leads to recruitment of transcription factors (e.g. TFII/TATA protein) 
and transcription activators (CBP/p300) which further enhances VDR 
transcriptional activities (Figure 1-15) (Kamei et al. 1996; Takeshita et al. 1996; 
Yao et al. 1996).  
Thirdly, an increase in cytoplasmic-nuclear cycling of the VDR could partly 
explain the increase in VDR nuclear expression. At basal level, VDR mainly 
resides in the cytoplasm (Ruth Wu-Wong et al. 2006). In agreement with our 
result (Figure 3-8), previous study using enterocyte-like cell line has shown that 
incubation with 100nM 1,25(OH)2D3 does not result in an increase in nuclear 
VDR expression (Klopot et al. 2007). However, an increase in nuclear VDR was 
observed after chemical damage (induced by photobleaching), in the presence 
of 1,25(OH)2D3 (Klopot et al. 2007). The increase in nuclear translocation of 
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VDR is possibly to be mediated via recruitment of importin α to the VDR (Prufer 
and Barsony 2002; Yasmin et al. 2005; Klopot et al. 2007). Upon binding to the 
nuclear localisation sequence on VDR, importin α directs the mobilization of  
VDR-RXR heterodimer through the nuclear pore into the nucleus, manifested as 
an increase in nuclear VDR expression (Figure 3-8) (Morrill et al. 2016) 
Cholecalciferol or 25(OH)2D3 did not modulate VDR nuclear expression 
In contrast, incubation of human dermal fibroblasts with cholecalciferol or 
25(OH)D3 did not increase VDR nuclear expression, in both non-scratched and 
scratched conditions (Figure 3-9 and Figure 3-10). This concurs with the finding 
in the migration assay, which showed that the precursors did not modulate 
dermal fibroblast migration, further supporting the hypothesis that dermal 
fibroblast is not efficient in autocrine production of 1,25(OH)2D3 from their 
precursors in culture.  
4.5 Knockdown of VDR by siRNA abolishes the inhibitory effect 
of 1,25(OH)2D3 on dermal fibroblast migration in a scratch 
wound assay 
In order to understand the mechanism behind the inhibition of dermal 
fibroblast migration in response to 1,25(OH)2D3 and the role of the VDR in 
modulating that effect, the migration study was repeated with the introduction of 
VDR small interfering RNA (siRNA). Knockdown of VDR was highly efficient 
with the introduction of VDR siRNA in dermal fibroblast, showing a 89-91% 
reduction of VDR mRNA expression in comparison to the non-target siRNA 
control (Figure 3-11). Based on previous studies, a period of at least 24 hours 
incubation with VDR siRNA is necessary for successful fibroblast uptake of the 
guide strand of the siRNA into an RNA-induced silencing complex (RISC) that 
directs degradation of VDR mRNA (Janjetovic et al. 2009; Pratt and MacRae 
2009; Holmes et al. 2010). In view of this, all transfection with siRNA was 
performed for 24 hours prior to commencing the scratch wound assay. In the 
present study, silencing of VDR abrogates the inhibitory effect of 1,25(OH)2D3 
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on dermal fibroblast migration (Figure 3-12). In concur with the increase in VDR 
nuclear expression as shown in the immunofluorescence study (Figure 3-8), this 
further confirms the hypothesis that the inhibitory effect of 1,25(OH)2D3 on 
dermal fibroblast migration is primarily a genomic response, mediated via the 
VDR.  
4.6 1,25(OH)2D3 and its precursors modulate mRNA expression 
of VDR and CYPs in epidermal keratinocytes and dermal 
fibroblasts  
Scratching did not modulate relative mRNA expression of VDR and CYPs 
(Figure 3-13) 
To elucidate whether the process of wounding modulate the expression of 
VDR and CYPs in epidermal keratinocytes and dermal fibroblasts, quantitative 
real-time PCR was performed. Scratching in itself does not modulate VDR or 
CYP2R1, CYP27B1 and CYP24A1 level of mRNA expression, in both 
keratinocytes and fibroblasts. Nevertheless, in the presence of exogenous 
1,25(OH)2D3 or its precursors, the level of mRNA expression of CYPs changes 
in both cells, but VDR is only upregulated in dermal fibroblasts and remains 
unchanged in epidermal keratinocytes (Table 3-1).  
 
1,25(OH)2D3 and its precursors modulate VDR and CYPs mRNA 
expression 
Previous studies have shown that the CYP24A1 gene is highly inducible 
by 1,25(OH)2D3 (Lu et al. 2017). In fact, it is the most strongly regulated VDR-
target gene, with its promoter containing multiple VDREs (Väisänen et al. 2005; 
Gocek et al. 2014). Meyer et al (2017) showed that 1,25(OH)2D3 induces rapid 
VDR-RXR binding to the VDREs containing the CYP24A1 gene, and the 
upregulation is dose-dependent (Meyer et al. 2007). In the present study, 
incubation with either 10nM of 1,25(OH)2D3 or cholecalciferol, or 25(OH)D3, all 
resulted in an upregulation of CYP24A1 expression in the dermal fibroblast. The 
same was also observed in the keratinocytes when they were incubated with 
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10nM 1,25(OH)2D3, which is in agreement with a study by Schuessler et al 
(Schuessler et al. 2001). CYP24A1 is a mitochondrial inner-membrane 
cytochrome P450 enzyme that exhibits multiple catalytic functions (St-Arnaud 
2011). It plays a major role in the catabolism of 25(OH)D3 or 1,25(OH)2D3 to 
their ‘inactive’ form, to prevent tissue-level 1,25(OH)2D3 intoxication 
(Hosogane et al. 2003; Jones 2008). This is achieved via hydroxylation of 
the C23 or the C24 side-chain carbons of 25(OH)D3 or 1,25(OH)2D3 (St-Arnaud 
2011). In humans, the 24-hydroxylase activity predominates with 24,25(OH)2D3 
and 1,24,25(OH)3D3 being the major products (Bikle 2017). In the present study, 
by upregulating CYP24A1 (Table 3-1), rapid degradation of 25(OH)D3 and 
1,25(OH)2D3 helps to reduce the ability of these two metabolites to continuously 
activate VDR-dependent  and VDR-independent pathways that could be 
detrimental to cell survival and proliferation (Pols et al. 1990; Girgis et al. 2014). 
This CYP24A1 upregulation effect in response to incubation with 1,25(OH)2D3 is 
conserved over a wide variety of human cell types (e.g. epidermal 
keratinocytes, dermal fibroblasts, osteoblasts, colonic cells), signifying the 
importance of fine tuning of local bioavailability of 1,25(OH)2D3 in the dermis 
(Zierold et al. 1995; Schuster et al. 2001; Díaz et al. 2015; Norlin et al. 2017). 
 The present study has shown that 10nM of cholecalciferol increases 
VDR mRNA expression in scratched dermal fibroblasts (Table 3-1). This finding 
concurs with the result of a study by Tokar et al (2005) which demonstrated that 
cholecalciferol upregulates VDR expression (Tokar and Webber 2005). 
However, it is important to note that in the current study, an upregulation of 
cholecalciferol mRNA transcription did not translate into an increase in nuclear 
VDR protein expression, as demonstrated in the immunofluorescence staining 
(Figure 3-9). A functional study using the scratch wound assay also showed a 
lack of phenotypic changes to dermal fibroblast migration following incubation 
with cholecalciferol. This could be attributed to post-transcriptional regulation of 
VDR protein expression by dermal fibroblast (Greenbaum et al. 2003; Maier et 
al. 2009; Liu et al. 2016). Further studies such as Western Blotting could 
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determine the correlation between the cellular mRNA expression and protein 
expression in dermal fibroblast.   
In non-scratched dermal fibroblasts, 10nM cholecalciferol only upregulated  
CYP27B1 mRNA expression (Table 3-1). This is in contrast with an 
upregulation of CYP2R1, CYP27B1 and CYP24A1 mRNA expression in 
scratched fibroblasts. The recently discovered non-classical cholecalciferol 
metabolising pathway can partly explain these findings (Slominski et al. 2014). 
CYP11A1 can also catalyse hydroxylation of the side chain of cholecalciferol at 
C20 with 20(OH)D3 being the major metabolite (Figure 4-4) (Guryev et al. 2003; 
Slominski et al. 2005; Tuckey et al. 2008; Tuckey et al. 2011). As CYP11A1 is 
unable to hydroxylate 20(OH)D3 further, CYP27B1 is required for further 
hydroxylation of 20(OH)D3 to 1,20(OH)2D3, a compound with active biological 
functions in epidermal keratinocytes that include reducing proliferation and 
increasing differentiation  . Furthermore, other products downstream of 
20(OH)D3 metabolism also require CYP27B1 for further hydroxylation (Figure 4-
4). This could explain the upregulation of CYP27B1 in non-scratched dermal 
fibroblasts (Table 3-1). The finding that CYP24A1 is not upregulated could be 
due to the fact that most of the end products of this metabolising pathway such 
as 20(OH)D3 and 20,23(OH)2D3 can only act as partial agonists of the VDR 
(Slominski et al. 2014). As a result, induction of CYP24A1 expression was not 
significant as CYP24A1 is a VDR-targeted downstream gene (Väisänen et al. 
2005; Gocek et al. 2014). The question still remains as to why the dermal 
fibroblast utilises the CYP11A1 pathway rather than the classical CYP2R1 
pathway in culture. Further studies comparing the relative mRNA expression of 
CYP11A1 and CYP2R1 by dermal fibroblast could help in our understanding on 






Figure 4-4: The novel, alternative pathway of cholecalciferol metabolism utilising 
CYP11A1 compared to the classical pathway which involves CYP2R1. The expression of 
CYP11A1 in non-classical steroidogenic tissues such as skin is relatively low and unlikely to 
have major systemic effects. Adapted from (Slominski et al. 2014) 
 
4.7 Knockdown of VDR upregulates CYP27B1 in scratched 
dermal fibroblasts, in the absence or presence of 
1,25(OH)2D3 
We report, for the first time, the possible existence of a feedback control on 
the key vitamin D enzymes CYP27B1 through VDR-independent signalling in 
the human dermal fibroblasts. This is in contrast with previous study using 
human corneal epithelial cell where VDR silencing and incubation with 
1,25(OH)2D3 did not modulate CYP27B1 protein expression (Lu et al. 2017).  
Intracellular calcium regulates cellular mechanics in motile fibroblasts 
following wounding (Evans and Falke 2007; Wei et al. 2009). Acting via myosin 
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II and calmodulin, calcium has a multifunctional role in traction force generation, 
directional sensing and relocation of focal adhesions in migrating fibroblasts 
(Wei et al. 2008). 1,25(OH)2D3 has been shown to down-regulate the L-type 
voltage-sensitive calcium channels (LVSCC) (Brewer et al. 2001), a possible 
pathway for non-genomic signalling of 1,25(OH)2D3. Conversely, an 
upregulation of LVSCC has been observed following VDR knockdown in neuron 
cells (Gezen-Ak et al. 2011).  
Migration assay in the present study showed that incubation with 
1,25(OH)2D3 downregulated dermal fibroblast migration as early as 4 hours 
(Figure 3-5), a non-genomic effect that could be explained via modulation of 
calcium channel (inhibition of LVSCC expression). Upon VDR silencing, 
CYP27B1 expression is upregulated by scratched dermal fibroblast in order to 
produce more 1,25(OH)2D3, with the aim to achieve downregulation of LVSCC 
as an alternative route to achieve inhibition of fibroblast migration, independent 
of the VDR. 
4.8 10nM 1,25(OH)2D3 downregulates α-SMA in scratched 
human dermal fibroblasts  
Alpha-SMA is a biomarker for differentiation of dermal fibroblasts into 
myofibroblasts, which are important effector cells of tissue fibrogenesis (Zhao et 
al. 2018). In a cutaneous wound, myofibroblasts play a central role in wound 
contraction (Gabbiani 2003; Chitturi et al. 2015). Mechanical stress and TGF-β 
signalling are two major factors contributing to the transition from fibroblast to 
myofibroblast (Gabbiani 2003). In this study, immunofluorescence staining for α-
SMA was performed to confirm if human dermal fibroblasts increase their 
expression of this protein in response to mechanical wounding, as previously 
described (Stevenson 2005; Pomari et al. 2014), and to determine whether 
1,25(OH)2D3 or its precursors could modulate it. There was a demonstrable 
increase in α-SMA staining following scratching at 24 hours, in agreement with 
Stevenson et al (2005) and Pomari et al (2014). However, α-SMA protein 
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expression in scratched dermal fibroblasts was markedly reduced in the 
presence of 10nM 1,25(OH)2D3 for 24 hours (Figure 3-15 and Figure 3-16). In 
contrast, there was no demonstrable change in α-SMA expression in response 
to 10nM of cholecalciferol or 25(OH)D3 (Figure 3-15 and Figure 3-16). This is 
the first study to examine the role of 1,25(OH)2D3 and its precursors on human 
dermal fibroblast differentiation in vitro. It suggests that 1,25(OH)2D3 can 
modulate the fibroblast phenotype in wounded conditions, in agreement with 
findings from previous studies using fibroblasts from other organs such as 
human lung fibroblasts and human renal interstitial fibroblasts (Li et al. 2005; 
Tan et al. 2007; Zhang et al. 2015). This response may be due a reduction in 
stress fibre formation, characteristic of myofibroblast activation (Gabbiani 2003; 
Meredith et al. 2015). In addition, 1,25(OH)2D3 can down-regulate transforming 
growth factor (TGF)-β and indirectly modulating its downstream effectors 
SMAD2 and SMAD3 which regulate the target gene (α-SMA)  involved in 
myofibroblast differentiation (Shin et al.; Ding et al. 2013). Once again, 
cholecalciferol and 25(OH)D3, both precursors of 1,25(OH)2D3 failed to 
modulate α-SMA expression in vitro, supporting the hypothesis that cultured 
dermal fibroblasts are ineffective in autocrine production of active 1,25(OH)2D3.  
4.9  1,25(OH)2D3 downregulates soluble MMP-2 activity while 
cholecalciferol has the opposing effects, in scratched 
dermal fibroblasts 
MMPs are a group of proteases that play important roles during the wound 
healing process (Xue et al. 2006). MMPs regulate inflammatory processes and 
degrade the extracellular matrix to facilitate remodelling of the ECM and 
cutaneous wound closure (Caley et al. 2015; Rohani and Parks 2015). 
Specifically, an interaction between vitamin D3 and MMP-2/MMP-9 in fibroblasts 
(derived from nasal polyps) has been demonstrated (Wang et al. 2015). Using 
ELISA and Western blot analysis, Wang et al (2015) showed that TNF-α-
induced MMP-2 and MMP-9 productions are inhibited by 1,25(OH)2D3 after 24 
hours. MMP-2 and MMP-9 are both gelatinases, therefore gelatine zymography 
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was utilised to assess the activity of soluble MMP-2 and MMP-9 secreted by 
human dermal fibroblasts at basal conditions and upon scratching (Figure 3-17). 
This present study also investigated the relative activity of both MMPs in 
response to 1,25(OH)2D3 and cholecalciferol (Figure 3-17).  
MMP-9 activity remained undetectable in gelatine zymography (Figure 3-
17), which could be due to the relatively low concentration of MMP-9 in the 
conditioned media collected from the cells cultured in 6-well plates. Similar 
experiment could be performed on dermal fibroblasts cultured in larger flasks 
such as in T75 or T225 flasks, to obtain a higher amount of secreted MMP-9. 
An alternative would be to use other sensitive techniques such as RT-PCR or 
Western Blot to assess MMP-9 mRNA or protein expression. Similar finding 
was reported in a study by Singer et al (2002) using breast cancer-derived 
human fibroblasts. They suggested that low MMP-9 activity is attributed to a 
lack of stromal-epithelial cell interaction in vitro (Singer et al. 2002). Co-culture 
of epidermal keratinocytes and dermal fibroblasts or using reconstructed human 
skin model would be useful methods to elucidate whether mesenchymal-
interaction is necessary to stimulate MMP-9 production by fibroblasts.  
In scratched dermal fibroblasts, incubation with 10nM of cholecalciferol 
significantly upregulated MMP-2 whereas 10nM of 1,25(OH)2D3 downregulated 
it (Figure 3-17). This appears to be a paradoxical finding, but the alternative 
CYP11A1-mediated cholecalciferol metabolism pathway could partly explain it 
(Figure 4-4). Cholecalciferol is possibly to be metabolised to other CYP11A1-
derivatives which exhibit different effects as compared to that shown by 
1,25(OH)2D3. Table 4-1 summarises the phenotypic effects of some of the 
CYP11A1-derived hydroxyderivatives of vitamin D3 on epidermal keratinocytes 
and dermal fibroblasts in vitro (Slominski et al. 2014). As demonstrated by the 
work of Slominski et al (2014), derivatives from CYP11A1-mediated metabolism 
of cholecalciferol downregulates TGF-β expression (Slominski et al. 2014). As 
TGF-β is known to suppress the expression of MMP-2, an inhibition of TGF-β 
by these derivatives result in higher MMP-2 activity (Risinger et al. 2010).  
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On the other hand, 10nM of 1,25(OH)2D3 downregulated MMP-2 activity in 
scratched dermal fibroblasts (Figure 3-17). As the MMP-2 downregulatory effect 
was only observed in scratched dermal fibroblasts, but not in non-scratched 
fibroblasts (Figure 3-17), it could be postulated that an overall decrease in 
MMP-2 secretion is beneficial for fibroblasts under wounded conditions. A 
decrease in MMP-2 secretion could be important to prevent excessive 
breakdown of extracellular matrix at wound site commonly associated with 
inflammation, thereby helping to accelerate wound closure. This finding (Figure 
3-17) also provides supportive evidence to the hypothesis as discussed in 
section 4.2 where 1,25(OH)2D3 could mediate a decrease in MMP-2 protein 
expression in dermal fibroblasts that manifested as an inhibition in fibroblast 



























Proliferation Differentiation Proliferation 
20(OH)D3 ↓ ↓ ↓ ↓ 
20,23(OH)D3 ↓ ↓ ↓ ↓ 
22(OH)D3 and 
20,22(OH)2D3 
ND ↓ ↑ ↓ 




ND ND ND ND 




ND ND ND ND 
Table 4-1: All primary cell used in the experiments were derived from female (F) facial 
skin. ↑ - stimulation; ↓ - inhibition, * - defined as inhibition of TGF-β induced hyaluronate and 
collagen production. All primary cells were derived from scleroderma and normal donors, ND- 




4.10 1,25(OH)2D3 downregulates the type I to III collagen ratio in 
scratched dermal fibroblasts.   
As fibroblasts differentiate into myofibroblasts, they secrete collagen I and 
III, two of the major components of ECM (Klingberg et al. 2013). To investigate 
the effect of 1,25(OH)2D3 on collagen secretion by dermal fibroblasts and how 
this may be regulated in the context of wound healing, intact and mechanically 
wounded dermal fibroblasts were cultured in the presence or absence of 
1,25(OH)2D3. The relative mRNA expression of collagen I and collagen III was 
determined using qRT-PCR.  
Depending on the depth of the dermal layer, papillary and reticular dermal 
fibroblasts exhibit differences in their gene expression (Sorrell and Caplan 
2004; Janson et al. 2012). In the present study, only the papillary dermal 
fibroblasts were used as they are closer to epidermal keratinocytes anatomically 
and thus more possibly to be involved in epithelial-mesenchymal paracrine 
regulation of vitamin D3 homeostasis. Mechanical scratching of cultured human 
dermal fibroblasts upregulated collagen type I mRNA expression after 24 hours, 
but had no effect on type III collagen mRNA expression (Figure 3-18). This 
finding concurs with the observation by Meigel et al (1997) where type I 
collagen is the predominant collagen type in the papillary dermis, whereas type 
III collagen constitutes a large proportion of the reticular dermis (Meigel et al. 
1977; Gay et al. 1980; Haukipuro et al. 1991; Ali Bahar et al. 2004). Although 
there are some studies which reported that type III collagen expression is higher 
during the early stages of wound healing, these studies were done on murine 
fibroblasts, and did not specifiy the type of dermal fibroblast, i.e. papillary or 
reticular, that were used (R Merkel et al. 1988; Volk et al. 2011).  
1,25(OH)2D3 significantly upregulated type I collagen mRNA expression in 
non-scratched dermal fibroblasts at both 10nM and 100nM, thereby increasing 
the collagen type I to type III ratio (Figure 3-19). This finding is in agreement 
with the results shown by Dobak et al (1994) where 1,25(OH)2D3 significantly 
increased collagen type I and type III production by neonatal foreskin fibroblast 
as measured by ELISA (Dobak et al. 1994). In normal skin, decreasing levels of 
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type I and III collagen production, and the type I to III collagen ratio are 
associated with ageing, and associated loss of tension and elasticity in the skin 
(Cheng et al. 2011). This indicates the potential use of 1,25(OH)2D3 to counter 
the effects of collagen loss associated with ageing. In fact, murine studies have 
shown that VDR-knockout mice developed premature skin ageing phenotype 
with thinning of skin and wrinkling (Keisala et al. 2009; Tuohimaa 2009).  
In scratched dermal fibroblasts, 1,25(OH)2D3 downregulated both collagen 
type I and type III mRNA expression, which was also accompanied by a 
decrease in the type I to III ratio (Figure 3-19). A higher type I to III collagen 
ratio is associated with abnormal hypertrophic scarring, and studies have also 
shown that vitamin D deficiency stimulates fibroblasts transition into 
myofibroblasts in Dupuytrens’s disease (profibrotic changes in skin) (Cheng et 
al. 2011; Shi et al. 2013; Seyhan et al. 2018). Taken together with the effect of 
1,25(OH)2D3 in abrogating myofibroblast differentiation as shown in the 
immunofluorescence study (Figure 3-15), this indicates that 1,25(OH)2D3 may 
be able to modulate the scarring process and promote wound remodelling (Lee 
et al. 2017).  
4.11 Incubation with 1,25(OH)2D3 increases the rate of wound 
closure in human skin ex vivo  
The beneficial role of vitamin D3 in cutaneous wound healing has been 
shown in human clinical trials where reposition of vitamin D in patients with 
vitamin D insufficiency speeds up the healing of venous ulcers (Burkiewicz et al. 
2012).  However, no work has been done to delineate the exact molecular 
mechanisms by which 1,25(OH)2D3 exerts its effects on different components of 
human skin using a human ex vivo wound healing model. The model used in 
the current study was adapted from Stojadinovic and Tomic-Canic (2013).  
Human full-skin ex vivo models have been used extensively in the past 
for studies investigating the expression of cytokines in psoriatic skin, the 
behaviour of epidermal Langerhan cells and functional studies of the role of 
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epidermal growth factor (EGF) in psoriasis (Rambukkana et al. 1995; 
Yoshinaga et al. 1995; Varani et al. 1998). An ex vivo model mimics the three 
dimensional wound environment and can be utilised to investigate the paracrine 
regulation of vitamin D at the wound site and its relationship to the rate of 
wound healing. The main limitation of any ex vivo wound healing model is that it 
does not have an endogenous blood supply. Nutritional supply to the dermal 
fibroblasts and epidermal keratinocytes depends on passive diffusion of 
nutrients from the media into the cells. It has been shown previously that 
incubation with 10% FBS is sufficient for complete re-epithelialisation of human 
ex vivo cutaneous wounds in culture (Kratz 1998). Hence, in this study 10% 
FBS was used as a positive control to study the stimulatory effects on the rate 
of wound closure in the presence 1,25(OH)2D3 and cholecalciferol (Figure 3-21, 
Figure 3-22 and Figure 3-23). De novo re-epithelialisation was confirmed using 
H&E staining on cryosections of the wounded skin explants (Figure 3-20). The 
increase in granulation tissues density at wound bed over the 6 days period 
(Figure 3-20) also supports the use of this ex vivo wound healing model as a 
feasible model to study the wound healing response.  
The present study used whole skin cultures derived from two different 
anatomical sites (abdominal and breast), from female donors of different ages 
(34 years and 59 years). The results showed that 1,25(OH)2D3, either in the 
presence or absence of serum, accelerated wound closure ex vivo after three to 
four days (Figure 3-21, Figure 3-22 and Figure 3-23). In the in vitro study, it was 
shown that 1,25(OH)2D3 increased epidermal keratinocyte migration (Figure 3-
3), but in contrast inhibited dermal fibroblast migration (Figure 3-4 and Figure 3-
5). While these results suggest that dermal fibroblast migration may not be an 
important determinant in the up-regulation of wound closure, it must be 
considered that fibroblasts may respond differently in a 2-dimensional 
monolayer environment than they would in a three-dimensional wound setting. 
Recent studies have shown that dermal fibroblasts behave differently when 
allowed to form 3-dimensional cultures e.g. cultured on scaffolds when 
compared to their 2-dimensional counterparts cultured in monolayers (Rothan et 
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al. 2014; Smithmyer et al. 2014). It would be interesting to carry out further 
studies to compare the response of dermal fibroblasts to 1,25(OH)2D3 in 2-D 
and 3-D culture. For example, wounded dermal fibroblast differentiation into 
myofibroblast is potentially to be upregulated at basal condition in a 3-D culture, 
owing to the external stress/tension generated by the three-dimensional 
collagen lattices (Kessler et al. 2001; Rothan et al. 2014). In addition, secretion 
and deposition of collagen fibres is potentially to be upregulated due to cell-
matrix interactions and an increase in cell-cell interaction across three 
dimensions (Maione et al. 2015).  
Other factors such as, epithelial-mesenchymal interactions, the 
inflammatory response, granulation tissue formation and modulation regulated 
by dermal fibroblasts may be more essential for wound closure and promoting 
re-epithelialisation (Garner 1998; Wang et al. 2015). Co-cultures of epidermal 
keratinocytes and dermal fibroblasts using a Transwell® inserts system could 
help to investigate the paracrine regulation of key enzymes, cytokines and 
growth factors involved in wound closure, in response to 1,25(OH)2D3 (Wang et 
al. 2012). On the other hand, it has been well established that 1,25(OH)2D3 is a 
potent inducer of cathelicidin, an antimicrobial peptide that helps to fight 
infection, which is important during early phases of wound healing (Gombart 
2009).  Furthermore, 1,25(OH)2D3 has been shown to reduce inflammation via 
regulation of the inflammatory cytokines (e.g. TNF-α and IL-1) and inhibiting the 
proliferation of proinflammatory cells such as macrophages and neutrophils 
(Takahashi et al. 2002; Du et al. 2009; Kuo et al. 2010; Yin and Agrawal 2014). 
Further studies investigating the level of inflammatory cytokines secreted by 
scratched dermal fibroblasts in response to 1,25(OH)2D3 would be useful to 
delineate the molecular mechanism by which vitamin D3 helps in resolving 
excessive inflammation in cutaneous wound, a process if unchecked, could lead 
to chronic wounds and abnormal scarring.   
In contrast, cholecalciferol did not alter the rate of wound closure (Figure 
3-21 and Figure 3-22). This suggests that epidermal keratinocytes and dermal 
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fibroblasts lack the ability to metabolise exogenous cholecalciferol into 
1,25(OH)2D3 in an ex vivo wound healing model. If the CYP11A1 pathway has 
been preferentially activated to metabolise cholecalciferol, this also suggests 
that derivatives from CYP11A1-mediated metabolism are not effective in 
stimulating wound closure in an ex vivo model. In the present study, an 
upregulation of CYP2R1 and CYP27B1 were not observed following scratching 
of epidermal keratinocytes in vitro (Figure 3-13). This indicates that wounded 
epidermal keratinocytes does not upregulate the metabolism of cholecalciferol 
or 25(OH)2D3 into 1,25(OH)2D3 in culture.  This could be due to prioritisation of 
metabolic energy expenditure by wounded epidermal keratinocytes to activities 
such as cell migration and proliferation with the aim of re-establishing epithelial 
barrier.  
Approximately 99% of circulating 25(OH)D3 and 1,25(OH)2D3 are bound 
to the vitamin D binding protein (DBP) or albumin under normal physiological 
conditions (Yousefzadeh et al. 2014). In humans, both passive diffusion across 
cell membrane and active endocytosis via cell surface receptors help in the 
uptake of 25(OH)D3 and 1,25(OH)2D3 into cells (Chen and Farese 1999; 
Nykjaer et al. 1999). Hence, in the presence of 10% FBS, some of the 
1,25(OH)2D3 may be bound, which could affect its bioavailability and therefore 
its ability to elicit a response in the ex vivo model. This could partly explain the 
lack of synergistic effect in further accelerating ex vivo wound closure rate at 
day 3 when incubated with both FBS and 1,25(OH)2D3 (Figure 3-21).  
Cytokines and proteolytic enzymes secreted locally at the wound site in 
response to wounding could have potentially denatured some of the exogenous 
cholecalciferol and 1,25(OH)2D3 before they reach the cells to exert any effects. 
This may be a limitation of this model. Lastly, prolonged elevated expression of 
MMP can lead to excessive ECM degradation and impair wound closure. As 
shown in our gelatine zymography study, 1,25(OH)2D3 is able to downregulate 
MMP-2 activity by scratched dermal fibroblast (Figure 3-17). This is evidently 
important to allow rapid formation of granulation tissue that acts as tissue 
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scaffold to support early re-epithelialisation process, as demonstrated in our 























For decades, vitamin D has been employed as a therapeutic agent for 
skin disorders such as psoriasis (MacLaughlin et al. 1985; Trémezaygues and 
Reichrath 2011). Its immunomodulatory roles related to the production of anti-
microbial peptides such as cathelicidin and defensin are now well established 
(Wang et al. 2004). It has also been suggested that cathelicidin can act as an 
enhancer of the epithelial barrier, and thereby could potentially aid in re-
epithelialisation of skin (Niyonsaba et al. 2006; Otte et al. 2009; Schwalfenberg 
2011). Despite the apparent importance of skin as an important source and 
target organ for vitamin D, studies specifically looking at the roles of vitamin D in 
cutaneous wound healing remain sparse.  
The human cutaneous epidermis is a unique site of vitamin D3 production 
as keratinocytes contain all the machinery necessary for the autocrine 
production of bioactive vitamin D (Schuessler et al. 2001). Expression of vitamin 
D receptors in both epidermal keratinocytes and dermal fibroblasts shows that 
they are also important target cells. Using both donor-matched and non donor-
matched epidermal keratinocytes and dermal fibroblasts, this study has shown 
for the first time that dermal fibroblasts have a higher relative mRNA expression 
of VDR, suggesting they are more responsive than epidermal keratinocytes to 
1,25(OH)2D3. . In contrast, epidermal keratinocytes express higher levels of 
mRNA for the CYPs required for the metabolism of vitamin D3. This high 
expression in keratinocytes indicates a paracrine, rather than an endocrine 
source of 1,25(OH)2D3 could be more important for regulating vitamin D3 
bioavailability in dermal fibroblasts. 
 While 1,25(OH)2D3 stimulated human epidermal keratinocyte migration at 
24 hours after mechanical scratching in contrast, it inhibited the migration of 
human dermal fibroblasts, as early as 4 hours and for up to 24 hours after 
scratching. The difference in the response time to 1,25(OH)2D3 could be 
explained by both genomic and non-genomic actions of 1,25(OH)2D3. The VDR 
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plays a central role in mediating genomic responses. This is clearly 
demonstrated by the immunofluorescent staining of VDR in dermal fibroblasts 
incubated with 1,25(OH)2D3 which markedly increased nuclear VDR protein 
expression without a corresponding increase in VDR mRNA transcription. The 
nucleo-cytoplasmic cycling of VDR following ligand activation by 1,25(OH)2D3 
and subsequent association with retinoid X receptor allows the VDR-RXR 
complexes to interact with vitamin D response elements and regulate target 
genes transcription (Klopot et al. 2007). The stimulation of epidermal 
keratinocyte migration was only observed after 24 hours, indicating a genomic 
response. Furthermore, VDR knockdown by siRNA abolished the inhibitory 
effect of 1,25(OH)2D3 on dermal fibroblast migration, suggesting that the anti-
migratory effect in dermal fibroblasts was mediated largely via the genomic 
pathway, with a non-genomic pathway possibly only playing a small part.  
Findings from the Alamar Blue assay confirmed that the inhibition of 
migration observed in dermal fibroblasts was not due to cell death or a 
reduction in dermal fibroblast proliferation capability following incubation with 
1,25(OH)2D3 or its precursors. Mechanical scratching of monolayers of dermal 
fibroblasts, in the absence of 1,25(OH)2D3 did not modulate the mRNA 
expression of VDR or the CYP enzymes involved in vitamin D3 metabolism. 
This suggests that the active ligand, 1,25(OH)2D3, is needed to stimulate a 
response by the dermal fibroblast during wound healing. This hypothesis is 
supported by the immunofluorescence finding that an increase in nuclear 
translocation of VDR was only observed in scratched dermal fibroblasts, and 
only in the presence of 1,25(OH)2D3.  
Incubation with 1,25(OH)2D3 and its precursors significantly up-regulated 
CYP24A1 mRNA expression in both epidermal keratinocytes and dermal 
fibroblasts, suggesting that a finely-tuned regulatory system is in place to 
convert excess 1,25(OH)2D3 to the inactive form. Even though cholecalciferol 
and 25(OH)2D3 down-regulated CYP24A1 expression, their effect was not as  
pronounced as the modulation observed in the presence of the active form, 
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1,25(OH)2D3. This suggests that they or their metabolites have a lower binding 
affinity to the VDR.  This is also supported by the lack of any change in VDR 
protein expression when dermal fibroblasts were incubated with cholecalciferol 
or 25(OH)D3, or the lack of functional  modulation as seen in the migration 
assay or the ex vivo wound healing assay in the presence of cholecalciferol or 
25(OH)D3 Even though cholecalciferol up-regulated both VDR and CYP 
enzyme mRNA expression, the effect is possibly to be mediated by the novel 
CYP11A1 metabolism pathway, where the metabolites such as 20(OH)D3 can 
act as a partial agonist to VDR, in contrast to 1,25(OH)2D3 which has a high 
binding affinity. This also explains the differences seen with 1,25(OH)2D3 in the 
modulation of MMP-2 activity, and the migration and ex vivo wound healing 
assays.  
Incubation with 10nM 1,25(OH)2D3 decreased α-SMA protein expression 
in scratched dermal fibroblasts. It also down-regulated MMP-2 activity and the 
type I to III collagen ratio. Taken together, this suggests that 1,25(OH)2D3 can 
modulate the phenotypic transition of the fibroblast into a myofibroblast, 
decrease extra-cellular matrix breakdown by MMP-2 and regulate collagen 
deposition in the newly formed granulation tissue. Hence, 1,25(OH)2D3 could 
have a central role in the modulation of wound healing and the scarring 
process. The findings from the ex vivo wound healing model further confirmed 
that 1,25(OH)2D3 aids in wound closure by enhancing the re-epithelialisation 
process and deposition of granulation tissue, independently of other growth 
factors which are present in serum.  
In summary, dermal fibroblasts are important target cells for 
1,25(OH)2D3. They are more responsive to 1,25(OH)2D3 than epidermal 
keratinocytes since they express higher levels of VDR transcripts. Even though 
1,25(OH)2D3 inhibits dermal fibroblast migration in a monolayer scratch assay, it 
may have a more important role in extracellular matrix and collagen deposition 
during the early stages of wound healing. Close epithelial-mesenchymal 
interaction, in particular, between keratinocytes and fibroblasts, is vital for local 
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homeostasis of vitamin D3. The major findings of the study are summarised in 
Figure 5-1. Further elucidation of the different vitamin D pathways in the skin 








Figure 5-1: Summary of the roles of 1,25(OH)2D3 in cutaneous wound healing. A) 
1,25(OH)2D3 upregulated  nuclear VDR expression B) 1,25(OH)2D3 increased keratinocyte 
migration but inhibited fibroblast migration; 1,25(OH)2D3 increased ex vivo wound closure C) 
1,25(OH)2D3 downregulated α-SMA expression D) 1,25(OH)2D3 downregulated soluble MMP-2 








6 FURTHER STUDIES 
This study has provided strong evidence that both epidermal 
keratinocytes and dermal fibroblasts express the vitamin D3 metabolising 
enzymes at the transcriptional level. The present study also shows that 
exogenous 1,25(OH)2D3 is a viable therapeutic agent with the potential to 
improve cutaneous wound healing with a possible role in modulating the 
scarring process. However, it also raises questions on the preferred vitamin D3 
metabolic pathways in human skin. In particular, what is the role of CYP11A1 in 
the production of vitamin D metabolites in the skin? To determine whether the 
CYP11A1 or the classical CYP2R1 pathway is preferentially activated in 
epidermal keratinocytes and dermal fibroblasts, qRT-PCR followed by Western 
Blotting could be performed to compare the relative expression of each 
cytochrome enzyme at both the mRNA and protein level, following incubation 
with cholecalciferol. This can be followed by experiments to investigate the 
synthesis of CYP11A1-derived metabolites by epidermal keratinocytes and 
dermal fibroblasts in vitro, under both wounded and non-wounded conditions. 
This could be most accurately achieved by performing liquid chromatography 
and mass spectrometry (LC-MS) analysis to separate and determine the 
concentrations of expected CYP11A1-derived metabolites, following incubation 
with cholecalciferol (Slominski et al. 2017).  
In addition, it would be interesting to determine the biological effects of 
the metabolites derived from the CYP11A1 metabolic pathway in the context of 
cutaneous wound healing. To achieve this, several assays could be performed 
including the migration assay, collagen gel assay and ex vivo wound healing 
assay. Specifically, 20(OH)D3 and  20,23(OH)2D3 are the candidate metabolites 
that are of primary interest due to their partial agonist activity on the VDR. 
Unfortunately, these metabolites are not commercially available as yet, but they 
could be synthesised and purified using methods as described by Slominski et 
al (2005) (Slominski et al. 2005). 
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Thirdly, the interplay between the RXR, VDR and RAR signalling 
pathways is possibly to be an important regulator in 1,25(OH)2D3-induced 
phenotypic changes, as suggested by the migration assay results  (Figure 3-3, 
Figure 3-4, and Figure 3-5). Incubation of epidermal keratinocytes and dermal 
fibroblasts with 1,25(OH)2D3 leads to opposing effects in dermal fibroblast 
migration (Figure 3-3, Figure 3-4 and Figure 3-5). 9-cis retinoic acid, the natural 
ligand for RXR, is required to stimulate the release of the nuclear co-repressor 
from VDR-RXR heterodimers (Kang et al. 1997; Sanchez-Martinez et al. 2008). 
However, as 9-cis RA can bind to both RAR and RXR, the level of RAR 
expression in keratinocytes and fibroblasts could indirectly determine VDR-
dependent gene transcription due to exhaustion of endogenous 9-cis RA 
(Huang et al. 2013). Loss-of-function studies using gene knockouts of RAR in 
cultured dermal fibroblasts could provide valuable insight into whether the 
inhibitory effect on migration seen in dermal fibroblast is due to competitive 
depletion of 9-cis RA (mediated via RAR-binding). 
The promiscuity of RXR when forming heterodimers with other nuclear 
receptors warrants further studies to elucidate the interplay between different 
steroid nuclear receptors (Hyter and Indra 2013). In particular, overlapping of 
the vitamin D and retinoic acid (RA) signalling pathways and their convergence 
at a common response element has been reported (Tavera-Mendoza et al. 
2006). Competition for this shared DNA sequence of the two overlapping steroid 
response elements has been demonstrated by Cao et al (1996); with retinoic 
acid blunting vitamin D3-mediated integrin transcription as a result (Cao et al. 
1996). Similarly, vitamin D3 was also found to reduce the biological effects of 
RA via transcriptional interference of activated VDR on the retinoid acid 
response element (Jiménez-Lara and Aranda 1999). To establish the affinity of 
the VDR-RXR and RAR-RXR complexes for their respective response elements 
in dermal fibroblasts, Scatchard analysis can be performed as previously 
described (Schräder et al. 1994; Cao et al. 1996). This can be followed by 
alternative knockdown of VDR and RAR, while in the presence of 1,25(OH)2D3, 
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to determine whether there is any difference in phenotypic changes (e.g. cells 
migration and proliferation) observed.  
 Lastly, to translate the results of this study into changes in clinical 
practice, the first step would be to determine whether there is a correlation 
between low serum level of vitamin D3 with the prevalence of chronic wounds 
and abnormal scarring (e.g. keloid and hypertrophic scarring) among burns 
patients. If a correlation is found, a double-blinded randomized controlled trial 
can be designed with vitamin D3-deficient patients being allocated into the 
treatment (oral vitamin D3 supplement) or placebo groups. Prospective data can 
then be collected to determine whether oral vitamin D3 supplements produce 
any changes in the wound healing or scarring response. A cohort study can 
also be set up to establish the therapeutic differences between oral vitamin D3 
supplement and topical application of vitamin D3 in chronic wound and 
abnormal scar. However, more in vitro and in vivo studies using models such as 
ex vivo wound healing assay and collagen gel assays are required to provide 
preliminary data prior to application in clinical trials. This is especially important 
among groups of patients that are not vitamin D3-deficient since this may raise 
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9.1 Gelatine zymography solutions preparation 
9.1.1 Gelatine zymography reagents and solutions 
Separating Gel Buffer (1.5M Tris Base) 
 90.86g Tris-base, final concentration 1.5M 
 275 ml distilled water 
 The Tris base was dissolved in 275 ml distilled water and made up to 
500 ml solution, the pH was adjusted to 8.8, and stored at 4ºC. 
 
Stacking Gel Buffer (0.5M Tris base) 
 6g Tris base, final concentration 0.5M 
 60 ml distilled water 
 The Tris base was dissolved in 60 ml distilled water and made up to 
100ml solution, the pH was adjusted to 6.8 and stored at 4ºC. 
 
Running Buffer 
 15g Tris base, final concentration 25 mM 
 72g Glycine, final concentration 200 mM 
 5g SDS, final concentration 0.5% w/v 
 The Tris base, glycine and SDS were dissolved in 1L distilled water and 
was stored at 4ºC. The prepared solution was diluted using the ratio 280 
ml distilled water plus 70 ml running buffer when used.  
 
2x Non-reducing Sample Buffer 
 3.125 ml (0.5 M Tris base, pH 6.8) Stacking gel buffer, final concentration 
62.5 mM 
 10 ml 10% SDS, final concentration 40% v/v 
 10 ml glycerol, final concentration 50% v/v 
 1.87 ml distilled water 
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 125 μl Bromophenol Blue 
 All components were mixed gently and the final solution was stored at 
room temperature.  
 
12.5x Washing Buffer 
 125 ml Triton X-100 
 875 ml distilled water 
 The 125 ml Triton X-100 was added as 5 parts until full dissolved and 
stored at room temperature. The solution was diluted as 200 ml distilled 
water plus 50 ml Triton X-100 when used.  
 
10x Incubation Buffer 
 78.8g Tris base, final concentration 50 mM 
 14.7g CaCl2●2H2O, final concentration 100 mM 
 29.2g NaCl, final concentration 50 mM 
 5 ml Brij-35, final concentration 0.5% v/v 
 All components were dissolved in 1L distilled water, the pH was adjusted 
at 7.6, and stored at 4ºC. The solution was diluted as 180 ml distilled 
water plus 20 ml incubation buffer when used.  
 
Coomassie Blue Staining Solution 
 0.2g Coomassie brilliant blue R-250, final concentration 0.02% v/v 
 100 ml glacial acetic acid, final concentration 10% v/v 
 250 ml methanol, final concentration 25% v/v 
 All components were dissolved in 1L distilled water with magnetic stirring 
overnight, and the solution was stored at room temperature.  
 
Destain Solution 
 50 ml Methanol, final concentration 5% v/v 
 50 ml Glacial acetic acid, final concentration 5% v/v 
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 The Methanol and Glacial acetic acid were dissolved in 1L distilled water, 
and was stored at room temperature.  
 
10% SDS Solution 
 10g SDS  
 80 ml distilled water 
 The SDS was dissolved in 80 ml distilled water and made up to 100 ml 
distilled water, and when fully dissolved, was stored at room 
temperature.  
 
10% APS Solution 
 0.12g ammonium persulfate (APS) 
 1.2 ml distilled water 
 The APS dissolved in 1.2 ml distilled water, and was stored at -20ºC, 

















9.2 1,25(OH)2D3 down-regulates α-SMA protein expression in 
scratched human dermal fibroblasts and the effect was 
dose-dependent 
Western blotting confirmed that 10nM and 100nM 1,25(OH)2D3 down-
regulated protein expression of α-SMA in scratched human dermal 
fibroblasts after a 24 hour incubation.  
 
 
Figure 9-1: α-SMA expression by scratched dermal fibroblast after 24 hours incubation 
with 1,25(OH)2D3. (A) Western Blot image of α-SMA expression by fibroblasts after incubation 
with vehicle control (0.01% ethanol), 1nM 1,25(OH)2D3, 10nM 1,25(OH)2D3 and 100nM 
1,25(OH)2D3; (B) Relative alpha-SMA protein expression in scratched dermal fibroblasts after 24 
hours, quantitated by imageJ. Relative protein expression was normalised against vehicle 
control. Data presented as mean of three readings ± SEM. ** Denotes p<0.01 using one-way 
ANOVA.  
